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Abstract 
 
Cellular senescence is a stable cell cycle arrest associated with the secretion of pro-
inflammatory factors, also known as the senescence-associated secretory phenotype (SASP), 
which can act in a paracrine manner and induce senescence in neighbouring cells. Accumulation 
of senescent cells has been shown to contribute to age-associated tissue dysfunction. 
Melanocytes positive for senescence markers have been shown in the skin of middle-aged 
human donors, however, very little is known about the mechanisms underlying melanocyte 
senescence, and their contribution to skin ageing. In this study, I aimed to investigate whether 
telomere dysfunction is a driver of melanocyte senescence, and whether senescent melanocytes 
contribute to skin ageing phenotypes by affecting surrounding cells in a paracrine manner.  
I found that melanocytes bearing dysfunctional telomeres accumulate in human skin with age. 
Importantly, I found that telomere dysfunction occurred independently of telomere length and 
could be induced in vitro as a result of exposure to different stressors. Furthermore, in human 
skin in vivo, I observed that telomeric damage was significantly higher in keratinocytes 
surrounding melanocytes with higher numbers of dysfunctional telomeres, suggesting that 
senescent melanocytes exert a bystander effect in vivo. Consistent with this, I found that 
senescent melanocytes secrete soluble factors which induce telomere dysfunction and repress 
proliferation of dermal fibroblasts in culture. Importantly, I identified that CXCR3, a cell-
surface receptor for the cytokine IP-10, is involved in bystander telomere damage induction. 
Finally, I have shown in three-dimensional human epidermal equivalents that senescent 
melanocytes can induce paracrine telomere damage and senescence in surrounding 
keratinocytes, thereby contributing to epidermal thinning, a characteristic of ageing skin. 
Overall, this study provides evidence that length-independent telomere dysfunction plays a role 
in melanocyte senescence both in vivo and in vitro. Moreover, senescent melanocytes induce 
paracrine DNA damage and senescence in neighbouring cells, and consequently contribute to 
age-associated epidermal changes. 
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Chapter 1: Introduction 
 
 Cellular senescence 
Cellular senescence is characterised by an irreversible cell-cycle arrest, and was first described 
by Hayflick and Moorhead in 1961, who demonstrated that human diploid cells have a finite 
proliferative capacity in vitro, entering a state of terminal arrest following long-term serial 
passaging, a phenomenon also known as “replicative senescence” (Hayflick and Moorhead, 
1961). Despite their inability to proliferate, senescent cells remain metabolically active, and 
undergo a series of dramatic phenotypic changes which will be discussed in further detail 
throughout this chapter.  
This stable loss of proliferative potential is not merely a cell culture artefact, as it was once 
believed by the scientific community (Holliday et al., 1977). In fact, senescence acts as a 
tumour suppressor mechanism by inhibiting proliferation of pre-malignant cells (Serrano et al., 
1997), and more recently, senescent cells have been implicated in many other biological 
processes such as embryonic development (Rajagopalan and Long, 2012; Munoz-Espin et al., 
2013), and wound healing (Jun and Lau, 2010; Demaria et al., 2014). On the other hand, 
senescent cells have been shown to accumulate in a variety of mammalian tissues with age, 
contributing to impaired tissue homeostasis (Campisi and d'Adda di Fagagna, 2007a), and were 
more recently shown to be causal players in age-related pathologies (Baker et al., 2011; Baker 
et al., 2016). Therefore, senescence can be viewed as an example of antagonistic pleiotropy 
(Williams, 1957); a process which is beneficial in early life by promoting development and 
preventing tumour formation, however it later becomes detrimental and contributes to 
organismal ageing.        
 Causes of senescence 
Senescence can be induced by a variety of different stimuli, including telomere dysfunction, 
stressors that lead to extensive DNA damage, and also oncogene activation. In this section, each 
of these triggers will be discussed in detail. 
1.2.1. Telomere dysfunction 
Telomeres are specialised structures present at the ends of linear chromosomes, which are 
critical in maintaining genomic stability (Blackburn, 1991). They consist of tandem 5’-
TTAGGG-3’ repeats, and contain a C-rich lagging strand and a G-rich leading strand, where 
the latter is composed of 3’ single-stranded nucleotide repeats giving rise to the G-overhang 
Chapter 1   Introduction 
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(McElligott and Wellinger, 1997; O'Sullivan and Karlseder, 2010). It has been proposed that 
this 3’-overhang invades upstream double-stranded telomeric regions, and binds to one of the 
DNA strands, forming a structure known as the telomere-loop (T-loop), thereby physically 
protecting the ends of chromosomes from being recognised as double-stranded breaks (DSBs) 
(Griffith et al., 1999; Lin et al., 2014). Telomeres also differ from the rest of the genome by 
associating with a six-subunit protein complex known as shelterin, which is comprised of TRF1, 
TRF2, RAP1, TIN2, TPP1, and POT1 (O'Sullivan and Karlseder, 2010; Sfeir, 2012). Both 
TRF1 and TRF2 bind to double-stranded telomeric sequences, whereas POT1 binds the single-
stranded 3’G-overhang (Zhong et al., 1992; Bianchi et al., 1997; Bilaud et al., 1997; Baumann 
and Cech, 2001). Each shelterin component plays essential roles that are important for telomere 
homeostasis; for example, both TRF1 and TRF2 have been implicated as negative regulators of 
telomere length, as overexpression of either of these proteins resulted in telomere shortening in 
telomerase-positive cells (van Steensel and de Lange, 1997; Smogorzewska et al., 2000). It was 
suggested that both proteins make telomere ends inaccessible to telomerase, the enzyme 
responsible for elongating telomeres, due to their ability to promote t-loop formation, creating 
a physical barrier such that telomerase cannot act on chromosome ends (Smogorzewska et al., 
2000). This is believed to contribute to telomere length homeostasis, preventing excessive 
telomere elongation, a mechanism which is key to maintaining constant telomere length in the 
germline over generations for example, despite high telomerase activity in these cells 
(Smogorzewska et al., 2000). As well facilitating T-loop formation (Stansel et al., 2001), TRF2 
has also been shown to protect telomeres by inhibiting ATM-dependent DNA-damage response 
(DDR) and DNA ligase IV-dependent non-homologous end-joining (NHEJ), thus preventing 
end-to-end fusions and chromosomal instability (van Steensel et al., 1998; Smogorzewska et 
al., 2002; Karlseder et al., 2004; Denchi and de Lange, 2007). It has been suggested that TRF2 
confers protection from NHEJ partly by recruiting its binding partner, RAP1, which alone was 
shown to be sufficient to prevent this repair mechanism (Bae and Baumann, 2007; Sarthy et al., 
2009). In contrast to TRF2, POT1 is responsible for inhibiting ATR-dependent DDR signalling, 
and it also interacts with TRF1 to regulate telomere length (Loayza and De Lange, 2003; Denchi 
and de Lange, 2007). Telomere length homeostasis is also maintained by TPP1, which has been 
shown to directly interact with and recruit telomerase to the ends of chromosomes (Xin et al., 
2007). Moreover, this shelterin protein directly interacts with POT1 and increases its affinity 
for single-stranded telomeric sequences (Lu et al., 2013). Assembly of the shelterin complex is 
also dependent on TIN2, which bridges TRF1 and TRF2, and such interaction is stabilised by 
TPP1, ensuring robust formation of this complex which is crucial for telomere protection 
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(O'Connor et al., 2006). Moreover, TIN2 stabilises TPP1/POT1 complexes on single-stranded 
telomeric sequences, and contributes to effective repression of ATR activation at telomeres 
(Takai et al., 2011). 
Telomere dysfunction can occur as a result of telomere shortening that happens with each round 
of cell division, due to the so called “end-replication problem”. This was first described by 
Olovnikov and Watson in the early seventies, and stems from the inability of conventional DNA 
polymerases to completely replicate the lagging-strand of DNA (Olovnikov, 1971; Watson, 
1972). In order for lagging strand synthesis to occur, RNA primers are inserted where 
polymerases can initiate replication; however, upon removal of the final primer at the 3’ end, 
the newly synthesised strand is shorter than the template by a few nucleotides, leading to loss 
of telomeric repeats with each round of replication. This was later confirmed experimentally by 
reports showing that telomere shortening indeed occurs in human fibroblasts with age, and it 
was suggested that extensive telomere attrition was involved in replicative senescence (Harley 
et al., 1990; Harley, 1991). This idea was then corroborated when a study showed that 
expression of telomerase in normal human cells was sufficient to extend their lifespan in 
culture, implicating telomere shortening as causal in the senescence process (Bodnar et al., 
1998).  
It is believed that extensive telomere attrition results in loss of shelterin components (i.e. 
uncapping), which in turn destabilises the T-loop and exposes the ends of chromosomes, 
subsequently triggering a DDR similar to double-stranded breaks and inducing cell-cycle arrest 
(d'Adda di Fagagna et al., 2003; Takai et al., 2003; Herbig et al., 2004; O'Sullivan and 
Karlseder, 2010). Indeed, inducing uncapping by expressing a dominant-negative allele of 
TRF2 in human fibroblasts has been shown to activate a DDR at telomeres (Takai et al., 2003). 
Telomeres in these cells became associated with DNA damage response factors such as 53BP1, 
Mre11 complex, and phosphorylated forms of ATM, H2AX and Rad17, showing that uncapped 
telomeres resemble DNA breaks (Takai et al., 2003). Moreover, conditional deletion of Pot1a 
in mice was shown to result in telomere deprotection and activation of a DDR at telomeres (Wu 
et al., 2006a). These cells also displayed aberrant homologous recombination (HR) at 
telomeres, and developed a senescent phenotype comparable to replicative senescence, 
supporting the idea that uncapping results in genomic instability and activates downstream 
DDR signalling to induce senescence (Wu et al., 2006a). In accordance to this, telomeres in 
human fibroblasts undergoing replicative senescence have been shown to associate with DDR 
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proteins such as 53BP1, MC1 and NBS1, as well as markers of DSBs such as γH2AX (d'Adda 
di Fagagna et al., 2003).   
Although cellular replication is a main contributor to telomere attrition, other factors can 
influence the rate at which telomeres shorten. For example, it has been widely demonstrated 
that mild oxidative stress accelerates telomere shortening and reduces the proliferative capacity 
of cells, inducing a permanent cell-cycle arrest that resembles replicative senescence (von 
Zglinicki et al., 1995; Xu et al., 2000; von Zglinicki, 2002; Saretzki et al., 2003).  Moreover, 
interventions that result in decreased levels of intracellular peroxide such as overexpression of 
the antioxidant enzyme superoxide dismutase (SOD3) in human fibroblasts or antioxidant 
treatment, reduce the rate of telomere shortening and extend replicative lifespan, reinforcing 
the involvement of reactive oxygen species (ROS) in telomere-dependent senescence (von 
Zglinicki et al., 2000; Serra et al., 2003). In addition, one study has shown that cells with lower 
antioxidant capacity have a shorter lifespan and increased rates of telomere shortening 
compared to cells with a better antioxidant capacity, suggesting that intracellular oxidative 
stress levels is directly related to the rate of telomere shortening (Richter and von Zglinicki, 
2007). Reactive oxygen species derived from mitochondria have also been shown to play a role 
in telomere shortening, as treatment of fibroblasts with MitoQ, a mitochondrial-targeted 
antioxidant, was shown to reduce the rate of telomere shortening and extend proliferative 
capacity under conditions of mild oxidative stress (i.e. hyperoxia) (Saretzki et al., 2003). 
Moreover, reducing mitochondrial ROS production by mild uncoupling of mitochondria slows 
the rate of telomere shortening and extends lifespan of human fibroblasts. On the other hand, 
inducing severe depolarisation by using FCCP, a cyanide analogue that disrupts the 
mitochondrial membrane potential, leads to mitochondrial dysfunction, increased ROS 
production and consequently accelerated telomere shortening (Liu et al., 2002). 
The susceptibility of telomeres to oxidative stress is thought to be a result of their high content 
of guanine triplets, which are extremely prone to oxidative modifications (Oikawa and 
Kawanishi, 1999). In accordance to this, studies demonstrated that mild oxidative stress causes 
single-stranded breaks to preferentially accumulate at telomeres, and this in turn contributes to 
telomere shortening by stalling the replication fork, which results in incomplete replication of 
telomeric DNA (Petersen et al., 1998; von Zglinicki, 2000). Moreover, damage at telomeres 
has been shown to be less efficiently repaired when compared to non-telomeric damage, mainly 
as a consequence of the presence of shelterin components (Kruk et al., 1995). For example, 
proteins such as TRF2 and RAP1 inhibit DNA-PK, a double-stranded break repair complex, 
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preventing NHEJ to occur at telomeres (Bombarde et al., 2010). In agreement with this notion, 
recruitment of ligase IV is impaired if DSBs are induced adjacent to telomeric repeats in 
budding yeast, whereas in mammalian cells a persistent DDR is observed when TRF2 is 
expressed in the vicinity of DSBs, providing further evidence to the irreparability of telomeric 
damage (Fumagalli et al., 2012).  
Although a number of studies have focused on senescence induced by telomere shortening, it 
is now becoming increasingly evident that telomere dysfunction can also occur independently 
of length. For example, a persistent DDR signalling has been shown to occur at telomeres 
irrespectively of length when human fibroblasts in vitro and mouse neurons in vivo were 
exposed to genotoxic stress (Fumagalli et al., 2012; Hewitt et al., 2012). The presence of DNA 
damage proteins at longer telomeres has also been reported during the ageing process in vivo, 
where an increase in length-independent telomere damage was seen in the gut and liver of mice 
with age (Hewitt et al., 2012; Jurk et al., 2014). Moreover, an age-dependent accumulation of 
dysfunctional telomeres has also been shown in hippocampal neurons and liver of baboons 
(Fumagalli et al., 2012), suggesting that such signalling contributes to cellular senescence and 
plays a role in tissue dysfunction during ageing. Length-independent telomere damage has also 
been shown in cells undergoing oncogene-induced senescence, such as in melanocytic nevi, 
and interestingly, some dysfunctional telomeres were still associated with TRF2 (Suram et al., 
2012), suggesting that factors other than shortening and uncapping (i.e. loss of shelterin 
components) may trigger a DDR at telomeres. In accordance to this, telomere dysfunction 
independently of length has also been reported in replicative senescence, where TRF2 and 
RAP1 where still present in a portion of DDR-positive telomeres (Kaul et al., 2011), suggesting 
that DDR activation at telomeres is not always accompanied by the loss of shelterin proteins. 
In contrast to telomere dysfunction arising due to shortening or uncapping, which is usually 
referred to as telomere-induced foci (TIF), stress-induced telomere damage is also known as 
telomere-associated foci (TAF), and has been suggested to occur due to DSBs within telomeric 
regions (Hewitt et al., 2012), although until recently, it was unclear whether activation of a 
DDR indicated physical DNA double stranded-breaks or if it merely represented changes in 
chromatin without an associated lesion. However, it is now possible to identify physical DNA 
breaks by using a new method, which involves DNA damage in situ ligation followed by 
proximity ligation assay. By doing this, it has been demonstrated that acute genotoxic stress 
causes DNA double stranded breaks to occur, both in vitro and in vivo, and these also co-localise 
with DDR proteins (Galbiati et al., 2017). 
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It has been proposed that longer telomeres are more susceptible to DNA damage as they 
represent a more abundant target for lesion formation, thus explaining the occurrence of DDR 
activation independently of telomere length (Fumagalli et al., 2012). In fact, elongating 
telomeres in human cancer cells significantly increases their susceptibility to ionising radiation, 
suggesting that telomeres exceeding a critical length are more prone to accumulating DSBs 
(Fairlie and Harrington, 2015). However, evidence so far does not clearly indicate that longer 
telomeres accumulate more damage than shorter ones. Analysis of individual telomere length 
in melanocytic nevi and in mice have failed to identify a significant difference in length between 
damaged and non-damaged telomeres (Hewitt et al., 2012; Suram et al., 2012). This could be 
a consequence of the low sensitivity of current methods available to measure individual 
telomere length in tissues, whereby very short telomeres are not detected, thus making it 
difficult to identify significant differences in length between dysfunctional and functional 
telomeres.  
It has been proposed that telomeres may exist in three different states, possibly explaining the 
observation that telomeres can signal a DDR in the presence of shelterin components (Cesare 
et al., 2009).  The first is known as the closed or fully capped state, whereby telomeres maintain 
sufficient length such that t-loop conformation remains intact, preventing DDR activation, and 
inhibiting NHEJ due to the presence of shelterin proteins. However, if T-loop conformation is 
lost, telomeres may adopt an intermediate state, where a DDR is activated but sufficient levels 
of shelterin proteins are still maintained to prevent end-to-end fusions. This may occur in a 
length-dependent and –independent manner, explaining how telomeres that are not critically 
short and still contain shelterin proteins can accumulate damage. Lastly, the fully uncapped 
state occurs when the T-loop is completely lost due to extensive telomere erosion. This results 
in loss of shelterin components, such that a DDR is activated and NHEJ is no longer inhibited, 
leading to end-to-end fusions (Cesare et al., 2009). 
In summary, it is now evident that telomeres play a much more intricate role in modulating 
DNA damage responses in senescence, and do not simply act as “mitotic clocks”. Instead, they 
serve as sensors of stress and damage, and maintain genomic stability by limiting proliferation 
of cells which have accumulated extensive genomic damage.  
1.2.2. Non-telomeric DNA damage 
DNA damage signalling occurring at non-telomeric regions has also been shown to be involved 
in the senescence growth arrest. In fact, half of DNA damage foci have been shown to be located 
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in genomic sites other than telomeres, and despite being short-lived, these are constantly 
renewed during senescence (Passos et al., 2010; Hewitt et al., 2012). This is likely a result of 
increased ROS production in senescent cells, as inhibition of ROS leads to a rescue in the 
proliferation arrest in a fraction of cells (Passos et al., 2010). Double-stranded breaks usually 
occur as a result of acute and severe stresses, such as ionising radiation, and these are very 
effective in inducing senescence (Di Leonardo et al., 1994). Other DNA damage-inducing 
agents include chemotherapeutic drugs, such as bleomycin, which has been shown to induce 
senescence in both normal and tumour cells (Robles and Adami, 1998; te Poele et al., 2002). 
The latter is also known as drug-induced senescence, and it is now being used as a possible 
cancer therapy (Schmitt et al., 2002; Roninson, 2003). Exposing cells to hyperoxia, which leads 
to an increase in intracellular ROS, has also been shown to cause single-stranded and double-
stranded breaks, leading to a persistent DDR and inducing senescence (Roper et al., 2004). 
Moreover, UVB irradiation, which as well as causing DNA breaks also induces highly 
carcinogenic lesions such as cyclobutane-pyrimidine dimers (CPD), has been shown to induce 
premature senescence in human keratinocytes in vitro (Lewis et al., 2008). Although it is 
thought that the aforementioned stressors induce senescence independently of telomeres, as 
telomerase overexpression does not rescue irradiation-induced senescence (Hewitt et al., 2012), 
it is possible that DDR signalling at telomeres contributes to the persistence of the arrest.   
1.2.3. Oncogene-induced senescence 
Oncogene-induced senescence (OIS) occurs as a result of oncogene activation, which involves 
mutations in specific genes that predispose cells to become cancerous. This phenomenon was 
first reported by studies showing that expression of oncogenic RAS, a transducer of mitogenic 
signals, resulted in a permanent cell-cycle arrest in mouse and human fibroblasts, which was 
also accompanied by an increase in p16 and p53, and was phenotypically identical to cellular 
senescence (Serrano et al., 1997). Since then, other genes involved in the RAS signalling 
pathway have also been implicated in OIS, such as RAF, MEK, and BRAF (Lin et al., 1998; 
Michaloglou et al., 2005). It has been suggested that oncogene activation causes DNA 
replication stress, leading to stalling of replication forks, ultimately triggering a DDR (Bartkova 
et al., 2006; Di Micco et al., 2006). Inhibition of a DDR was shown to prevent induction of 
senescence as well as allowing RAS-induced senescent cells to resume proliferation, suggesting 
that DDR signalling is important for both induction and maintenance of OIS (Bartkova et al., 
2006; Di Micco et al., 2006). It has also been shown that telomere damage plays a role in cells 
undergoing OIS (Suram et al., 2012). Cells overexpressing telomerase, which prevents 
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telomeric DDR foci formation in response to oncogene activation, were able to bypass growth 
arrest, indicating that telomere dysfunction is also important to reinforce oncogene-induced 
senescence (Suram et al., 2012). Moreover, accumulation of damage at telomeres has also been 
shown in cancer precursor lesions, such as human melanocytic nevi, ductal breast hyperplasia, 
and colonic adenoma, suggesting that activation of a DDR at telomeres is also important in vivo 
as a tumour-suppressor mechanism (Suram et al., 2012). 
1.2.4. Epigenetic modifications 
Transcriptional activity of genes is regulated by modifications in chromatin structure, which 
can be either organised into heterochromatin (i.e. compressed) or euchromatin (loosely packed). 
Whereas the latter is normally associated with transcriptionally active genes, heterochromatin 
results in gene silencing, and such chromatin organisation is controlled by posttranslational 
modifications of histones, such as acetylation and methylation (Schulz and Tyler, 2005). Early 
studies showed that treating human fibroblasts with histone deacetylase inhibitors (HDACi), 
which stimulate chromatin relaxation, resulted in a senescence-like growth arrest, providing 
evidence that changes in chromatin were involved during the senescence process (Ogryzko et 
al., 1996). In contrast, it was later reported that senescent human fibroblasts accumulated foci 
of transcriptionally inactive DNA that were associated with heterochromatin markers, such as 
hypoacetylated histones (histone H3 methylated on lysine 9) and the heterochromatin protein 
HP1 (Narita et al., 2003). These were termed senescence-associated heterochromatic foci 
(SAHF), and were suggested to be important for the stable proliferation arrest by repressing 
transcription of E2F target genes that promote progression through the cell cycle (Narita et al., 
2003). It has also been shown that SAHF are enriched in the histone H2A variant, macroH2A, 
which is known to be transcriptionally repressive, and its formation involves the activity of 
histone chaperones, Asf1a and HIRA, which are responsible for the development of 
transcriptionally inactive heterochromatin in yeast, flies and plants (Zhang et al., 2005; Adams, 
2007). Moreover, SAHF formation relies on the Rb pathway, which was suggested to be due to 
the ability of Rb to promote nucleation of heterochromatin at specific areas in the genome, 
which are then propagated with the help of histone methyltransferases and recruitment of HP1 
proteins (Narita et al., 2003). The latter are capable of forming dimers, facilitating the 
development of high order chromatin structures (Brasher et al., 2000; Nielsen et al., 2001). 
Ultimately, heterochromatin organisation during senescence contributes to a permanent cell 
cycle arrest by silencing genes required for proliferation. In accordance to this, down-regulation 
of the histone acetyltransferase p300/CBP, which results in heterochromatin formation, has 
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been reported in senescent human melanocytes (Bandyopadhyay et al., 2002). The observation 
that senescence can be induced by both chromatin relaxation, as in the case of HDACi-induced 
senescence, and by heterochromatin formation is contradictory; however it has been suggested 
that they both cause dramatic but incomplete changes in chromatin organisation, altering 
expression of different important genes, and the outcome might vary between cell types 
(Campisi and d'Adda di Fagagna, 2007a).  
 Senescence signalling pathways 
The majority of senescence-triggering stimuli activate the DNA damage response, as shown in 
stress-induced (Hewitt et al., 2012), oncogene-induced (Suram et al., 2012) and replicative 
senescence (d'Adda di Fagagna et al., 2003). In turn, the p53-p21 and p16-pRb pathways are 
activated, which then establish and maintain the senescence growth arrest (Figure 1.1). 
Although these pathways interact to some extent, they are activated in response to different 
stimuli, and the ability of each pathway to induce senescence is cell-type and species-specific 
(Campisi and d'Adda di Fagagna, 2007a).  
1.3.1. The DNA damage response 
Activation of a DDR follows as a result of both telomeric and non-telomeric DNA damage, and 
the recognition of lesions and subsequent repair mechanism can differ depending on the type 
of damage. In general, proteins of the phosphatidylinositol 3-kinase-like protein kinase (PIKK) 
family, such as ATM, ATR and DNA-PK, and members of the poly(ADP-ribose) polymerase 
(PARP) family mediate a DDR signal transduction (Ciccia and Elledge, 2010). Double-stranded 
breaks are primarily recognised by ATM and DNA-PK, where the latter controls proteins 
involved in non-homologous end joining (Meek et al., 2008; Ciccia and Elledge, 2010). On the 
other hand, ATR is activated in response to single-stranded breaks that may occur as a result of 
stalled replication forks, although it has also been implicated in DSB signalling (Cimprich and 
Cortez, 2008). In addition, PARP1 and PARP2 have also been shown to be involved in both 
SSB and DSB repair, and are important for the recruitment of other DDR proteins to the site of 
damage by catalysing the addition of poly(ADP-ribose) chains on specific proteins (Schreiber 
et al., 2006).  
Double-stranded breaks are initially recognised by the MRE11-RAD50-NBS1 (MRN) 
complex, which then recruits ATM via the C-terminus of NBS1 (van den Bosch et al., 2003; 
Falck et al., 2005; d'Adda di Fagagna, 2008). This is followed by autophosphorylation of ATM, 
which triggers dissociation of the inactive protein dimer, activating ATM kinase activity 
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(Bakkenist and Kastan, 2003). Upon activation, ATM then phosphorylates a range of target 
proteins at the site of damage, including the histone variant H2A.X at serine 139, giving rise to 
phosphorylated H2A.X (γH2A.X) (Rogakou et al., 1998; Rogakou et al., 1999). The phospho-
specific domain of MDC1 (mediator of DNA damage checkpoint 1) then recognises the 
phosphorylated form of H2A.X, and MDC1 stimulates further recruitment of the MRN 
complex. This results in a positive feedback loop such that local ATM activity is amplified and 
γH2A.X is spread to adjacent areas from the initial site of damage, where the latter can be 
visualised as discrete nuclear foci (Rogakou et al., 1999; Stucki and Jackson, 2006). The 
exposure of modified histone residues has also been shown to recruit the DNA-damage 
mediator 53BP1 to sites of damage, which helps maintain the DDR by interacting with MDC1  
(Huyen et al., 2004; Eliezer et al., 2009).  
In contrast, single-stranded breaks, such as those caused by UV exposure or stalled replication 
forks in response to replication stress, are coated by the single-stranded DNA-binding protein 
RPA (replication protein A), which triggers recruitment of ATR (Cortez et al., 2001). In 
addition, ssDNA coated with RPA can also be formed during the end resection of DSBs, leading 
to activation of ATR (Cimprich and Cortez, 2008). ATR then binds to RPA-coated ssDNA via 
interactions with ATR-interacting protein (ATRIP), and this recruits the 9-1-1 complex 
(composed of RAD9, RAD1 and HUS1) and TOPBP1, which are important for promoting and 
amplifying ATR kinase activity (Kumagai et al., 2006; Cimprich and Cortez, 2008; d'Adda di 
Fagagna, 2008).  
An increase in local ATM and ATR activities above a certain threshold level is crucial to 
activate other DDR factors that act distantly from the initial site of damage (d'Adda di Fagagna, 
2008). For example, the checkpoint kinases Chk1 and Chk2 freely diffuse through the nucleus 
upon phosphorylation by ATR and ATM, respectively, and are then able to spread DDR 
signalling through the nucleus by phosphorylating their downstream targets (Lukas et al., 2003; 
Buscemi et al., 2004; Bekker-Jensen et al., 2006). It is important to note that Chk1 and Chk2 
can be phosphorylated by both ATM and ATR, and that their selective substrate specificity was 
shown to be dependent on the type of DNA damage inducing agent (Helt et al., 2005). 
Ultimately, phosphorylated Chk1 and Chk2 act on downstream targets that are involved in cell 
cycle progression, such as cell-division cycle 25 (CDC25) phosphatases and the tumour 
suppressor protein p53 (d'Adda di Fagagna, 2008). Phosphorylation of CDC25, a phosphatase 
required for G1-S phase progression, induces its rapid degradation and thus cell cycle arrest in 
response to DNA damage (Mailand et al., 2000). Moreover, phosphorylation of p53 at Ser-15 
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and Ser-20 by Chk2 and ATM, respectively, leads to dissociation of p53 from its negative 
regulator HDM2, which in turn stabilises p53 and promotes its ability to induce transcription 
of the cyclin-kinase inhibitor p21, again inducing cell-cycle arrest (Di Leonardo et al., 1994; 
Turenne et al., 2001; Campisi and d'Adda di Fagagna, 2007a; d'Adda di Fagagna, 2008). In 
summary, checkpoint kinases are key components of the DDR signalling pathway which 
transduce the DDR into cell cycle-arrest in order to allow cells to repair DNA damage. If 
damage remains unrepaired, this results in persistent DDR signalling and senescence-associated 
growth arrest. Importantly, such persistent DDR signalling has been observed at telomeres in 
cells undergoing replicative (d'Adda di Fagagna et al., 2003), stress- (Hewitt et al., 2012) and 
oncogene-induced senescence (Suram et al., 2012), with one study reporting persistent 
telomeric damage in vivo in mouse hippocampal neurons even after three months after exposure 
to genotoxic stress (Fumagalli et al., 2012). Therefore, unrepaired telomeres are thought to be 
a significant source of persistent DNA damage signalling which is involved in the establishment 
of senescence.   
1.3.2. p53-p21 pathway 
Generally, stimuli that activate a DDR induce senescence mainly through the p53 pathway 
(Campisi and d'Adda di Fagagna, 2007a). The p53 protein is a tumour suppressor and 
coordinates antiproliferative cellular responses in response to stress-inducing stimuli. 
Activation of p53 in response to signals such as DNA damage, oncogene activation or hypoxia, 
will then trigger apoptosis, transient cell-cycle arrest or senescence (Zilfou and Lowe, 2009). 
The fate adopted by the cell in response to p53 activation is context-dependent, and can vary 
depending on a number of factors, including cell type and microenvironment (Zilfou and Lowe, 
2009). Under normal conditions, p53 is maintained at low levels by its interaction with the E3 
ubiquitin protein ligase human double minute 2 (HDM2), which both inhibits the ability of p53 
to activate transcription of target genes and also targets it for degradation (Haupt et al., 1997). 
Upon DDR activation, p53 undergoes a series of post-translational modifications, which 
contribute to its stabilisation (Zilfou and Lowe, 2009). For example, ATM has been shown to 
phosphorylate p53 at Ser15 in response to ionising radiation (Banin et al., 1998), whereas ATR 
phosphorylates both Ser15 and Ser37 in cells exposed to UV light (Tibbetts et al., 1999). 
Moreover, Chk1 and Chk2 phosphorylate p53, and such phosphorylation events prevents 
binding of HDM2, stabilising p53, and allowing it to regulate transcription of its target genes 
(Chehab et al., 2000; Shieh et al., 2000; Zilfou and Lowe, 2009). One major downstream target 
of p53 is the cyclin-dependent kinase inhibitor (CDKi) p21, which physically interacts with 
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cyclin-CDK2, -CDK1, and –CDK4/6 complexes, as well as inhibiting PCNA, thus preventing 
progression through the cell cycle during the G1 and S phases (Stein et al., 1999; Georgakilas 
et al., 2017). Moreover, p21 can also inhibit CDKs that target the RB tumour suppressor protein, 
which then inhibits E2F, a transcription factor that regulates expressions of proliferation genes 
(Zilfou and Lowe, 2009). Indeed, p21-deficient mouse embryonic fibroblasts (MEFs) have been 
shown to bypass senescence in response to DNA damage (Brugarolas et al., 1995). 
Additionally, Chk2 inactivation results in decreased p21 expression and extends the replicative 
lifespan of human fibroblasts, consistent with the observation that p53 fails to be activated in 
response to both telomere erosion and DNA damage (Gire et al., 2004). Therefore, these studies 
support the importance of the p53-p21 pathway to the stable senescence-growth arrest. 
1.3.3. p16-pRb pathway 
The p16-pRb pathway is also important for cell-cycle arrest in response to DNA damage 
inducing stimuli. The cyclin-dependent kinase inhibitor p16 binds to CDK4/6, thus inhibiting 
its kinase activity and preventing Rb phosphorylation. In turn, Rb remains bound to the 
transcription factor E2F1, promoting its nuclear exclusion, thus preventing transcription of 
E2F1 target genes, which are necessary for the G1/S transition (Rayess et al., 2012). Although 
this pathway is generally thought to act secondary to the activation of p53, some cell types 
primarily induce p16 to promote growth arrest. For example, inactivation of the p16-pRb 
pathway together with induction of telomerase activity are both necessary to achieve 
immortalisation of human epithelial cells, which was shown to be independent of p53 
expression (Kiyono et al., 1998). However, studies so far have provided conflicting data on the 
involvement of p16 in telomere-induced senescence. It has been shown that p16 can be 
activated independently of telomere dysfunction in human fibroblasts (Herbig et al., 2004). On 
the other hand, deletion of p16 in Wrn-deficient mice, which lack a protein needed for efficient 
telomere replication and thus have dysfunctional telomeres, rescued proliferation of MEFs 
(Zhang et al., 2012). DDR signalling that occurs upon expression of the telomere damaging 
protein TRF2(ΔBΔM), which induces uncapping, was partially attenuated by p16 deletion in 
MEFs isolated from Wrn knock out mice, as well as preventing these cells and wild-type MEFs 
from undergoing senescence (Zhang et al., 2012). Therefore, these data implicate p16 as an 
important contributor to telomere dysfunction-induced growth arrest (Zhang et al., 2012). 
Moreover, inducing acute telomere damage by expressing a dominant-negative allele of TRF2 
in human fibroblasts resulted in increased p16 expression (Jacobs and de Lange, 2004). 
Although p16 deficiency in these cells only partially rescued growth arrest induced by telomere 
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dysfunction, proliferation was almost completely restored when both p16 and p53 were 
inhibited, suggesting that p16 may act as a second barrier to inhibit proliferation following 
telomere dysfunction (Jacobs and de Lange, 2004). In accordance to this, it has been 
demonstrated that cell-cycle arrest induced by telomere damage is primarily maintained by p53 
and can be rescued by inhibiting this transcription factor (Beausejour et al., 2003). It was shown 
that cells with low levels of p16 at senescence resumed proliferation upon p53 inhibition, 
whereas proliferation arrest of cells with high levels of p16 could not be reversed upon p53 
inactivation, suggesting that the p16-pRb pathway provides a second barrier to cell-cycle 
progression (Beausejour et al., 2003). Interestingly, cells that fully engage in the p16-pRb 
pathway for several days do not resume proliferation even after p16 or pRb inactivation 
(Beausejour et al., 2003). Overall, it is evident that both the p53 and p16 pathways play an 
important role in reinforcing senescence, however the extent of their contribution varies 
amongst different cell types. In addition, the kinetics of each pathway has been shown to differ 
during the senescence process. Levels of p21 were highest at the early stages of growth arrest 
and then declined, whereas p16 levels gradually increased and remain high in senescent 
fibroblasts, suggesting that p16 upregulation is crucial in the final stages of the senescence cell-
cycle arrest (Alcorta et al., 1996). Although the mechanism by which p16 expression is induced 
upon senescence-causing stimuli is not fully understood, it is possible that a DDR activates p38 
MAPK signalling, which in turn upregulates p16 (Bulavin et al., 2004; Wood et al., 2009; 
Spallarossa et al., 2010) Other triggers of the p16 pathway include oncogenic RAS, which was 
also shown to upregulate p16 expression through the activation of Ets1 and Ets2 transcription 
factors (Serrano et al., 1997; Ohtani et al., 2001). The latter are known downstream targets of 
Ras-Raf-MEK signalling, and have been shown to induce p16 expression by binding to a 
conserved ETS-binding site at the p16INK4a promoter (Ohtani et al., 2001) 
The p16-pRb pathway is also important for the generation of SAHF, as previously discussed 
(Narita et al., 2003). Once established, SAHF can be self-maintained, which is likely due to the 
ability of pRb to interact with histone-modifying enzymes that form repressive chromatin 
(Narita et al., 2003; Macaluso et al., 2006). Moreover, the p16-pRb pathway has been shown 
to act together with mitogenic signals to increase intracellular ROS in senescent cells. This in 
turn activates protein kinase C delta (PKCδ), which promotes further production of ROS, 
resulting in a positive feedback loop between ROS and PKCδ. It was suggested that sustained 
activation of such signalling contributes to the irreversible cell-cycle arrest partly by reducing 
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the levels of WARTS, a mitotic exit network (MEN) kinase which is required for cytokinesis, 
thus blocking this process (Takahashi et al., 2006).   
1.3.4. p38 MAPK pathway 
Mitogen activated protein kinases (MAPKs) mediate signalling to various biological processes, 
and consist of a family of proteins including ERK, JNK and p38. For example, cell proliferation 
is usually controlled by the Erk pathway, whereas the JNK and p38 pathways are activated by 
cellular stresses such as ROS, UV light exposure, X-rays and inflammatory cytokines (Chang 
and Karin, 2001). Activation of the p38 MAPK signalling has been shown to contribute to the 
senescence-growth arrest by activating both the p53-p21 and p16-pRb pathways (Lin et al., 
1998). Indeed, p38 activation is crucial for oncogenic RAS-induced senescence (Wang et al., 
2002), which acts through the Raf-MEK-ERK pathway to induce a permanent cell-cycle arrest 
(Zhu et al., 1998). Consistent with this, constitutively active mutants of Raf-1 and MEK1 have 
been shown to induce senescence, whereas inhibiting this pathway delays the onset of 
senescence (Lin et al., 1998; Shin et al., 2013). Induction of the ERK pathway then leads to 
downstream activation of MKK3/6 which mediates p38 activation, although the mechanism by 
which this occurs is not fully understood (Xu et al., 2014b). One possibility is that ROS 
mediates the connection between MEK-ERK and MKK3/6-p38, since Ras activation leads to 
an increase in ROS, and the latter has been shown to activate p38 (Nicke et al., 2005; Zdanov 
et al., 2006). It is also possible that hyper-proliferation induced by MEK-ERK activation causes 
DNA damage which is known to activate p38, leading to senescence (Wang et al., 2000; 
Bartkova et al., 2006; Di Micco et al., 2006). Moreover, p38 activation has also been implicated 
in telomere-dependent senescence, such that p38 inhibition increased replicative lifespan of 
fibroblasts in culture (Iwasa et al., 2003). Finally, p38 has also been linked to the stability of 
senescence through a positive-feedback loop where activation of a DDR acts through signalling 
pathways that involve p38MAPK (Passos et al., 2010). This ultimately leads to increased 
mitochondrial ROS production, which replenishes DNA damage foci, and stabilises the 
senescence growth arrest through continuous activation of p21 (Passos et al., 2010).  
Moreover, activation of p38 has also been shown to drive T cell senescence, and thus plays a 
role in the decline of immune function with ageing (Henson et al., 2014; Lanna et al., 2014). It 
was demonstrated that senescent CD4+ T cells exhibited increased p38 phosphorylation, which 
occurred as a result of DDR-dependent AMPK activation (Lanna et al., 2014). In turn, AMPK 
forms a complex with the scaffold protein TAB1, which then recruits p38 and stimulates its 
autophosphorylation, leading to decreased proliferation and telomerase activity of T cells 
Chapter 1   Introduction 
15 
 
(Lanna et al., 2014). Moreover, enhanced p38 activity was shown to contribute to CD8+ T cell 
senescence by inhibiting autophagy in an mTORC1-independent manner (Henson et al., 2014). 
It was shown that p38 inhibition increased autophagy in these cells, thus increasing the 
availability of metabolic precursors, and providing the energy necessary to resume proliferation 
of senescent CD8+ T cells (Henson et al., 2014). 
Overall, a number of stimuli culminate in activation of the p38MAPK pathway, which can then 
drive senescence through regulation of downstream pathways that ultimately affect cell-cycle 
progression. 
1.3.5. mTOR signalling 
The mammalian target of rapamycin (mTOR) is a protein kinase that belongs to the PI3KK 
family that plays a role as a nutrient and energy sensor and coordinates cellular responses such 
as cell growth and metabolism (Xu et al., 2014a). There are two conserved TOR complexes, 
which are known as mTORC1 (TOR complex 1) and mTORC2 (TOR complex 2), and these 
are distinguished through their association with different adaptor proteins, namely Raptor and 
Rictor, respectively (Xu et al., 2014a). These two complexes have distinct roles within the cell, 
with mTORC1 being the most well characterised between the two. It has been shown that 
mTORC1 is the main mediator of nutrient signalling, and it also converts signals from growth 
factors, stress and energy availability into cellular responses such as protein synthesis, lipid 
biosynthesis, glucose metabolism and autophagy (Johnson et al., 2013). mTORC1 then acts via 
downstream effectors, such as ribosomal protein S6 kinases (S6Ks) and eukaryotic translation 
initiation factor 4E-binding protein 1 (4E-BP1), which are involved in regulation of translation 
initiation (Xu et al., 2014a). On the other hand, mTORC2 is poorly characterised, however it 
has been implicated in spatial organisation of cytoskeleton, which interacts with the mTORC1 
machinery to increase cytoplasmic volume (Xu et al., 2014a). 
Emerging data now implicates mTOR in the senescence process. It has been shown that 
continuous mTOR activity is required for the permanent cell-cycle arrest associated with 
senescence in cells overexpressing p21 (Demidenko and Blagosklonny, 2008). Serum 
starvation or treatment with rapamycin, which inhibits mTORC1, decreased the expression of 
senescence markers. Interestingly, p21-arrested cells in the absence of serum, where mTOR 
activity is low, were capable of resuming proliferation when p21 was no longer induced, 
whereas in the presence of serum, cells were irreversibly arrested. This suggests that a 
permanent proliferation arrest in response to p21 overexpression is dependent of continuous 
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mTOR activity (Demidenko and Blagosklonny, 2008). Studies have also demonstrated that 
rapamycin treatment can attenuate the senescent phenotype of fibroblasts treated with the DNA 
damaging agent, doxorubicin (DOX) (Demidenko and Blagosklonny, 2008). This has also been 
observed in human fibroblasts undergoing either OIS or replicative senescence, whereby 
treatment with rapamycin not only increased replicative lifespan of these cells but also 
attenuated several phenotypes associated with senescence, such as Sen-β-Gal activity, and 
expression of p21 and IL-8 (Kolesnichenko et al., 2012). Similar observations have been 
reported in rat embryonic fibroblasts (Pospelova et al., 2012). Consistently, constitutive Wnt1 
activation, which was shown to activate mTOR, induces premature senescence in mouse 
keratinocytes, and contributes to loss of the epidermal stem cell compartment, and progressive 
hair loss in mice. This phenotype was partially rescued by rapamycin treatment, providing 
further evidence that decreasing mTOR activity by using rapamycin can decelerate cellular 
senescence (Castilho et al., 2009). More recently, mTOR has been shown to integrate signals 
downstream of a DDR, whereby ATM induces Akt phosphorylation and mTORC1 activity, 
which in turn promotes PGC-1β-dependent mitochondrial biogenesis (Correia-Melo et al., 
2016). Consequently, this contributes to increased ROS generation, which generates further 
DNA damage, maintaining a DDR as part of a positive feedback loop that contributes to the 
senescent phenotype (Correia-Melo et al., 2016).  
Moreover, mTOR has been shown to regulate NF-κB activity, a transcription factor responsible 
for regulating genes involved in the pro-inflammatory phenotype of senescent cells (Dan et al., 
2008; Chien et al., 2011b; Laberge et al., 2015). It has been demonstrated that mTOR indirectly 
affects NF-κB activity by regulating translation of the pro-inflammatory cytokine IL-1α 
(Laberge et al., 2015). Activation of IL-1 receptor (IL-1R) signalling by IL-1α activates kinases 
such as interleukin-1 receptor-associated kinase 1 (IRAK1), which ultimately enhances the 
transcriptional activity NF-κB (Orjalo et al., 2009). The latter then induces the expression of 
pro-inflammatory genes, such as IL-6 and IL-8; therefore, IL-1α is an important positive 
regulator of IL-6 and IL-8 expression by regulating NF-κB in senescent cells (Orjalo et al., 
2009). Indeed, inhibition of mTOR by rapamycin treatment has been shown to diminish 
translation of IL-1α, and supress secretion of a number of pro-inflammatory cytokines, 
including IL-6, suggesting that mTOR is involved in controlling the senescence-associated 
secretory phenotype (SASP) (Laberge et al., 2015). Moreover, mTORC1 can also directly 
interact with components involved in NF-κB signalling, such as IKKα, promoting 
phosphorylation of IκB and RelA/p65 subunit, which is associated with increased 
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transcriptional activity of NF-κB (Dan et al., 2008). mTOR has been also been shown to 
regulate the SASP by promoting translation of the MK2 kinase (Herranz et al., 2015). The latter 
then phosphorylates the RNA-binding protein ZFP36L1, a Zn-finger protein responsible for 
destabilising mRNAs, and by doing so, stabilises the transcripts of many SASP factors in 
senescent cells (Herranz et al., 2015). Therefore, mTOR is a major regulator of the SASP during 
senescence.  
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Figure 1.1 - The DNA damage response and downstream senescence effector pathways. 
The majority of stimuli that induce senescence, such as telomere dysfunction and DNA damage, 
trigger a DNA damage response (DDR). This involves phosphorylation and activation of ATM 
and ATR kinases, which then phosphorylate the histone variant H2AX, giving rise to γH2AX 
foci. Phosphorylation of downstream kinases ultimately results in activation of the p53-p21 and 
p16-pRb pathways. Induction of p53 induces a senescence-associated growth arrest by 
increasing the expression of the cyclin-dependent kinase (CDK) inhibitor p21, which prevents 
phosphorylation and thus inactivation of pRb. DDR signalling can also activate p16, which is 
also a CDK inhibitor, and inhibits pRb inactivation. pRb remains associated with E2F, 
inhibiting the activity of this transcription factor regulates expression of genes required for cell-
cycle progression. Moreover, ATM can promote mTORC1 activity, which induces PGC-1β 
dependent mitochondrial biogenesis, leading to increased ROS generation, which generates 
further DNA damage, maintaining the DDR. 
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 Senescence phenotype 
Cellular senescence is accompanied by many phenotypic changes, including apoptosis 
resistance, altered gene expression, increased ROS production, and secretion of pro-
inflammatory factors (Campisi and d'Adda di Fagagna, 2007a). These features will be discussed 
in more detail in the sections below. 
1.4.1. Growth arrest 
Senescence is characterised by a stable arrest in the cell cycle, which is the result of continuous 
expression of key cell-cycle inhibitors, as previously mentioned. Despite their inability to 
divide, senescent cells remain metabolically active (Campisi and d'Adda di Fagagna, 2007a). 
Senescence growth arrest usually occurs with a DNA content typical of G1 phase, which is the 
case in most mouse and human fibroblasts (Di Leonardo et al., 1994; Herbig et al., 2004). 
However, cells have also been shown to arrest in other stages of the cell cycle, which appears 
to vary according to cell type and the nature of the senescence-inducing stimuli. For example, 
mouse fibroblasts with a defect in the stress-signalling kinase MKK7 were shown to arrest at 
G2/M phase (Wada et al., 2004). Similarly, oncogene activation can also trigger G2 growth 
arrest (Zhu et al., 1998; Di Micco et al., 2006). Nonetheless, the senescence growth arrest is 
deemed to be permanent, since senescent cells cannot be stimulated to re-enter the cell cycle by 
known physiological stimuli (Campisi and d'Adda di Fagagna, 2007a).   
1.4.2. Apoptosis resistance 
Similarly to senescence, apoptosis is a controlled and extreme response to stress, and also serves 
as a tumour-suppressor mechanism (Green and Evan, 2002). It is not clear what determines a 
cell to undergo senescence over apoptosis, and vice-versa, although different cell types appear 
to preferentially adopt different fates in response to damaging stimuli. For example, fibroblasts 
and epithelial cells usually become senescent upon damage, whereas lymphocytes normally 
undergo apoptosis (Campisi and d'Adda di Fagagna, 2007a). The type and intensity of stress 
are also important determinants of cellular response. For example, low doses of doxorubicin 
induces senescence, whereas high doses leads to apoptosis in rat cardiomyocytes (Spallarossa 
et al., 2009). Consistently, exposure to low doses of UVB irradiation causes skin fibroblasts 
and keratinocytes to become senescent, and apoptosis occurs at high doses (Kuhn et al., 1999; 
Debacq-Chainiaux et al., 2005). Other DNA damaging drugs, such as the alkylating agent 
busulfan, induces senescence, but not apoptosis, in fibroblasts in a dose-independent manner 
(Probin et al., 2006). Moreover, cell fate is also likely controlled by the balance between pro-
senescent and pro-apoptotic pathways, which is controlled by their common regulator, p53. For 
Chapter 1   Introduction 
20 
 
example, MEFs expressing a mutant version of p53 that impairs p53-dependent apoptosis, 
preferentially senescence in response to UVB exposure (Tavana et al., 2010). These cells also 
failed to upregulate pro-apoptotic factors such as PUMA and NOXA, and expressed high levels 
of the pro-survival gene BCL-2 (Tavana et al., 2010). H2O2 treatment at levels which induced 
both apoptosis and senescence in human fibroblasts caused an increase in p53, and p53 levels 
were 2-fold higher in apoptotic compared to senescent cells (Chen et al., 2000). Other factors 
involved in determining cell fate also include the kinetics of p53 expression, as it was shown 
that low level of γ-irradiation induces a transient rise in p53 levels, which results in a transient 
cell-cycle arrest followed by recovery. On the other hand, preventing p53 degradation by 
Nutlin-3a treatment, which inhibits MDM-2, results in high and stable levels of p53, and 
promotes senescence (Purvis et al., 2012). In agreement with this, stabilising p53 by Nutlin-3a 
treatment induces senescence in MEFs exposed to oxidative stress, with no evidence of 
apoptosis (Efeyan et al., 2007). Therefore, p53 appears to be an important regulator of cell fate 
in response to damage.  
The majority of senescent cells become resistant to apoptosis, such as senescent human 
fibroblasts which are resistant to ceramide-induced apoptosis. However, this is not seen across 
all cell types, as senescent endothelial cells were shown to undergo apoptosis in response to the 
same stimulus (Hampel et al., 2004). Resistance to apoptotic stimuli might be one of the reasons 
senescent cells can remain in culture for prolonged periods of time, and could also partly explain 
the increase in senescent cells with age (Campisi and d'Adda di Fagagna, 2007a). However, the 
mechanisms that contribute to apoptosis resistance are not fully understood. It has been shown 
that senescent cells fail to stabilise p53 in response to DNA damage, which contributes to their 
inability to undergo p53-dependent apoptosis (Seluanov et al., 2001). Moreover, evidence 
suggests that chromatin modifications contributes to apoptosis resistance of senescent cells by 
altering the expression levels of the anti-apoptotic gene, Bcl-2, and the pro-apoptotic gene, Bax 
(Sanders et al., 2013). It has also been shown that in response to DNA damaging stimuli, p53 
preferentially promotes expression of growth arrest genes rather than apoptosis regulators in 
senescent human fibroblasts, offering another mechanism through which senescent cells 
acquire resistance to apoptosis (Jackson and Pereira-Smith, 2006). 
1.4.3. Changes in gene expression  
Senescent cells display vast changes in gene expression, often related to genes that regulate 
cell-cycle progression (Yoon et al., 2004; Jackson and Pereira-Smith, 2006; Trougakos et al., 
2006). For example, the CDKIs p21 and p16 are usually highly expressed in senescent cells, 
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and these are responsible for establishing and maintaining the growth arrest by inhibiting pRb 
phosphorylation and thus promoting its activity, as previously discussed (Di Leonardo et al., 
1994; Alcorta et al., 1996; Herbig et al., 2004). In addition, genes that stimulate proliferation, 
such as c-FOS, cyclin A, cyclin B and PCNA, are often repressed in senescent cells (Seshadri 
and Campisi, 1990; Stein et al., 1991; Pang and Chen, 1994). Expression of some of these genes 
is repressed since E2F, the transcription factor responsible for inducing them, is inhibited by 
pRb. Moreover, as previously mentioned, pRb has also been implicated in the formation of 
SAHF, which play a role in silencing E2F target genes (Narita et al., 2003). Interestingly, 
senescent cells also overexpress genes that encode secreted proteins, such as extracellular 
matrix (ECM) degrading proteins, pro-inflammatory cytokines and growth factors (Shelton et 
al., 1999). This is known as the senescence-associated secretory phenotype, and will be 
discussed in more detail below.  
1.4.4. Senescence markers 
Senescent cells can be identified by many markers in culture and in vivo, although the markers 
identified so far are not strictly specific for senescent cells. Since a hallmark of senescence is 
the loss of replicative potential, a commonly used marker to detect lack of DNA replication is 
5-bromodeoxyuridine (BrdU) or 3H-thymidine incorporation. Loss of proliferation can also be 
detected by immunostaining for proteins such as PCNA and Ki-67 (Lawless et al., 2010). 
However, these markers also identify quiescent or differentiated post-mitotic cells.  
Another marker that is widely used to identify senescent cells is senescence-associated β-
galactosidase (Sen-β-Gal) activity. It was first described by Dimri and colleagues that increased 
Sen-β-Gal expression was a feature of senescent human fibroblasts and keratinocytes in culture, 
which was histochemically detectable at pH 6, and this was not present in quiescent or post-
mitotic cells (Dimri et al., 1995). An age-dependent increase in Sen-β-Gal-positive cells was 
also reported in human skin samples (Dimri et al., 1995). It has been shown that Sen-β-Gal 
results from increased expression of lysosomal β-galactosidase and probably reflects increased 
lysosomal biogenesis that occurs in senescent cells (Lee et al., 2006). However, Sen-β-Gal is 
also not specific for senescent cells, as it can also be detected in cells which have been cultured 
in prolonged confluence (Severino et al., 2000).   
Senescent cells can also be detected by p16, since this CDKI is upregulated in senescence and 
mediates the cell-cycle arrest (Alcorta et al., 1996; Serrano et al., 1997; Stein et al., 1999). 
However, p16 levels may vary in different cell types, and it can also be expressed by some 
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tumour cells, particularly in those that have lost pRb function (Beausejour et al., 2003; Gil and 
Peters, 2006). Moreover, p21 is often used as a marker of senescence, as upregulation of the 
p53-p21 pathway is also involved during the senescence process (Di Leonardo et al., 1994; 
Herbig et al., 2004), although elevated p21 levels can also be indicative of a transient cell-cycle 
arrest in response to stress (Barnouin et al., 2002).   
The formation of SAHFs during senescence also offers another marker for the detection of these 
cells. SAHFs can be detected by the preferential binding of DNA dyes, such as 4’,6-diamidino-
2-phenylindole (DAPI), and are also enriched in specific heterochromatin-associated histone 
modifications, such as H3 Lys9 methylation, and proteins, for example HP1 (Narita et al., 
2003).  
Since senescence has been associated with activation of a DDR, senescence-associated DNA-
damage foci (SDFs) are also commonly used to identify senescent cells both in vitro and in 
vivo. SDFs comprise foci containing activated DDR proteins, including phospho-ATM, 
phospho-ATR, 53BP1 and γH2AX (d'Adda di Fagagna et al., 2003; Herbig et al., 2004; Rodier 
et al., 2009). It has been suggested that such foci, also termed DNA-SCARS (DNA segments 
with chromatin alterations reinforcing senescence), are distinguishable from transient foci, and 
contribute to persistent DDR signalling which is important for the growth arrest and secretory 
phenotype of senescent cells (Rodier et al., 2011). As well as genomic DNA damage, these foci 
also arise from dysfunctional telomeres, including both TIF and TAF, which have been shown 
to increase with age in many mammalian tissues with age (d'Adda di Fagagna et al., 2003; Takai 
et al., 2003; Hewitt et al., 2012; Jurk et al., 2014). Moreover, p38MAPK has been implicated 
in regulatig the SASP in a DDR-independent manner, and it was shown to be phosphorylated 
in response to a range of senescence-inducing stimuli (Freund et al., 2011). 
Senescence is usually accompanied by striking morphological changes, such as an increase in 
cell size, as well as becoming flat and sometimes multinucleated (Serrano et al., 1997; Chen et 
al., 2001; Dikovskaya et al., 2015). Moreover, senescent cells often show increased nuclear 
size and irregularity of the nuclear envelope (Mehta et al., 2007). In addition, nuclear envelope 
proteins, such as lamin B1, has been shown to decline in both human and mouse fibroblasts that 
are induced to senesce by DNA-damage, replicative exhaustion and oncogene activation, as 
well as in mouse tissues following irradiation (Freund et al., 2012). Loss in lamin B1 was not 
observed in quiescent cells, suggesting that this might serve as a biomarker of the senescent 
state both in vitro and in vivo (Freund et al., 2012). It has been suggested that lamin B1 
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downregulation contributes to the vast chromatin reorganisation that occurs during senescence, 
and impacts the gene expression changes associated with the phenotype (Shah et al., 2013).        
In summary, although a variety of markers can be used to identify senescent cells, they are not 
exclusive to the senescent state, and thus must be used in combination to precisely analyse 
cellular senescence.  
1.4.5. The senescence-associated secretory phenotype 
Senescent cells develop a distinct secretome profile, known as the senescence-associated 
secretory phenotype (SASP), which involves the strong upregulation of soluble signalling 
proteins such as cytokine, chemokines, growth factors, and proteases, such as matrix 
metalloproteases (MMPs) (Malaquin et al., 2016). Although the SASP is fairly conserved in 
mammals, its composition is highly dependent on cell type and senescence-inducing stimuli 
(Coppe et al., 2008; Coppe et al., 2010b). The SASP is thought to have evolved as a way for 
senescent cells to communicate with the immune system, potentially to facilitate their own 
clearance (Xue et al., 2007; Krizhanovsky et al., 2008). Indeed, inducing senescence in liver 
cancer cells was shown to activate an innate immune response in mice, which contributed to 
tumour clearance (Xue et al., 2007). Moreover, immune responses against senescent cells have 
also been shown to play a role in limiting liver fibrosis. Induction of liver damage in mice 
resulted in increased frequency of senescent hepatic stellate cells, which were shown to be 
killed by natural killer cells, facilitating the resolution of fibrosis (Krizhanovsky et al., 2008). 
It has also been demonstrated that the SASP can act as an extracellular signal to promote tissue 
regeneration by inducing cellular plasticity and stemness in neighbouring cells. Transiently 
exposing mouse keratinocytes to the SASP induced expression of stem cell markers and 
increased their regenerative capacity in vivo, as demonstrated by the ability of these cells to 
develop large patches of hair follicles when grafted into full-thickness wounds of nude mice 
(Ritschka et al., 2017). This was also demonstrated in vivo, as inducing senescence in single 
hepatocytes in mouse liver in vivo activates tissue-specific expression of stem cell markers, 
supporting that the SASP induces stem cell properties in the surrounding tissue (Ritschka et al., 
2017). Another beneficial role of the SASP was demonstrated during the wound healing 
process, whereby senescent cells were shown to secrete PDGF-AA, inducing myofibroblast 
differentiation, which possess contractile function, thereby accelerating wound healing 
(Demaria et al., 2014).  
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The presence of senescent cells in the aforementioned contexts are, however, transient, possibly 
to avoid the detrimental effects associated with persistent senescent cells. It has been shown 
that senescent cells can induce paracrine senescence in normal neighbouring cells via secretion 
of SASP factors, such as TGF-β family ligands (Acosta et al., 2013). Given that there is an 
accumulation of senescent cells in many tissues with age, it is possible that the SASP 
contributes, in part, to age-associated tissue dysfunction (van Deursen, 2014). Indeed, chronic 
exposure to the SASP induces senescence and impairs the regenerative capacity of 
keratinocytes in vivo (Ritschka et al., 2017). Moreover, clearance of senescent cells attenuated 
age-related dysfunction in many tissues and delayed onset of age-related pathologies in mice, 
supporting that the presence of senescent cells negatively impacts tissue function (Baker et al., 
2011; Baker et al., 2016).  Paradoxically, prolonged exposure to the SASP can also promote 
tumorigenesis, as it has been shown that factors released by senescent human fibroblasts 
stimulate proliferation of premalignant and malignant cells in culture, and promotes tumour 
formation in mice (Krtolica et al., 2001). Moreover, MMPs secreted by senescent dermal 
fibroblasts were shown to promote epithelial-mesenchymal transition (EMT), and thus enhance 
migratory capacity of transformed keratinocytes, an important step during cancer invasion 
metastasis (Malaquin et al., 2013).        
As well as inducing paracrine senescence, certain SASP factors have also been shown to act in 
a cell-autonomous manner, reinforcing the senescent phenotype. For example, activation of 
CXCR2, a receptor for IL-8, was shown to reinforce both replicative and oncogene-induced 
senescence, whereby the growth arrest is maintained by a self-amplifying secretory network 
activated by senescent cells (Acosta et al., 2008). Consistent with the role of SASP factors in 
autocrine senescence, IL-6 has also been shown to be crucial for the establishment of OIS 
(Kuilman et al., 2008). It was shown IL-6 depletion was sufficient to promote OIS bypass in 
dermal fibroblasts expressing the oncogene BRAFE600 (Kuilman et al., 2008). Depletion of IL-
6 in BRAFE600-senescent fibroblasts allowed cells to resume proliferation, suggesting that IL-6 
is also required to the maintenance of OIS (Kuilman et al., 2008).  
The development and maintenance of the SASP has been shown to heavily rely on persistent 
DDR signalling, as depletion of DDR proteins that associate with DNA-SCARS, such as ATM, 
CHK2 and H2AX, abolished the secretion of many SASP factors, including IL-6 and IL-8 
(Rodier et al., 2009; Rodier et al., 2011). Consistent with this, it has been shown that inducing 
senescence in human fibroblasts by overexpressing p16 or p21 does not trigger a DDR, and 
consequently occurs without a SASP, suggesting that the secretory phenotype is not a 
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consequence of the growth arrest but rather a result of DNA damage response (Coppe et al., 
2011). This observation, however, is contradictory to previous studies showing that p21 
promotes ROS generation and consequently induces secondary DNA damage (Passos et al., 
2010). Nevertheless, activation of the DDR alone does not fully account for the development 
of the SASP. Firstly, DDR activation occurs almost immediately following DNA damage, while 
the mature SASP develops over several days. Therefore, if the DDR alone was necessary and 
sufficient for the SASP, this phenotype would be detectable within hours of damage induction 
(Malaquin et al., 2016). Indeed, a DDR-independent mechanism regulating the SASP has been 
identified, involving p38MAPK activation (Freund et al., 2011; Alspach et al., 2014). It has 
been shown that inhibition of p38MAPK activity, which does not inhibit the DDR, reduces the 
secretion of the majority of SASP factors, whereas constitutive p38MAPK activation was 
sufficient to induce a SASP despite depletion of DDR proteins, such as ATM and CHK2 
(Freund et al., 2011). Moreover, the kinetics of p38MAPK activation closely resembles the 
kinetics of early and mature SASP development, suggesting that it could be an important 
regulator of the SASP (Freund et al., 2011).  
Chromatin modifications also appear to be important in establishing the SASP. For example, 
recent work has shown that cells undergoing senescence with persistent DNA damage (by 
replicative exhaustion, etoposide treatment and oncogenic RAS activation) accumulate high 
levels of the H2A.J histone variant, which was shown to be required for production of SASP 
factors (Contrepois et al., 2017). Mechanistically, it is not clear how a DDR promotes H2A.J 
accumulation, and how the latter stimulates SASP gene expression; however, these data suggest 
that chromatin modifications that occur during senescence also play a role in the SASP 
development (Contrepois et al., 2017). 
The NF-κB family of transcription factors have been shown to be key regulators of the 
expression of SASP factors. For example, inhibiting NF-κB by deletion of the subunit p65, has 
been shown to reduce expression of many SASP factors in OIS and stress-induced senescent 
fibroblasts (Chien et al., 2011b; Freund et al., 2011). Mechanistically, it is unclear how NF-κB 
is activated during senescence; however, it has been shown that a DDR can activate NF-κB via 
ATM, which interacts with NF-κB modulators, activating NF-κB signalling (Wu et al., 2006b). 
Moreover, the p38MAPK pathway can also indirectly induce NF-κB via activation of MSK1 
and MSK2, which phosphorylate the NF-κB subunit, p65, promoting its nuclear translocation, 
where it can regulate transcription of inflammatory genes (Vanden Berghe et al., 1998; 
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Kefaloyianni et al., 2006). Furthermore, as previously discussed, mTORC1 can enhance NF-
κB transcriptional activity either indirectly through regulating IL-1α translation (Laberge et al., 
2015) or directly by interacting with IKK (Dan et al., 2008), thus providing another mechanism 
of NF-κB activation in senescent cells. Hence, regulation of the SASP appears to occur at 
multiple levels, with a DDR, p38 activity, NF-κB and chromatin modifications playing 
important roles for the establishment of the pro-inflammatory secretory phenotype. 
 The role of reactive oxygen species in senescence 
Reactive oxygen species (ROS) are generated as byproducts of aerobic metabolism, and are 
important signalling molecules that regulate many physiological processes (Finkel, 2011). 
However, oxidative stress that arises from an imbalance in ROS homeostasis can lead to 
damage in cellular components such as lipids, proteins and DNA (Schieber and Chandel, 2014). 
Given that, Denham Harman proposed the “Free Radical Theory of Ageing”, suggesting that 
accumulation of oxidative damage in cells over time contributes to organismal ageing (Harman, 
1956). Considering that mitochondria are a major source of intracellular ROS production, it 
was later suggested that mitochondria were the main contributors of ROS-induced cellular 
damage and ageing (Harman, 1972). The mitochondrial theory of ageing postulates that ROS 
produced as a consequence of mitochondrial oxidative phosphorylation causes mitochondrial 
DNA (mtDNA) damage and accumulation of mtDNA mutations, which in turn impairs 
oxidative phosphorylation, leading to increased ROS production, ultimately instilling a “vicious 
cycle” that perpetuates ROS generation and promotes oxidative stress (Alexeyev et al., 2004). 
Indeed, ROS have been shown to play a role during senescence, as increased ROS levels are 
observed in replicative, stress-induced and oncogene-induced senescence (Saretzki et al., 2003; 
Passos et al., 2007; Ogrunc et al., 2014). Treating human fibroblasts with sub-lethal 
concentrations of H2O2 induces senescence in a p53-dependent manner (Chen et al., 1998). 
Moreover, mild oxidative stress has been shown to cause telomeric SSBs, accelerating the rate 
of telomere shortening, and leading to premature senescence (von Zglinicki et al., 1995; von 
Zglinicki et al., 2000; von Zglinicki, 2002). Consistently, treatment with antioxidants or other 
interventions that reduce ROS levels prevents telomere shortening and extends replicative 
lifespan (Saretzki et al., 2003; Serra et al., 2003). Dysfunctional mitochondria have been shown 
to accumulate as cells reach the end of their replicative potential, which leads to increased ROS 
generation and also contributes to telomere shortening (Passos et al., 2007). Interestingly, 
overexpressing TERT (the catalytic subunit of telomerase) decreases mitochondrial superoxide 
production and protects human fibroblasts against oxidative stress independently of telomere 
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length (Ahmed et al., 2008). Under conditions of mild stress, TERT is excluded from the 
nucleus, and co-localises with mitochondria, suggesting a protective role for telomerase 
independent from its role in telomere elongation (Ahmed et al., 2008).  
ROS are not only involved in the induction of senescence via direct DNA damage, but are also 
believed to act as an effector mechanism during senescence. Indeed, inducing senescence in 
fibroblasts by overexpression of p21, which acts downstream of the DDR, increases 
intracellular ROS (Macip et al., 2002). The p21-induced growth arrest was reversed by 
antioxidant treatment, suggesting that ROS are important for the maintenance of the senescent 
phenotype (Macip et al., 2002). Moreover, a positive feedback loop has been shown to exist 
whereby DNA damage leads to sustained activation of p21, inducing mitochondrial dysfunction 
and leading to increased ROS production through a series of signalling pathways involving 
GADD45-p38MAPK-TGFβ (Passos et al., 2010). This increase in ROS then replenishes short-
lived DNA damage foci, thus maintaining the DDR and stabilising senescence (Passos et al., 
2010). In addition, late generation TERC-/- mice, which have dysfunctional telomeres, show 
increased markers of oxidative damage in tissues which can be significantly decreased by 
deletion of p21 (Passos et al., 2010). Another study has also shown that short telomeres activate 
p53, which in turn binds and represses PGC-1α and PGC-1β promoters, inducing mitochondrial 
dysfunction and contributing to elevated ROS levels (Sahin et al., 2011). It has been recently 
shown that clearance of mitochondria, which significantly reduces ROS, ameliorates many 
senescence-associated phenotypes, including the SASP (Correia-Melo et al., 2016). It was 
demonstrated that a DDR acts via ATM, Akt and mTORC1 to induce PGC-1β-dependent 
mitochondrial biogenesis, contributing to ROS production that further activates a DDR and 
stabilises senescence (Correia-Melo et al., 2016).  
Interestingly, ROS have also been involved in the so-called bystander effect of senescent cells, 
where a DDR is induced in neighbouring cells via gap junction-mediated cell-cell contact in a 
process involving ROS (Nelson et al., 2012). Prolonged co-culture with senescent cells induced 
senescence in surrounding fibroblasts in vitro, and clusters of hepatocytes positive for 
senescence markers were also shown in the liver of mice, suggesting that ROS might also play 
a role in spreading senescence both in vitro and vivo (Nelson et al., 2012).  
 The role of senescence in vivo 
Traditionally, senescence was regarded as a tumour-suppressor mechanism by controlling 
proliferation of cells, thus imposing an important barrier against tumourigenesis (Serrano et al., 
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1997). Additionally, recent data now indicates that senescent cells play a variety of other 
beneficial roles during biological processes such as embryonic development, wound healing 
and tissue repair (Krizhanovsky et al., 2008; Munoz-Espin et al., 2013; Demaria et al., 2014; 
Ritschka et al., 2017). In contrast, senescent cells have been shown to accumulate in many 
tissues with age, and this contributes to the loss of tissue regeneration and function during the 
ageing process (Baker et al., 2011; van Deursen, 2014; Baker et al., 2016). The impact of 
senescence cells in different physiological processes will be discussed in more detail below.  
1.6.1. Senescence and tumour suppression 
Since tumour development requires cell proliferation (Hanahan and Weinberg, 2000), 
senescence can mediate tumour suppression by preventing uncontrolled cell growth. Indeed, 
senescence markers have been observed in many pre-malignant lesions in vivo, such as human 
melanocytic nevi, which are composed of growth-arrested melanocytes with oncogenic 
mutations such as BRAFV600E (Pollock et al., 2003). Importantly, BRAF acts as a downsteam 
effector of Ras, activation of which was shown to induce OIS in vitro (Serrano et al., 1997). 
Indeed, expression of BRAFV600E induced senescence in human melanocytes in culture 
(Michaloglou et al., 2005). Moreover, analysis of human nevi in vivo revealed that melanocytes 
within these pre-malignant lesions displayed markers of senescence, such as increased Sen-β-
Gal activity and p16 expression, with no sign of telomere shortening, suggesting that oncogene-
induced senescence limits proliferation of pre-cancerous cells in vivo (Michaloglou et al., 
2005). Interestingly, p16 expression levels are heterogeneous in nevi cells, suggesting that the 
growth arrest at this stage is not primarily maintained by the p16/pRb pathway (Michaloglou et 
al., 2005; Suram et al., 2012). In fact, it has been reported that melanocytic nevi accumulate 
dysfunctional telomeres independently of length, whereas telomere damage levels are much 
lower in melanoma cells, suggesting a role for telomere dysfunction in oncogene-induced 
senescence (Suram et al., 2012). It was suggested that oncogene activation induces DNA 
replication stress and fork stalling at telomeres, leading to telomere dysfunction, thus 
implicating telomere dysfunction-induced senescence (TDIS) as an important tumour 
suppressor mechanism in humans (Suram et al., 2012). The importance of the senescence-
growth arrest in preventing oncogene induced tumour progression has been demonstrated by 
mouse tumour models, whereby deletion of p53 or p21 was sufficient to promote 
tumourigenesis in HRASG12V-induced mammary tumour and in BRAFV600E-induced 
melanomas, for example (Sarkisian et al., 2007; Goel et al., 2009). Senescent cells have also 
been reported in other pre-malignant lesions, such as prostate intraepithelial neoplasia (PIN) 
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and premalignant human colon adenomas, and other mutations are usually required for their 
transformation into malignant tumours (Chen et al., 2005; Bartkova et al., 2006). 
In light of the aforementioned evidence, genetic manipulations or chemotherapeutic drugs that 
induce senescence in tumour cells seem attractive as potential cancer therapies (Roninson, 
2003). For example, it has been shown that overexpression of p53, p21 or p16 induces 
senescence in human tumour cells (Sugrue et al., 1997; Fang et al., 1999; Dai and Enders, 
2000). Consistent with this, treatment with chemotherapeutic drugs, such as doxorubicin, 
induced a senescence-like growth arrest in malignant cells, which was associated with increased 
p53 and p21 expression (Chang et al., 1999b). This was also demonstrated in vivo, where human 
tumour xenografts grown in nude mice show increased Sen-β-Gal activity when treated with 
chemotherapy drugs such as a retinoid (Chang et al., 1999a). However, it is important to note 
that accumulation of senescent cells can also trigger tumourigenesis depending on the 
surrounding microenvironment, a characteristic which is attributed to the development of the 
SASP, as previously mentioned (Krtolica et al., 2001). Indeed, injecting pre-neoplastic cells 
together with senescent cells leads to tumour formation in mice (Krtolica et al., 2001). More 
recently, it was shown that therapy-induced senescent cells persist and contribute to several 
chemotherapy side-effects and cancer recurrence (Demaria et al., 2017). 
1.6.2. Senescence during embryonic development 
A role for senescence during mammalian embryogenesis has been recently uncovered, 
suggesting that this process is also important for normal physiological functions. Senescent 
cells have been reported in multiple locations during embryonic development in mice, including 
the mesonephros and the endolymphatic sac of the inner ear (Munoz-Espin et al., 2013), and 
the apical ectodermal ridge (AER) (Storer et al., 2013), and was also observed in human and 
chick embryos (Munoz-Espin et al., 2013; Storer et al., 2013). Interestingly, the presence of 
senescent cells in these structures was transient, likely a result of macrophage clearance of these 
cells (Munoz-Espin et al., 2013) but a role for apoptosis has also been proposed (Storer et al., 
2013). Importantly, accumulation of senescent cells in the AER was diminished in p21-
deficient mice, which showed severe limb patterning defects (Storer et al., 2013). It was shown 
that developmentally programmed senescence occurred independently of DNA damage and 
p53, but was dependent on p21 and is regulated by the TGF-β/SMAD and PI3K/FOXO 
pathways (Munoz-Espin et al., 2013). Similarly, senescent cells in the AER showed increased 
p21 and Sen-β-Gal, however DNA damage and p16 were not detected. Although these cells 
also developed a SASP, common components such as IL-6 and IL-8 were not increased, 
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suggesting that developmental senescence could represent a more primitive form of senescence 
that plays a role in transient signalling during the development process (Storer et al., 2013).  
1.6.3. Senescence and wound healing  
Tissue repair, such as wound healing, is a multistep process involving four distinct phases: 
hemostasis, inflammation, proliferation and remodelling. In the skin, wound closure occurs 
during the proliferation phase as a result of wound contraction, which relies on the function of 
specialised contractile fibroblasts known as myofibroblasts (Tomasek et al., 2002; Midwood et 
al., 2004). Moreover, soluble factors, including some known SASP components, facilitate the 
process of tissue repair. 
Senescent cells have been shown to accumulate in cutaneous wounds of mice (Jun and Lau, 
2010). It was demonstrated that the matricellular protein CCN1, which is highly expressed in 
granulation tissue (i.e. newly deposited connective tissue and blood vessels) during cutaneous 
wound healing, induces senescence in fibroblasts by activating a DDR and inducing p53. 
Moreover, signalling downstream of CCN1 resulted in increased ROS levels and p16, 
mediating fibroblast growth arrest. Senescent cells were shown to be myofibroblasts, and were 
associated with expression of anti-fibrotic genes, suggesting that senescence induced by CCN1 
helps to regulate the fibrotic response during cutaneous wound healing (Jun and Lau, 2010). 
Indeed, CCN1 mutant mice failed to accumulate senescent cells at wound sites, resulting in 
increased fibrosis, which could be attenuated with topical application of CCN1 (Jun and Lau, 
2010). Consistent with this, another group has demonstrated a role for senescent cells in optimal 
wound healing by using a mouse model (p16-3MR) where senescent cells can be visualised in 
the living animal and also eliminated upon treatment with ganciclovir (Demaria et al., 2014). 
They showed that following a full-thickness punch biopsy, senescent cells were transiently 
detected at the site of injury, peaking at around 6 days after wounding and returning to basal 
levels between 9 and 12 days. Interestingly mRNA levels of p16, p21 and of SASP factors such 
as IL-1α, PAI-1 and VEGF showed similar kinetics, confirming that senescent cells transiently 
appear during the wound healing process. However, eliminating senescent cells by ganciclovir 
treatment abolished the increase of p16 and p21 mRNA at the site of injury, and these mice 
showed slower kinetics of wound closure, suggesting that senescent cells accelerate repair 
(Demaria et al., 2014). Importantly, wounds in p16-3RM-treated mice eventually heal, albeit 
with slower kinetics, suggesting that senescent cells facilitate but are not essential for wound 
repair. It was suggested that the SASP factor PDGF-AA secreted by senescent cells at the site 
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of injury promotes myofibroblast differentiation, which is required for optimal formation of 
granulation tissue and wound closure (Demaria et al., 2014).    
The beneficial role of senescent cells, and the resulting SASP, during development and tissue 
repair is probably due to the fact that these cells only appear transiently, thus avoiding the 
deleterious effects posed by the prolonged presence of senescent cells, as it will be discussed 
below. 
1.6.4. Senescence in ageing and age-related diseases 
Although evidence suggests that senescent cells are subject to clearance by the immune system 
(Xue et al., 2007; Krizhanovsky et al., 2008; Kang et al., 2011), many studies have now shown 
an age-dependent accumulation of senescent cells in many mammalian tissues. It has been 
shown that Sen-β-Gal-positive cells increase in an age-dependent manner in human skin 
samples (Dimri et al., 1995). Moreover, cells with senescent markers have also been detected 
in a number of tissues in mice and primates with age (Herbig et al., 2006; Krishnamurthy et al., 
2006; Wang et al., 2009). Consistent with a role for telomeres in the ageing process, telomere 
shortening is observed in telomerase knock-out mice in a generation-dependent manner (Blasco 
et al., 1997), which results in both cell senescence and apoptosis (Lee et al., 1998). These mice 
not only display a bone phenotype that resembles age-related osteoporosis (Brennan et al., 
2014), but accelerated telomere shortening in this model has been shown to compromise stem 
cell function, regeneration, organ homeostasis, and decrease lifespan (Wong et al., 2003). 
Moreover, telomere dysfunction has been shown to increase with age in vivo in the skin of 
primates, and in the liver, gut, and lung of wild-type mice (Herbig et al., 2006; Jeyapalan et al., 
2007; Hewitt et al., 2012; Birch et al., 2015). In fact, reintroducing telomerase activity in 
telomerase-deficient mice was sufficient to rescue premature ageing phenotypes in tissues such 
as spleen, intestines and testes, suggesting that telomere damage contributes to tissue 
dysfunction with age (Jaskelioff et al., 2011). Interestingly, evidence is now emerging showing 
that post-mitotic cells also acquire senescent-like phenotypes in vivo. For example, one study 
has reported an increase in TAF in hippocampal neurons in baboons with age (Fumagalli et al., 
2012). Consistent with this, neurons expressing senescence markers such as Sen-β-Gal, IL-6 
and γH2AX have been shown in the brain of ageing mice (Jurk et al., 2012).  
Furthermore, accumulation of senescent cells has been associated with age-related diseases 
(Naylor et al., 2013). For example, adipose tissue from patients with diabetes shows increased 
markers of senescence, such as Sen-β-Gal, p53 and p21, as well as significantly increased 
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expression of inflammatory cytokines (Minamino et al., 2009). A similar upregulation in 
senescence markers is seen in adipose tissue of mice with type 2 diabetes, which was 
ameliorated by adipocyte-specific deletion of p53. Inhibition of p53-dependent senescence 
decreased the expression of pro-inflammatory cytokines as well as improving insulin resistance 
in these mice, suggesting an involvement of senescent cells in type 2 diabetes (Minamino et al., 
2009). Moreover, cells with markers of senescence such as increased Sen-β-Gal activity, 
telomere shortening, and high p16 and p21 expression, have been observed in articular cartilage 
of patients with osteoarthritis, an age-related pathology which is associated with chronic 
inflammation (Price et al., 2002). Indeed many pro-inflammatory factors associated with the 
SASP are increased in arthritic joint tissues, including IL-1β, IL-6, IL-8, and ECM-degrading 
proteins such as MMP-3 and MMP-13 (Freund et al., 2010). In addition, airway epithelial cells 
from lungs of patients with chronic obstructive pulmonary disease (COPD) display senescence 
markers including elevated p16, Sen-β-Gal, and telomere damage, suggesting that senescent 
cells contribute to lung dysfunction in COPD (Birch et al., 2015). Senescent cells have also 
been reported in affected tissues of patients with Alzheimer’s disease, atherosclerosis and 
pulmonary fibrosis (Naylor et al., 2013).  
Evidence suggests that accumulation of senescent cells with age may be a major contributing 
factor to the loss of tissue regeneration and function during the ageing process. This was 
elegantly demonstrated by the van Deursen group who showed that inducible elimination of 
p16-positive cells was able to delay the acquisition of age-related pathologies in a mouse model 
of accelerated ageing, the BubR1 progeroid mouse (Baker et al., 2011). Elimination of 
senescent cells from these mice not only delayed the onset age-related tissue degeneration but 
also slowed down the progression of already established conditions, suggesting a causal link 
between senescence and age-related tissue dysfunction (Baker et al., 2011). More recently, a 
similar system was developed by the same group, where they were able to eliminate p16-
expressing senescent cells in wild type mice, resulting in significant improvements in 
healthspan and lifespan of mice (Baker et al., 2016). Clearance of p16-positive cells delayed 
tumourigenesis and attenuated age-related dysfunction of several organs such as kidney, heart 
and fat, showing that senescent cells contribute causally to the ageing process (Baker et al., 
2016). These data suggest that interventions targeting senescent cells could be an attractive 
option as a therapy against ageing and age-related diseases. Indeed, pharmacological agents 
that selectively kill senescent cells, also known as senolytics, are now being identified, and their 
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use has been shown to improve age-related phenotypes in mice (Zhu et al., 2015; Chang et al., 
2016; Zhu et al., 2017). 
Although the mechanisms by which senescent cell accumulation leads to age-related tissue 
dysfunction are not fully understood, one possibility is that senescent cells impair the 
regenerative capacity of tissues. Indeed, senescent progenitor cells have been reported in muscle 
and fat of the BubR1 progeroid mice, and an increase in p16 expression has been shown in 
haematopoietic stem cells of mice with age (Janzen et al., 2006; Baker et al., 2013). As well as 
affecting tissue function in a cell-autonomous manner, decreasing the availability of progenitors 
capable of differentiating to repair the tissue, senescence in these cell populations can also 
contribute to ageing by affecting surrounding stem and progenitor cells, disrupting the local 
stem cell niche through secretion of SASP factors (Baker et al., 2013). Consistent with this 
idea, SASP factors such as IL-6 and GRO-α have been shown to regulate stem cell fate in vitro 
(Pricola et al., 2009; Krtolica et al., 2011). Moreover, muscle stem cells from aged mice 
undergo lineage conversion from a myogenic towards a fibrogenic lineage, which is associated 
with impaired muscle regeneration and favours a fibrotic response (Brack et al., 2007). It was 
shown that this myogenic-to-fibrogenic conversion was a result of factors present in the 
systemic environment of aged animals, as exposing old mice to a youthful systemic 
environment by parabiotic pairing with young mice significantly improved the regenerative 
potential of old stem cells (Brack et al., 2007). Accumulation of senescent cells might also lead 
to age-related tissue dysfunction by compromising tissue integrity and architecture, since 
proteases, which are components of the SASP, can cleave membrane-bound receptors, 
extracellular matrix proteins and other components important for maintaining tissue 
organisation (Parrinello et al., 2005). Moreover, chronic exposure to the SASP can contribute 
to tissue fibrosis by stimulating epithelial-to-mesenchymal transformation (EMT) (Laberge et 
al., 2012). Another way in which senescent cells can be detrimental to tissue function is by 
contributing to chronic tissue inflammation, which is characterised by lymphocyte and 
macrophage infiltration, fibrosis and cell death (van Deursen, 2014). Indeed, this phenomenon, 
also known as “inflammaging”, is associated with many age-related diseases (Franceschi et al., 
2007; Freund et al., 2010). It is thought that pro-inflammatory cytokines, chemokines and 
growth factors secreted by senescent cells contribute to this state of chronic inflammation, and 
thus are directly linked to the development of age-related diseases (Freund et al., 2010). 
Senescent cells have also been shown to promote a pro-tumourigenic microenvironment via the 
secretion of SASP factors, favouring survival and proliferation of malignant cells, thus possibly 
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contributing to the increased incidence in cancer development with age (Krtolica et al., 2001; 
Bavik et al., 2006; Coppe et al., 2008). Finally, the ability of the SASP to induce senescence in 
healthy neighbouring cells through paracrine mechanisms may intensify all the aforementioned 
detrimental effects, thus leading to age-related tissue deterioration (Nelson et al., 2012; Acosta 
et al., 2013) (Figure 1.2).  
The reason why senescent cells accumulate with age is also not fully understood. It is possible 
that the rate at which senescent cells are generated increases with age, since senescence-
inducing stimuli, such as DNA damage and ROS, also increase with age (Garinis et al., 2008; 
Sasaki et al., 2010); however, combined cellular stresses alone cannot account for senescent 
cell accumulation. Another possibility is that senescent cells are less efficiently eliminated with 
ageing. As previously mentioned, evidence suggests that senescent cells are subject to clearance 
by attracting both adaptive and innate immune cells, likely through the secretion of pro-
inflammatory factors (Xue et al., 2007; Krizhanovsky et al., 2008; Kang et al., 2011; Laberge 
et al., 2012; Sagiv and Krizhanovsky, 2013). However, immune cell function also declines with 
age, likely compromising immune surveillance and elimination of senescent cells (Nikolich-
Zugich, 2008; Montecino-Rodriguez et al., 2013; Sagiv and Krizhanovsky, 2013). In fact, 
immune cells also become senescent (Henson et al., 2014; Lanna et al., 2014), which can further 
contribute to age-associated immunodeficiency (Vicente et al., 2016). Furthermore, it has also 
been suggested that deeply senescent cells develop a highly heterogeneous SASP, such that 
immune cells can no longer recognise them, and thus are able to evade immune clearance (van 
Deursen, 2014).  
Overall, accumulation of senescent cells with age is a major contributor to age-related tissue 
dysfunction, and evidence now implicates senescence as causal during the ageing process.   
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Figure 1.2 - Accumulation of senescent cells contributes to age-related tissue dysfunction. 
The chronic presence of senescent cells with age may contribute to ageing and age-related 
diseases in a number of ways. For example, senescent stem or progenitor cells may lead to 
depletion of stem cell pools, which are crucial to maintain tissue homeostasis and regeneration. 
Secretion of SASP factors can also induce senescence in neighbouring stem cells, disrupting 
the local stem cell niche and contributing to stem cell dysfunction. Moreover, secretion of pro-
inflammatory factors by senescent cells promotes tissue dysfunction by causing degradation of 
extracellular matrix, and thus disrupting tissue architecture, as well as stimulating chronic tissue 
inflammation. Moreover, the detrimental effects of senescent cells are exacerbated due to the 
ability of SASP components to act in a paracrine manner, and induce senescence in healthy 
neighbouring cells. (Blue = healthy, young cells; brown with blue nucleus = primary senescent 
cells; brown with purple nucleus = secondary senescent cells; green = immune cells). 
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 Cellular senescence and skin ageing 
The skin is a highly dynamic, regenerating organ, and serves as the body’s primary line of 
defence against infections, as well as physical and chemical insults (Rittie and Fisher, 2015). 
Moreover, the skin is the largest sensory organ in the body, and is crucial in thermoregulation 
through controlling vasculature and sweat glands present throughout the skin (Romanovsky, 
2014).  
1.7.1. Skin structure 
The skin is composed of three main layers: the hypodermis, dermis and epidermis (Figure 1.3). 
The hypodermis, or subcutaneous layer, is the deepest layer of the skin, and consists mainly of 
adipose and connective tissue. It contains high fat storage capacity, and thus provides 
cushioning and insulation, as well as skin stability by connecting the dermis to internal organs 
(Farage et al., 2007). The dermis is the scaffolding component of the skin, and it is mainly 
composed of collagen and elastin fibres, as well as fibroblasts, blood vessels, lymph vessels 
and sweat glands (Fore, 2006). Immune cells also reside in the dermis, including mast cells, 
macrophages, dendritic cells, innate lymphoid cells (e.g. natural killer cells) and T cells, all of 
which orchestrate to prevent pathogen invasion (Heath and Carbone, 2013). For example, 
natural killer cells, which are present in small numbers in healthy skin, are involved in viral 
immunity and also play a role in tumour immunosurveillance (Heath and Carbone, 2013). 
Dendritic cells also play a role in protecting against viral infections, and are also important for 
presenting antigens to induce CD8+ (cytotoxic) T cell responses (Shortman and Heath, 2010). 
Moreover, the skin contains a large number of memory T cells of both the CD4+ (i.e. T-helper 
cells) and CD8+ subsets, which are located in the dermis and epidermis, respectively, enhancing 
protection against local infection (Heath and Carbone, 2013).The dermis also contains hair 
follicles and nerve fibres; the latter project into the epidermis, allowing the skin to transmit 
sensory information. Moreover, the blood supply within the dermis is responsible for providing 
circulatory support and nutrients to the epidermis, since the latter does not have its own blood 
supply (Fore, 2006). The epidermis is the outermost layer of the skin, and consists primarily of 
keratinocytes organised in a stratified epithelium (Rittie and Fisher, 2015). Proliferating 
keratinocytes are located in the basal layer of the epidermis (stratum basale), and their 
proliferative capacity is lost as they differentiate and migrate up the epidermis towards the 
stratum corneum. The latter is the outermost layer of the epidermis, and is composed of 
terminally differentiated keratinocytes, also known as corneocytes. These cells are flattened 
and anuclear but are rich in proteins, and are embedded in a lipid-rich extracellular matrix, 
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which provides an impermeable barrier, preventing water loss and entry of pathogens through 
the skin (Elias et al., 1977). Eventually, corneocytes are shed off the skin surface through a 
process known as desquamation, completing the cycle of epidermal differentiation (or 
keratinisation), which occurs approximately every 28 days (Marks, 2004). Moreover, 
Langerhan cells, which are antigen presenting cells, can also be found in the epidermis. These 
dendritic cells are involved in skin immunosurveillance by extending their dendrites upwards 
towards the cornified epithelial layer and sampling external antigens, and this has been shown 
to be important for priming immunity against skin pathogens (Chomiczewska et al., 2009; 
Heath and Carbone, 2013). The epidermis is also composed of melanocytes, which comprise 
approximately 1-2% of epidermal cells, and are present at a ratio of 1:10 melanocyte to 
keratinocytes. This ratio is maintained constant throughout life, and although the mechanisms 
controlling this are still poorly understood, it is believed that keratinocytes regulate melanocyte 
numbers through growth factors and other cell-surface molecules (Scott and Haake, 1991; 
Haass and Herlyn, 2005). Melanocytes are dendritic cells that reside in the basal layer of the 
epidermis, and produce the photoprotective pigment, melanin, in response to UV irradiation 
(Sklar et al., 2013). Melanocytes then transport melanin, which is packaged in vesicles called 
melanosomes, to surrounding keratinocytes through their dendrites. It has been shown that one 
melanocyte can transport melanin to approximately 36 neighbouring keratinocytes, and this 
interaction is also known as the epidermal melanin unit (Fitzpatrick and Breathnach, 1963; 
Haass and Herlyn, 2005). Unlike keratinocytes, epidermal melanocytes are very long-lived 
cells, and proliferate extremely rarely once they reach terminal differentiation (Cichorek et al., 
2013). A small percentage of dividing melanocytes has been shown in human and mouse skin 
(Jimbow et al., 1975). Moreover, a subpopulation of differentiated melanocytes that are capable 
of undergoing division has been identified in zebrafish, however, the proportion of new 
pigmented cells arising from differentiated melanocytes was very small (4.6%) (Taylor et al., 
2011). It is also thought that differentiated melanocytes contribute in part to re-pigmentation in 
wound healing and vitiligo (Hirobe, 1988; Falabella, 2009). However, new melanocytes arise 
mainly from a population of undifferentiated melanocytes, which also contribute to the increase 
in epidermal melanocyte number following exposure to UV irradiation in mice (Kawaguchi et 
al., 2001; van Schanke et al., 2005; Walker et al., 2009; Tanimura et al., 2011). Although the 
niche of melanocyte stem cells in the adult skin remains to be established, evidence suggests 
that the bulge area of hair follicles serves as a reservoir for such cells (Nishimura et al., 2002; 
Nishimura, 2011; Tanimura et al., 2011). However, studies suggest that a melanocyte stem cell 
niche can also be found in the dermis (Toma et al., 2005; Davids et al., 2009).  
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The epidermis also projects inwards towards the dermis, alternating with shallower protrusions 
back into the epidermis, such that the dermis and the epidermis interconnect via invaginations, 
giving rise to the rete ridges. These structures provide mechanical support for the epidermis, 
and are also important for nutrient exchange, as they increase the surface area of the epidermis 
which is exposed to capillaries and venules circulating near the epidermal-dermal junction 
(EDJ) (Briggaman and Wheeler, 1975). 
 
Figure 1.3 - Layers of the human skin. The innermost layer of the skin is the hypodermis, or 
subcutaneous layer, which is mainly composed of adipose tissue and acts as a shock absorber 
as well as providing insulation. The dermis connects the hypodermis to the epidermis, and has 
a high content of collagen and elastin fibres, providing strength, elasticity and support to the 
skin. The dermal compartment also harbours blood vessels, which supply nutrients to the 
epidermis, as well hair follicles and sweat glands. Moreover, nerves present within the dermis 
also make connection with the EDJ, and relay sensory information. The epidermis is the 
outermost layer, and is mainly composed of keratinocytes, which are constantly being turned 
over and shed off, providing an impermeable barrier to the skin. Melanocytes also reside within 
the basal layer of the epidermis, and they produce melanin when exposed to UV irradiation. 
Melanocytes interconnect with surrounding keratinocytes via dendrites, which mediate melanin 
transport to neighbouring cells, providing protection against the harmful effects of UV 
irradiation. Image obtained from (Winslow, 2008).      
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1.7.2. Characteristics of aged skin 
Skin ageing arises from a combination of both intrinsic and extrinsic factors, which ultimately 
compromise the structural integrity and physiological function of the skin (Kammeyer and 
Luiten, 2015). The changes associated with intrinsic or chronological ageing are in great part a 
result of the reduced proliferative capacity of skin cells. Indeed, studies have reported that 
keratinocytes, fibroblasts and melanocytes from old donors undergo less population doublings 
in culture when compared to those of young donors (Schneider and Mitsui, 1976; Gilchrest, 
1983; Gilchrest et al., 1984). Chronologically aged skin is characterised by a thin, dry 
appearance, and it is finely wrinkled (Rittie and Fisher, 2015). On the other hand, extrinsic 
ageing occurs as a result of environmental factors such as cigarette smoke, pollution factors, as 
well as UV exposure, which is also referred to as photoageing (Gilchrest, 1989; Yin et al., 2001; 
Bernhard et al., 2007). Clinically, photoaged skin appears leathery, lax, has coarse wrinkles and 
uneven pigmentation with brown spots (lentigines) (Rittie and Fisher, 2015).    
Generally, both chronological and extrinsic factors contribute to the profound changes that 
occur in the epidermal and dermal compartments during skin ageing.  For example, the volume 
of subcutaneous fat decreases with age. Moreover, in older adults, the number of cells in the 
epidermis decreases, keratinocytes become shorter and fatter, and basal keratinocyte 
proliferation is reduced, resulting in thinning of the epidermis with ageing (Marks, 1981; Grove, 
1989; Farage et al., 2007). Moreover, epidermal turnover rate is also slower in older individuals 
(Fore, 2006). The epidermal-dermal junction appears flattened, primarily as a result of the 
retraction of the rete ridges (Lavker et al., 1987). This in turn affects the exchange surface 
between the epidermis and dermis, diminishing nutrient supply to the epidermis, which might 
also contribute to reduced keratinocyte proliferation (Lavker et al., 1989). Flattening of the EDJ 
also reduces epidermal resistance to shearing forces, thus making the epidermis more fragile 
and increasing the potential for dermal-epidermal separation, which also contributes to 
wrinkling (Grove, 1986). Water content is also lower in aged skin, particularly in the stratum 
corneum. This occurs due to changes in amino acid composition of corneocytes, as well as a 
decrease in the amount of cutaneous natural moisturising factors, resulting in loss of the water-
binding capacity of the skin (Potts et al., 1984; Wilhelm et al., 1991). Low water content in the 
stratum corneum interferes with the process of desquamation, leading to accumulation of 
corneocytes in the skin surface, which gives aged skin a rough and flaky appearance (Jackson 
et al., 1993).  Although transepidermal water loss is similar under basal conditions in both 
young and aged skin, suggesting that the barrier function of the stratum corneum is not affected, 
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this barrier is more easily disrupted in older skin. Any disturbances result in increased water 
loss, and the reconstitution of an effective stratum corneum is slower (Yaar and Gilchrest, 
2001). Therefore, aged skin is more susceptible to external insults.  
Other age-related epidermal changes include decreased melanocyte density, which has been 
shown to decrease progressively during adulthood by approximately 10% per decade  (Gilchrest 
et al., 1979). The remaining melanocytes also show decreased melanogenic capacity, possibly 
contributing to the pale appearance of older skin, and also to reduced tanning capacity following 
UV exposure (Hawk, 1990; Yaar and Gilchrest, 2001; Shlivko et al., 2013). Indeed, expression 
of tyrosinase, the rate-limiting enzyme during melanin production, decreases with age in 
epidermal melanocytes (Kauser et al., 2011). Despite the gradual loss in pigment-producing 
cells, chronically sun-exposed areas contain higher numbers of melanocytes. However, these 
cells are less evenly distributed, contributing to uneven pigmentation in older skin (Ortonne, 
1990). In fact, a common feature of photoaged skin is the presence of pigmented lesions, such 
as solar lentigo, or “age spots”. A higher melanin content is observed in these areas, resulting 
in increased local pigmentation; however, the mechanisms controlling increased melanin 
production in these lesions are still not fully understood. One possibility is that altered 
signalling from keratinocytes stimulates aberrant melanogenic behaviour, although variant 
alleles of genes involved in melanin synthesis have also been shown to be involved in solar 
lentigines development (Praetorius et al., 2014).  
Dermal thickness also decreases with age, with concomitant loss of cellularity and vascularity 
(Farage et al., 2007). There is a reduction in the number of dermal fibroblasts, which leads to 
decreased collagen production in older skin (Gunin et al., 2011). Collagen degradation is also 
enhanced due to increased production of matrix metalloproteases, which compromises the 
structural integrity of the dermis (Ashcroft et al., 1997) (Figure 1.4). Moreover, the remaining 
collagen fibres become thicker and more disorganised, and collagen cross-links stabilise, 
leading to reduced elasticity in aged skin (Fenske and Lober, 1986).  Over time, fragmented 
collagen fibril remnants accumulate, leading to decreased mechanical resistance of the ECM, 
thus decreasing the mechanical forces within surrounding fibroblasts. Dermal fibroblasts are no 
longer efficiently supported by the ECM, and respond to low mechanical forces by increasing 
intracellular ROS levels, reducing collagen synthesis, and increasing expression of MMPs 
(Mauch et al., 1988; Eckes et al., 2006; Fisher et al., 2009). Therefore, collagen degradation 
leads to a self-sustainable positive feedback loop of oxidative stress, reduced collagen synthesis, 
and increased collagen degradation in aged skin. Elastin degradation is also increased due to 
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the action of MMPs, and the existing elastin fibres show higher degree of calcification with 
decreased functionality (Farage et al., 2007). Additionally, fibroblasts produce less hyaluronic 
acid, another major ECM component which is important for the water-retaining capacity of the 
dermis (Papakonstantinou et al., 2012). Aberrant dermal ECM homeostasis leads to loss of 
structural integrity, resulting in increased rigidity and decreased elasticity, ultimately 
contributing to skin fragility with age (Quan and Fisher, 2015).    
Furthermore, different phases of the wound healing process are affected by the changes that 
accompany skin ageing, resulting in delayed healing in aged individuals. For example, the 
proliferation phase is characterised by re-epithelialisation of the wound, as well as deposition 
of new ECM and blood vessels, which requires migration and proliferation of fibroblasts, 
keratinocytes and endothelial cells. However, the proliferative potential of these cells is reduced 
with age, delaying this process (Gosain and DiPietro, 2004; Sgonc and Gruber, 2013). 
Moreover, the final maturation phase, which involves collagen remodelling, might be affected 
due to an imbalance between the levels of MMPs and their inhibitors, as it has been reported 
that cutaneous wounds of elderly people have higher levels of MMP-2 and MMP-9, while 
inhibitors of MMP-1 and -2 were downregulated (Ashcroft et al., 2002). Levels of TGF-β1, 
which stimulates collagen synthesis and diminishes its degradation, was also shown to be 
reduced in wounds of aged skin (Ashcroft et al., 2002). Therefore, these age-related changes 
favour collagen breakdown, thus delaying wound closure.  
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Figure 1.4 - Structural characteristics of aged skin. Skin ageing characteristics include 
thinning of the epidermis, with decreased number of keratinocytes (shown in brown) and 
melanocytes (shown in orange). Retraction of the rete ridges (epidermal projections into the 
dermis, shown in purple) leads to flattening of the epidermal-dermal junction, which also 
contributes to a thinner epidermis appearance. Dermal thickness also decreases, accompanied 
by increased collagen and elastin degradation. The remaining collagen and elastin fibres are 
disorganised and have decreased functionality, contributing to loss of elasticity and increased 
fragility. Moreover, subcutaneous fat is also reduced in aged skin.  
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1.7.3. Contribution of UV exposure to skin ageing 
Photoaging is a major contributor to skin ageing (Friedman, 2005), and its effects are more 
prominent in fair skin individuals compared to people with darker skin, since melanin acts as a 
natural protective barrier against UV radiation. In fact, darker skin individuals contain a higher 
proportion of the dark pigment eumelanin, which is much more efficient in blocking UV than 
the lighter pigment, pheomelanin. Conversely, fairer skin is much more susceptible to the 
damaging effects of UV due to a low amount of epidermal eumelanin (Vincensi et al., 1998). 
As well as the pigmentation status of the skin, the severity of photoageing also depends on the 
cumulative dose of UV exposure experienced during life (Kammeyer and Luiten, 2015). Solar 
UV radiation is divided into three categories according to their wavelength, which include UVA 
(320-400 nm), UVB (290-320nm) and UVC (200-290 nm). Sunlight is primarily composed of 
UVA (90-95%) and UVB (5-10%), whereas UVC is completely filtered by the atmosphere, and 
does not actually reach the earth (Amaro-Ortiz et al., 2014). UVA plays a significant role in 
photoageing since it penetrates through the epidermis and into the dermis, where it can damage 
ECM components. On the other hand, UVB does not penetrate deeply into the skin, with the 
majority of the energy being absorbed in the epidermis, and thus it is largely responsible for the 
development of sunburn (D’Orazio et al., 2013). Nevertheless, both UVA and UVB can cause 
damage to epidermal and dermal components and contribute to photoageing.     
Although the majority of UVB is absorbed in the stratum corneum, some also reaches viable 
epidermal cells, where it causes DNA damage through the formation of cyclobutane-pyrimidine 
dimers (CPDs) and pyrimidine-pyrimidone (6-4) photoproducts ((6-4)-PP) (Goodsell, 2001). 
UV radiation also leads to ROS generation, which in turn can damage DNA, giving rise to 
oxidative DNA lesions such as 8-hydroxy-2’-deoxyguanine (8-OHdG) (Meyskens et al., 2001; 
Kunisada et al., 2005). If this damage is not correctly repaired by the nuclear excision repair 
(NER) or base excision repair (BER) mechanism, keratinocytes can arrest in the cell cycle and 
become senescent (Lewis et al., 2008). Accumulation of damage can also lead to keratinocyte 
apoptosis (Qin et al., 2002), whereas other mutations, such as those in the p53 gene, can lead 
to malignant transformation and tumour initiation (Ziegler et al., 1994). Moreover, UVB is 
absorbed by aromatic amino acids in epidermal proteins, resulting in protein modifications 
which can be affect its function. Modified proteins can also form aggregates which are 
detrimental for cellular function if not efficiently degraded by the ubiquitin-proteasome system 
(Pattison and Davies, 2006).   
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Studies have shown that ROS produced in response to UVA irradiation stimulates the synthesis 
of MMPs via the activation of MAPKs in the epidermis and upper dermis (Klotz et al., 1999; 
Maziere et al., 2001). Briefly, activated MAPKs phosphorylate the transcription factor c-Jun, 
which is then translocated into the nucleus where it interacts with c-Fos, and increases the 
expression of the transcription factor AP-1 (Rittie and Fisher, 2002). AP-1 stimulates the 
transcription of different ECM-degrading enzymes such as MMP-1, -3, and -9, which together 
have the ability to completely degrade fibrillary collagen and elastin in the skin (Fisher et al., 
1996; Benbow and Brinckerhoff, 1997). Indeed, UV irradiation of human skin in vivo has been 
shown to induce expression of MMP-1, -3, and -9 with a concomitant increase in collagen 
degradation (Fisher et al., 1996; Fisher et al., 1997). Moreover, repeated UV exposure has been 
shown to trigger deposition of abnormal elastin in the dermis (Lavker et al., 1995). AP-1 also 
represses expression of collagen precursors (procollagen I and III), thus significantly impairing 
collagen synthesis (Chung et al., 1996). Imbalance in collagen homeostasis by UV exposure is 
also mediated through downregulation of the TGF-β pathway, which plays a role in stimulating 
production of procollagen I and III, and in reducing transcription on MMP-1 (also known as 
collagenase) in skin fibroblasts (Massague, 1998). It has been shown that UV irradiation 
downregulates expression of TGF-β type II receptor in human skin in vivo (Quan et al., 2004), 
induces expression of Smad-7, an inhibitor of TGF-β signalling (Quan et al., 2005), and also 
reduces the levels of connective tissue growth factor (CCN2), which mediates the stimulatory 
effects of TGF-β on procollagen I synthesis (Quan et al., 2002). This results in diminished TGF-
β signalling, and impaired collagen homeostasis. Furthermore, it has been reported that UV 
exposure induces the expression of pro-inflammatory cytokines such as IL-1β in fibroblasts and 
keratinocytes in vitro, resulting in increased expression of MMP-1, which is one of the enzymes 
responsible for collagen degradation (Wlaschek et al., 1994; Wan et al., 2001). Another study 
proposed that UVB-induced wrinkling was mediated by keratinocyte IL-1α secretion, which 
can then diffuse into the dermis and stimulate the expression of elastase in skin fibroblasts. 
Increased elastase activity then leads to deterioration of elastic fibres in the dermis and 
contributes to wrinkle formation (Imokawa, 2009). Overall, UV irradiation activates 
intracellular signalling pathways that favour collagen and elastin degradation over production, 
contributing to the ECM deficit that is characteristic of aged skin.  
UV irradiation has also been shown to cause mitochondrial dysfunction, likely through 
damaging mitochondrial DNA (mtDNA) as a result of increased in ROS generation. Indeed, 
mtDNA is highly susceptible to oxidative stress, and accumulates more mutations than genomic 
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DNA due to a lack in repair mechanisms and histones (Yakes and Van Houten, 1997). Indeed, 
large-scale deletions in the mitochondrial genome have been associated with UV-induced 
photoageing of human skin (Berneburg et al., 1997; Birch-Machin et al., 1998). A study 
identified that a 4,977 base pair deletion in mtDNA, also known as “common deletion”, was 
more frequently found in sun-exposed skin compared with sun-protected sites of the same 
person, suggesting a role for mtDNA mutations in skin photoageing (Berneburg et al., 1997). 
Moreover, repeated exposure to sublethal doses of UVA irradiation induces these common 
deletions in the dermis of human skin in vivo and in skin fibroblasts in vitro, and causes 
mitochondrial dysfunction (Berneburg et al., 2005). Damage in mtDNA can also impair the 
oxidative phosphorylation process, which increases ROS generation, and in turn leads to further 
mutations in the mitochondrial genome (Wallace et al., 1998). In addition, inducing 
mitochondrial dysfunction by deletion of the mitochondrial antioxidant enzyme, Sod2,  has 
been shown to trigger cellular senescence and lead to skin ageing phenotypes in mice in vivo 
(Velarde et al., 2012). Therefore, mitochondrial dysfunction that arises as a result of UV 
exposure might also play a role in human skin ageing.  
Exposure of ex vivo human skin to suberythemal doses of UV radiation (i.e. doses that are not 
sufficient to provoke an erythemic response/reddening) has been shown to induce accumulation 
of p16 in basal epidermal cells (Pavey et al., 1999). Interestingly, p16 expression peaked at 24 
hours post-irradiation, and reduced at 72 hours, with p16-positive cells moving from the 
innermost basal and suprabasal layers to the outermost spinous and granular layers with time, 
reflecting the turnover of keratinocytes in the epidermis (Pavey et al., 1999). Additionally, it 
was later demonstrated that this increase in p16 expression corresponded to a G2 cell-cycle 
arrest of keratinocytes and melanocytes (Pavey et al., 2001). As well as facilitating DNA 
damage repair, a G2 arrest was also suggested to contribute to melanin synthesis and increased 
melanisation of keratinocytes, which protects against further UV-induced damage (Pavey et al., 
2001). Elevated p53 expression has also been demonstrated following UV radiation of human 
skin in vivo at doses that induce moderate erythema (Campbell et al., 1993). Therefore, given 
the damaging effects of UV radiation, it is likely that chronic UV exposure might contribute to 
senescent cell accumulation in the skin. Indeed, UVB radiation induces senescence in skin 
fibroblasts (Debacq-Chainiaux et al., 2005) and keratinocytes in vitro (Lewis et al., 2008), 
suggesting that senescence might occur as a protective response to ensure that UV-damaged 
cells harbouring extensive DNA mutations cannot replicate.  
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1.7.4. Senescence and skin ageing 
Senescent cells have been shown to accumulate in human skin in an age-dependent manner. 
Studies have reported an increase in Sen-β-Gal activity in both dermal fibroblasts and epidermal 
keratinocytes in the skin of older individuals in vivo (Dimri et al., 1995). Accordingly, the 
number of p16-positive cells has been shown to increase with age in both the dermis and 
epidermis of human skin in vivo (Ressler et al., 2006; Waaijer et al., 2012b). Since the skin is 
a highly proliferative tissue, and relies on proliferation of stem and differentiated cells for 
constant renewal, accumulation of senescent cells may contribute to tissue dysfunction by 
compromising homeostasis, regeneration and structure. In accordance to this, recent studies 
have demonstrated that generating living skin equivalent (LSE) models using neonatal dermal 
fibroblasts and keratinocytes from young donors (30 – 40 years) yields a more youthful-looking 
epidermis when compared to models that contain keratinocytes from older donors (53 – 66 
years) (Adamus et al., 2014). Moreover, overexpressing p16 in keratinocytes from young 
donors resulted in thinning of the epidermis, similar to the phenotype induced by keratinocytes 
from older donors. Silencing p16 expression in the aged donor LSE model resulted in 
morphological improvements such as epidermal thickening, suggesting that senescent cells 
might play an important role in the changes observed during skin ageing (Adamus et al., 2014). 
In agreement with this, inducing senescence in epidermal cells by Sod2 deletion, which causes 
mitochondrial dysfunction, leads to epidermal stem cell exhaustion, epidermal thinning, and 
delayed wound closure in old mice (Velarde et al., 2015). Therefore, these data suggest that 
epidermal cell senescence is a major contributor to skin ageing phenotypes.   
Accumulation of senescent cells can also contribute to skin ageing in a cell non-autonomous 
manner through secretion of SASP components. Indeed, senescent fibroblasts in vitro have 
increased expression of MMPs, whilst expression of MMP inhibitors, such as TIMP-1, is 
decreased, possibly contributing to an imbalance in ECM homeostasis (Millis et al., 1992). 
Moreover, MMPs have been shown to diffuse from the epidermis into the dermis following UV 
irradiation, where they can lead to degradation of dermal extracellular matrix (Quan et al., 
2009). In support of this, Waaijer et al. found an association between the number of p16-
positive cells in the epidermis and the morphology of elastin fibres in the papillary (upper) 
dermis, and a weaker association for the reticular (mid) dermis (Waaijer et al., 2016b). As 
previously mentioned, paracrine signalling has also been demonstrated to exist between UV-
irradiated keratinocytes and dermal fibroblasts, where IL-1α secreted from keratinocytes 
induced the expression of fibroblast elastase, the enzyme responsible for degrading elastin 
Chapter 1   Introduction 
47 
 
(Imokawa, 2009). Given that UV exposure can induce senescence in skin fibroblasts and 
keratinocytes (Debacq-Chainiaux et al., 2005; Lewis et al., 2008), and that the aforementioned 
pro-inflammatory factors and proteases are common components of the SASP (Coppe et al., 
2010b; Laberge et al., 2015; Waldera Lupa et al., 2015), then the accumulation of senescent 
cells, either via intrinsic ageing or photoageing, may contribute to age-associated degradation 
of dermal ECM through chronic exposure to the SASP. Interestingly, more recently, the histone 
variant H2A.J, which accumulates in senescent fibroblasts and promotes expression of SASP 
genes, was also shown to increase in epidermal cells of human skin in an age-dependent 
manner, suggesting that these cells also develop a SASP in vivo (Contrepois et al., 2017). 
Furthermore, fibroblasts isolated from chronic wounds show increased markers of senescence, 
including secretion of pro-inflammatory factors, suggesting that the prolonged presence of 
senescent cells impairs wound closure, likely through altering their microenvironment (Mendez 
et al., 1998; Vande Berg et al., 2005). This supports the notion that the accumulation of 
senescent cells in skin over long periods of time leads to a pro-inflammatory and ECM 
degradative environment.  
Other senescence-inducing stimuli have also been associated with skin ageing. For example, 
DNA damage has been shown to accumulate with age in human skin in vivo (Nassour et al., 
2016; Contrepois et al., 2017). Moreover, the frequency of DNA damage foci and TAF were 
shown to be higher in dermal fibroblasts isolated from older donors, with both markers being 
positively associated with chronological age (Waaijer et al., 2016a). An age-dependent increase 
in dysfunctional telomeres has also been reported in dermal fibroblasts in the skin of baboons, 
with one study showing that this correlated with increased p16 expression, suggesting that 
telomere dysfunction contributes to senescence during skin ageing (Herbig et al., 2006; 
Jeyapalan et al., 2007). Although it has been extensively reported that telomere length decreases 
with age in human skin in vivo (Lindsey et al., 1991; Butler et al., 1998; Friedrich et al., 2000; 
Nakamura et al., 2002), very few studies in humans have observed associations between DNA 
damage response proteins and telomeres in this tissue. However, telomere dysfunction-induced 
senescence has been reported in epidermal cells in vitro. For example, depletion of TRF2 in 
human keratinocytes, which causes uncapping, induces a senescence-like growth arrest with 
concomitant activation of p53 and p16, suggesting that telomere damage plays a role in 
keratinocyte senescence (Minty et al., 2008). Moreover, patients with the premature ageing 
disorder dyskeratosis congenita (DC), a condition associated with mutations in telomerase 
components TERT and TERC, and in genes involved in telomere maintenance, present with 
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many epidermal defects such as poor nail growth, early hair loss and skin atrophy (Knight et 
al., 1999; Vulliamy et al., 2001; Vulliamy et al., 2005; Savage et al., 2008; Buckingham and 
Klingelhutz, 2011). Indeed, keratinocytes isolated from DC patients have short telomeres and 
decreased proliferative capacity, suggesting that telomere dysfunction in these cells contributes 
to impaired epidermal homeostasis and skin ageing characteristics (Gourronc et al., 2010). 
Therefore, telomere dysfunction appears to be an important trigger of senescence in skin cells, 
and might also contribute to skin ageing.  
The majority of studies on cellular senescence in the skin have focused on fibroblasts and 
keratinocytes, whereas very little is known about the impact of melanocyte senescence in skin 
ageing. Indeed, p16-positive melanocytes have been shown to accumulate in human skin, which 
significantly associated with increased facial wrinkles, higher perceived age, and age-
associated elastin morphology (Waaijer et al., 2012b; Waaijer et al., 2016b). Unlike fibroblasts 
and other cell types, melanocyte senescence in vitro has been shown to be mainly dependent on 
the p16/pRb pathway (Bandyopadhyay and Medrano, 2000). Inducing melanocyte senescence, 
either by replicative exhaustion or stimulating melanogenesis, results in upregulation of p16, 
whilst p21 levels were shown to decrease (Bandyopadhyay and Medrano, 2000; 
Bandyopadhyay et al., 2001). However, an increase in p21 levels is observed upon UVB 
irradiation of human melanocytes, which possibly mediates the G1 growth arrest in order to 
allow repair of UV-induced DNA damage (Medrano et al., 1995). Therefore, in human 
melanocytes the p21/p53 pathway appears to play a role in the stress response but it may not be 
crucial for the senescence program (Bandyopadhyay et al., 2001). Consistent with this, mice 
overexpressing a hyperactive p53 mutant show signs of accelerated ageing in many tissues, 
including dermal thinning and hair sparseness; however, no pigmentation defects were 
observed in the hair and skin of these mice (Tyner et al., 2002). Given that melanocyte 
proliferation and differentiation are required for cyclic regeneration of the hair pigmentation 
unit (Botchkareva et al., 2001), these results indicate that melanocytes remained functional in 
mutant mice, suggesting that p53 overactivation does not induce melanocyte senescence in vivo 
(Tyner et al., 2002). 
Although the role of telomere dysfunction in melanocyte senescence has also been poorly 
explored, it has been shown that telomerase overexpression significantly extends the replicative 
lifespan of melanocytes, suggesting that telomere shortening plays a role in melanocyte 
senescence in culture (Bandyopadhyay et al., 2001). However, studies conducted in human 
nevi, which consist of oncogene-induced senescent melanocytes, showed that telomeres in these 
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cells were not shorter when compared to surrounding tissues, indicating that telomere 
shortening does not occur in melanocyte senescence in vivo, or at least not as a result of 
oncogene activation (Suram et al., 2012).  
As well as playing a role in senescence signalling, telomeres have also been shown to be 
important in the melanin synthesis process (i.e. melanogenesis). As previously mentioned, UV 
irradiation induces oxidative DNA damage, which preferentially accumulates at guanine 
repeats, regions that are enriched at telomeres (Oikawa and Kawanishi, 1999). Melanogenesis 
occurs in melanocytes as a response to UV-induced DNA damage (Freeman et al., 1989), and 
telomere disruption has been proposed to be involved in this process. For example, UV-induced 
melanin production can be mimicked by the use of T-oligos, DNA nucleotides homologous to 
telomeric sequences (Gilchrest et al., 2009). In fact, T-oligos that have greater telomere 
homology are more effective at increasing melanin content in murine melanoma cells in vitro 
and in human skin explants (Arad et al., 2006; Gilchrest et al., 2009). Moreover, inducing 
telomere uncapping by expression of a dominant-negative allele of TRF2 increases the melanin 
content of melanocytes in culture (Gilchrest et al., 2009). This tanning response is largely 
mediated by p53, as cells expressing a dominant-negative p53 do not show increased 
melanogenesis in response to UV irradiation, suggesting that melanin synthesis is a p53-
mediated adaptive response of melanocytes to DNA damage (Khlgatian et al., 2002). Therefore, 
it appears that telomeres in melanocytes act as sensors of damage, and coordinate responses 
such as melanogenesis and senescence. Moreover, it is possible that repeated exposure to solar 
irradiation throughout an individual’s life may induce extensive telomeric DNA damage, 
eventually triggering melanocyte senescence, and accumulation of these cells might contribute 
to age-related skin characteristics.  
Overall, although the specific trigger of senescence during skin ageing is still unclear, both 
chronological and photo-ageing contribute to an increase in senescent cells in the skin with age. 
Telomere damage signalling might represent a common pathway driving senescence in both 
scenarios, and accumulation of senescent cells might be major contributor to age-associated 
skin changes.  
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 Research aims 
Although cellular senescence has been implicated in human skin ageing, the majority of studies 
focus on keratinocyte and fibroblast senescence, whilst the impact of melanocyte senescence in 
the skin ageing process remains largely understudied. Moreover, the role of telomere 
dysfunction during melanocyte senescence and human skin ageing has been poorly 
investigated. The overall aim of this research was to investigate the role of telomere dysfunction 
in melanocyte senescence, and assess whether senescent melanocytes can contribute to age-
associated skin changes by affecting surrounding healthy cells through paracrine mechanisms.  
Specifically, the aims of this study were: 
1) To investigate melanocyte senescence in human skin ageing in vivo and determine the 
involvement of telomere dysfunction in this process; 
2) To characterise different models of melanocyte senescence in vitro, and determine 
whether telomere dysfunction was causal in the induction of senescence; 
3) To investigate whether senescent melanocytes could induce paracrine damage in 
surrounding cells through secretion of SASP factors, and if so, to determine the effects 
of paracrine damage induction in skin ageing phenotypes. 
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Chapter 2: Materials and Methods 
 
 Chemicals and Reagents 
Unless otherwise stated, all chemicals were obtained from Sigma-Aldrich Company Ltd (Poole, 
Dorset, UK). 
 Buffers and Solutions 
Table 2.1 outlines a list of buffers and solutions used during this research. 
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Solution Components 
Sen-β-Gal staining solution 150mM NaCl, 2mM MgCl2, 40mM citric acid, 12mM 
sodium phosphate pH 6.0, 400μg/ml X-Gal, 2.1mg/ml 
potassium hexacyanoferrat (II) trihydrate, 1.65mg/ml 
potassium hexacyanoferrat (III) trihydrate 
PBG-Triton 0.2% fish skin gelatin (Sigma, G7765), 0.5% BSA, 
0.5% Triton X-100, 1% PBS 
Hybridisation buffer for 
Immuno-FISH 
70% deionised formamide (Sigma), 25mM MgCl2, 1M 
Tris pH 7.2, 5% blocking reagent (Roche, Welwyn, 
UK), 4ng/μL Cy-3 labelled telomere specific 
(CCCTAA) peptide nucleic acid probe (Panagene, 
F1002-5), distilled H2O 
FISH wash buffer 70% formamide in 2 x SSC 
2 x SSC 17.53g NaCl, 8.82g sodium citrate, 1L distilled H2O 
(pH 7.0) 
Citrate buffer (0.01M) 29.41g trisodium citrate, 1L distilled H2O (pH 6.0) 
 
RIPA buffer 150mM NaCl, 1% Triton X-100, 0.5% sodium 
deoxycholate, 0.1% SDS, 50mM Tris pH 8.0, 1x 
phosphatase and protease inhibitors cocktail 
(ThermoFisher Scientific, 78442) 
Haematoxylin 5g haematoxylin, 40ml glacial acetic acid, 0.5g sodium 
iodate, 300ml glycerin, 50g aluminium potassium 
sulphate, in 700 ml H2O 
TBS-Triton 50mM Tris, 150mM NaCl and 0.25% Triton X-100, 
(pH 7.0) 
TAE buffer (50X) 242g Tris base dissolved in H2O, 57.1ml glacial acetic 
acid, 100ml of 500mM EDTA (pH 8.0), 1L distilled 
H2O 
LB medium 10g bacto-tryptone, 5g bacto-yeast extract, 10g NaCl 
made up to 1L H2O and autoclave 
Table 2.1 – Buffers and solutions used in this study. 
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 Cell culture 
2.3.1. Primary cells 
Primary human epidermal melanocytes were obtained from ThermoFisher Scientific (HEMn-
LP, #C0025C) and Lonza (NHEM-Neo, CC-2504) (Walkersville, MD, USA). Cells were 
isolated from the foreskin of lightly-pigmented neonatal donors. 
Primary human dermal fibroblasts isolated from neonatal foreskin were obtained from Lonza 
(NHDF, CC-2509).  
2.3.2. Cell culture 
Normal human epidermal melanocytes (NHEM) were cultured in MBM-4 basal medium 
supplemented with MGM-4 SingleQuot Supplements and Growth Factors (Lonza, CC-3249) 
and maintained at 37° C, 5% CO2. Cell culture was done using aseptic technique in a class II 
safety cabinet. Cell passaging included a phosphate buffered saline (PBS) wash, and 
trypsinisation was carried out using pre-warmed 0.05% Trypsin-EDTA (TE) (ThermoFisher, 
25300-062) at 37°C followed by neutralisation with an equal amount of trypsin neutraliser 
solution (ThermoFisher, R-002-100), and cell culture medium was then added to the 
suspension. Cells were collected by centrifugation, resuspended in fresh medium at the desired 
density and reseeded into tissue culture flasks or dishes. 
Normal human dermal fibroblasts (NHDF) were cultured in Dulbecco’s Modified Eagle’s 
Medium (DMEM) supplemented with foetal bovine serum (FBS) (10% v/v) (Sigma, 12133C), 
L-glutamine (2mM) (Sigma, G3126), penicillin (100 units/ml)/streptomycin (100 μg/ml) 
(Sigma, P4333) and maintained at 37° C, 5% CO2. Cell passaging included a PBS wash, and 
trypsinisation was carried out using pre-warmed Trypsin-EDTA (0.5% Trypsin, 0.2% EDTA) 
(Sigma, T3924) at 37°C followed by neutralisation with cell culture medium. Cells were 
collected by centrifugation, resuspended in fresh medium at the desired density and reseeded 
into tissue culture flasks or dishes. 
2.3.3. Cryogenic storage 
For melanocytes, freezing medium composed of melanocyte culture medium containing 30% 
dimethyl sulfoxide (DMSO) (Sigma, D2650) and 20% FBS was prepared in advance, filtered 
through a 0.2μm filter and stored at 4°C until it was needed.  
Exponentially growing adherent cells were trypsinised and centrifuged at 800 g for 5 minutes 
at room temperature. The supernatant was removed and melanocytes were resuspended in FBS 
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containing 50% (v/v) melanocyte freezing medium at a density of 1 x 106 cells/ml. For dermal 
fibroblasts, cells were resuspended in FBS containing 5% (v/v) DMSO also at a density of 1 x 
106 cells/ml. Aliquots of 1ml of cell suspension were immediately transferred to cryo-vials and 
placed in a NalgeneTM Cryo freezing container filled with isopropanol (ThermoFisher, 5100-
0001). Cells were placed at -80° for 24 hours to allow slow freezing prior to long-term storage 
in liquid nitrogen.  
2.3.4. Resuscitation of frozen cells 
Cryo-vials were removed from liquid nitrogen and immediately thawed for 1 to 2 minutes at 
37°C. Cells were then seeded in a 75 cm2 flask with 15ml pre-warmed medium. Fresh medium 
was added 24 hours later to remove DMSO and cell debris.  
2.3.5. Calculating cell density and population doublings 
Cell concentration at each passage was determined using a 0.2 mm Fuchs-Rosenthal 
haemocytometer (VWR International UK) with 20μl of cell suspension. Using a standard 
microscope (DMIL, Leica Microsystems,UK), cells were manually counted and the average of 
four counts of 8 adjacent squares was taken, giving the number of cells x 104/ml. Total number 
of cells was then calculated by multiplying the number of cells per ml by the total volume of 
cell suspension. In order to calculate population doubling (PD), the total cell number harvested 
and the number of cells previously seeded are necessary, and the following equation was used: 
PD = X + (ln(N1/N2)/ln2 
Where: 
PD = population doubling 
X = previous PD 
N1 = number of cells harvested 
N2 = number of cells treated 
 Cell treatments 
2.4.1. Replicative senescence 
Melanocyte replicate senescence was achieved by replicative exhaustion, and confirmed by 
over 80% of cells being positive for Sen-β-Gal, negative for the proliferation marker Ki67, and 
less than 0.5 PDs for at least 4 weeks. 
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2.4.2. X-ray irradiation  
Melanocytes at early passages (P5-P12) were seeded onto flasks or 6/12/24-well plates 
(Corning) 48 hours prior to irradiation. Cells were then exposed to 10Gy X-ray irradiation (X-
Rad 225, Precision X-Ray INC, N-Branford, CT, USA), and medium was refreshed 
immediately after treatment.   
2.4.3. Ultraviolet (UV) irradiation 
The UVA and UVB sources consisted of a Dr Honle SOL 500s lamp (Dr. Honle AG UV 
Technology, Munich, Germany) equipped with a UVA+UVB filter glass (Eurobond 
Adhesives), and emitting in the spectral range of 320-400 nm for UVA and 295-315 nm for 
UVB. No residual UVC is emitted. The time necessary to achieve the doses used in this study 
were measured using a UV meter (Honle UV Technology, serial no. 503337) prior to each 
exposure.  
Melanocytes at early passages (P5-P12) were seeded onto 6-/12-/24-well plates or 10 cm2 
dishes 48 hours prior to irradiation. Before UV exposure, culture medium was aspirated and 
replaced with pre-warmed PBS (+Ca2+, +Mg2) (ThermoFisher, 14040174). For genotoxic stress 
generation, cells were exposed to 0.4 J/cm2 of UVA and UVB, and fresh medium was added 
immediately after irradiation. Treatment was repeated once a day for five consecutive days. 
Control cells were treated identically but not exposed to UV irradiation.  
 Treatments 
2.5.1. Inhibition of mTORC1 
Melanocytes at early passages (P5-P12) were irradiated with 10Gy X-ray irradiation, and 
treated with 100nM rapamycin (Sigma, R8781) for 10 days. Rapamycin was replaced every 2 
days. Control cells were treated with the same concentration of DMSO.  
Rapamycin was removed, and cells were washed in pre-warmed PBS, 24 hours before cells and 
conditioned media were collected to be used in bystander experiments in order to ensure that 
no rapamycin was present during fibroblast culture.  
2.5.2. Inhibition of CXCR3 
In order to inhibit the chemokine receptor CXCR3, X-ray irradiated melanocytes were treated 
with 10μM AMG487 (Tocris, 4487) immediately following irradiation. Treatment was 
refreshed every 2 days, and cells were treated for 10 days before being harvested for analysis. 
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For bystander effect experiments, dermal fibroblasts cultured in senescent melanocyte 
conditioned media were treated with 10μM AMG487 (Tocris, 4487) for the duration of the 
experiment (48 hours). 
2.5.3. MitoQ treatment  
In order to assess the role of intracellular ROS in paracrine DNA damage induction, dermal 
fibroblasts cultured in senescent melanocyte conditioned media were treated with the 
mitochondria-targeted antioxidant MitoQ (provided and developed by Prof Mike Murphy) 
(20nM, diluted in dH2O) for the duration of the experiment (48 hours). Note that prior to the 
addition of melanocyte conditioned media, fibroblasts were pre-treated with MitoQ for 6 hours 
in normal culture conditions.  
 Co-culture of melanocytes with dermal fibroblasts 
Melanocytes were seeded together with early passage dermal fibroblasts (P8-13) in coverslips 
in 12-well plates at a 3:1 melanocyte: fibroblast ratio. Cells were co-cultured in culture medium 
containing a mixture of 50% MGM-4 and 50% DMEM, and were harvested for analysis 48 
hours after the co-culture was established.   
 Culture of dermal fibroblasts with melanocyte conditioned medium 
In order to assess paracrine DNA damage induction by secreted soluble factors, conditioned 
medium from control (proliferating) and stress-induced melanocytes (10Gy X-ray irradiation) 
was collected at 11 days following irradiation. Upon collection, conditioned medium was 
centrifuged at 1600 RPM for 5 minutes to eliminate any cell debris before it was added to 
fibroblasts.  
For short-term culture, early passage dermal fibroblasts (P8-13) were seeded onto glass 
coverslips in 12-well plates at a density of 2.5 x 104 cells/well 48 hours prior to treatment. 
Melanocyte conditioned medium was then added to fibroblasts at a ratio of 1:1 DMEM: 
conditioned medium, and cells were harvested 48 hours following initial treatment.   
For longer-term culture, fibroblasts (P8-13) were seeded in 25 cm2 flasks 48 hours prior to 
treatment. Melanocyte conditioned medium was then added to fibroblasts at a ratio of 1:1 
DMEM: conditioned medium. Medium was replenished every 3 days for the duration of the 
experiment (20 or 30 days). At either day 18 or 28, respectively, fibroblasts were trypsined and 
reseeded onto glass coverslips in 24-well plates. Cells were then harvested at 20 or 30 days 
following initial treatment.  
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 Creating stably expressing Flag-TRF1-FokI-NHEM melanocyte cell lines 
The fragments 3xFlag-TRF1-Fok1 and 3xFlag-TRF1-Fok1 (D450A) (contains a single 
nucleotide mutation which inactivates the endonuclease) were cloned into the doxycycline-
inducible lentiviral pCW57.1 backbone. The following steps were conducted: 
2.8.1. Plasmid expansion and purification 
Plasmid elution 
Plasmids (3xFlag-TRF1-Fok1 and 3xFlag-TRF1-Fok1 (D450A) were received precipitated on 
filter paper. The plasmid DNA was eluted by cutting out a small section of filter paper using 
sterile scissors, and placing it into a 1.5ml micro-centrifuge tube with 20μl of nuclease-free 
H2O. The filter paper was then mixed with the H2O using a sterile pipette tip, and left at room 
temperature for 2 minutes. 
Bacterial transformation 
2μl of eluted plasmid DNA (100pg – 100ng plasmid DNA) was added to 10μl of NEB Stable 
Competent E. coli cells, and mixed by gently flicking 5 times. The mixture was left on ice for 
30 minutes, and the cells were then heat shocked at 42°C for 30 seconds, and placed on ice for 
5 minutes. Next, 500μl of SOC outgrowth medium (Invitrogen, Cat. Number 15544-034) was 
added to the mixture, which was then placed on an orbital shaker at 250 RPM at 30°C for 60 
minutes. Meanwhile, agar selection plates with the appropriate antibiotic drug were warmed up 
at 30°C. Following the incubation period, cells were mixed thoroughly by flicking the tube, and 
50-100μl of cell suspension was streaked onto the agar selection plates. Cells were incubated 
for 24 hours at 30°C. 
Alternatively, when using previously transformed NEB Stable Competent E. coli cells that were 
stored in glycerol at -80°C, 50-100μl of cell stocks were transferred to SOC medium by using 
a sterile pipette tip. Cell suspension was streaked onto pre-warmed agar selection plates, and 
incubated 24 hours at 30°C.  
Plasmid expansion 
A single NEB Stable Competent E. coli colony was picked using a sterile pipette tip, which was 
then placed in 5ml lysogeny broth (LB) medium (Table 2.1) and incubated with horizontal 
shaking at 30°C for 6 hours. The cell suspension was then transferred to a vented conical flask 
containing 100ml LB with antibiotics (50ng/ml Ampicillin), and incubated on an orbital shaker 
at 180RPM at 30°C for 24 hours.  
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Bacterial glycerol stocks 
In order to make bacterial glycerol stocks, 2ml of cell suspension from the previous step was 
transferred to a 15ml centrifuge tube and centrifuged at 5000g for 10 minutes at room 
temperature. The supernatant was then aspirated and the cell pellet was re-suspended in 1ml of 
a solution containing 30% glycerol: 70% LB (v/v), and was then placed in a cryovial for long-
term storage at -80°C. 
Plasmid isolation 
Following expansion, plasmids were purified from NEB Stable Competent E. coli cells using 
the PureYieldTM Plasmid Midiprep System (Promega). Briefly, 100ml of LB and NEB Stable 
Competent E. coli cell suspension was transferred into two 50ml centrifuge tubes, and 
centrifuged at 5000g for 10 minutes at room temperature. The pellets were then re-suspended 
in 3ml of Cell Suspension Solution and combined together, followed by the addition of 3ml of 
Cell Lysis Solution, and then mixed by inverting 5 times. Following a 3 minute incubation, 5ml 
of Neutralisation Solution was added and mixed by inverting 10 times, and the lysates were 
centrifuged at 15,000g for 15 minutes. A PureYieldTM Clearing Column (blue) was placed on 
top of a PureYieldTM Binding Column (white) and assembled onto a vacuum pump. The liquid 
was poured into the column stack and a vacuum was applied until the solution was drawn 
through. 5ml of Endotoxin Removal Wash was added to the binding column, and again the 
solution was pulled through by applying a vacuum. 20ml of Column Wash was added, and a 
vacuum was applied to pull all the solution through. A vacuum was then applied to the dry 
binding column for 60 seconds, and was then removed and placed onto a paper towel to remove 
any excess ethanol. 
The DNA was eluted by placing the binding column into a clean 50ml centrifuge tube, followed 
by the addition of 600μl of nuclease-free H2O and incubating for 1 minute. Next, the binding 
column was centrifuged at 2,000g for 5 minutes in a swinging bucket rotor centrifuge, and the 
filtrate was collected into a clean 1.5ml Eppendorf tube.  
Assessing nucleic acid purity and quantification 
DNA quality and quantification was performed using Nanodrop® 1000 spectrophotometer 
(Thermo Scientific). For purity, a 260/280 ratio of around 1.8 was considered satisfactory. 
Plasmid solutions were stored at -20°C for future use.  
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2.8.2. Molecular cloning 
Following DNA purification, a Gibson assembly was performed in order to clone the 3xFlag-
TRF1-FokI and 3xFlag-TRF1-FokI (D450) fragments into the doxycycline-inducible pCW57.1 
lentiviral backbone. A GFP insert was also cloned into the final vector (Figure 2.1). 
Briefly, the Gibson assembly is a method of molecular cloning in which multiple DNA 
fragments can be joined by using a single, isothermal reaction. The DNA fragments should 
contain around 20-40 base pair overlap with the adjacent DNA fragments, which is added by 
PCR. The Gibson assembly reaction involves the activity of three enzymes: an exonuclease, 
which digests the 5’ end of the DNA, resulting in single-stranded regions that the DNA 
fragments can anneal; a DNA polymerase, which adds nucleotides to fill in any gaps once the 
fragments have annealed; and a DNA ligase, which covalently joins the adjacent fragments 
(Gibson et al., 2009).  
 
 
Figure 2.1 - Plasmid map of pCW57.1-GFP-3xFlag-TRF1-FokI. 
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Adding overlap regions into the fragments of interest by PCR 
Primers were designed in order to amplify the inserts of interest out of the HFUW backbone by 
PCR. The resulting fragments will contain a region of overlap with the adjacent fragments of 
interest (i.e. GFP and pCW57.1). Overlap regions were also added to the pCW57.1 backbone 
and to the GFP insert by the same method. Primers were designed using Benchling.  
The following was added to a PCR tube: 1μl 10X PfuUltra II Fusion HS DNA Polymerase 
(Agilent Technologies, 600670), 5μl 10X PfuUltra II reaction buffer + Mg2+, 2μl dNTP mix 
(10 mM), 1μl DNA template (10ng/μl stock), 3μl forward primer (5μM stock), 3μl reverse 
primer (5μM stock), and 35μl of RNase-free H2O.  
The PCR reaction parameters were as follows: 
1. 95°C for 1 minute 
2. 95°C for 30 seconds 
3. 60°C for 90 seconds 
4. 72°C for 3 minutes 
5. Repeat cycles 2 – 4 30 times 
6. 72°C for 10 minutes 
Gel electrophoresis for purification of PCR products  
A 0.8% agarose gel was prepared by mixing 0.48g of agarose with 60 ml 1X TAE (Table 2.1). 
The mixture was microwaved until the agarose was dissolved. 1X SafeView Nucleic Acid Stain 
(NBS Biologicals, NBS-SV) was added to the gel mixture, which was then poured into a casting 
tray. Meanwhile, 10μl of 6X Gel Pilot® loading dye (Qiagen, 154015626) was added to 50μl 
of each DNA reaction mixture obtained from the PCR above. Once the gel had set, it was then 
transferred onto the electrophoresis tank, and 1X TAE was added until the gel was fully 
covered. 50μl of each DNA mixture was added to different wells, and a GeneRulerTM 1kb Plus 
DNA Ladder (Sigma Aldrich, D0428-1VL) was also used. The gel was run at 120V for 1 hour. 
Following completion, the gels were analysed under a UV lamp, and the bands corresponding 
to the expected molecular weight of each fragment were cut out with a clean, sharp scalpel, and 
placed into a 1.5ml Eppendorf tube.  
DNA extraction of purified PCR products 
DNA fragments were extracted from the agarose gel using the QIAquick Gel Extraction Kit 
(Cat No. 28704), and the manufacturer’s protocol was followed. All centrifugation steps were 
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carried out at 13,000 RPM in a conventional table-top microcentrifuge at 15-25°C. Briefly, the 
gel excised was weighed in an Eppendorf tube, and 3 volumes of Buffet QG was added to 1 
volume of gel (100mg ≈ 100μl). The gel was incubated at 50°C for 10 minutes until it was 
completely dissolved, and the mixture was vortexed. For DNA fragments less than 500 bp or 
over 4 kb, 1 gel volume of isopropanol was added to the sample. A QIAquick spin column was 
placed in a 2ml collection tube, and the sample was added to the QIAquick column, followed 
by 1 minute centrifugation in order to bind the DNA to the column. The flow-through was 
discarded, and the QIA quick column was placed back in the collection tube. 0.5ml of Buffer 
QG was added to the QIAquick column and centrifuged for another 1 minute. The flow-through 
was discarded. Next, 0.75ml of Buffer PE was added to the column, and centrifuged again for 
1 minute. The flow-through was discarded, and the dry column was centrifuged for an 
additional 1 minute. In order to elute the DNA, the QIAquick column was then placed in a clean 
1.5ml microcentrifuge tube, and 30μl of H2O was added to the centre of the QIAquick 
membrane. The column was left to stand for 1 minute, and then centrifuged for 1 minute.  
DNA concentration and purity were analysed using a Nanodrop® 1000 spectrophotometer 
(Thermo Scientific). 
DNA Assembly Reaction (Gibson assembly) 
Assembly of the DNA fragments obtained was performed by following the NEBuilder® HiFi 
DNA Assembly Reaction Protocol. Each reaction tube contained 20μl of mixture with the 
following: 
- 10μl NEBuilder HiFi DNA Assembly Master Mix (New England BioLabs, E2621L) 
- X μl of each DNA fragment (0.03-0.2 pmols) (The concentration of each fragment for 
optimal assembly was calculated based on fragment length and weight. Each insert was 
added at a 2:1 insert: backbone ratio) 
- Volume was completed to 20μl with H2O, if necessary  
Samples were incubated in a thermocycler at 50°C for 60 minutes. 
Bacterial transformation 
5μl of the above Gibson assembly products was added to 45μl of B100 E. coli competent cells, 
and mixed gently by flicking the tube 5 times. The mixture was placed on ice for 30 minutes, 
and then heat shocked at 42°C for 30 seconds. The tubes were placed on ice for 2 minutes, and 
950μl of SOC outgrowth medium (Invitrogen, Cat. Number 15544-034) was added. The cells 
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were incubated at 31°C for 60 minutes with shaking at 250RPM. Meanwhile, agar selection 
plates were warmed up to 31°C. The full volume of cells were streaked onto the agar plates, 
and incubated overnight at 31°C.  
Plasmid expansion 
Individual colonies were selected and grown overnight at 37°C in 5ml LB medium (Table 2.1) 
with Ampicillin (50ng/ml). 
Plasmid isolation 
Following expansion, plasmids were purified from B100 E. coli cells using the PureYieldTM 
Plasmid Midiprep System (Promega), as described above. 
Plasmid analysis 
Following plasmid purification, the plasmid DNA was digested with the XhoI and XbaI 
restriction enzymes to confirm that the Gibson assembly yielded the correct plasmids.   
2.8.3. Transfection and transduction protocols 
Lentiviral plasmid transfection and viral production were carried out following class II safety 
procedures.  
NEB Stable Competent E. Coli cells transformed with the packaging plasmid, d8.9, or the 
envelope protein, VSVG, were grown and expanded as previously described under “Plasmid 
expansion”. DNA was purified as described under “Plasmid isolation” using the PureYieldTM 
Plasmid Midiprep System (Promega).  
Lentiviral vectors were produced by transfection of a three plasmid system into HEK293FT 
cells. 5x106 HEK293FT cells were seeded in a 10cm dish and incubated for 24 hours in 
antibiotic-free DMEM (supplemented with 1:100 non-essential amino acids and 1:100 sodium 
pyruvate (10mM stock; Sigma Aldrich, S8636). Cells were at 80% confluency before 
proceeding to transfection using LipofectamineTM 3000 reagent (Invitrogen, L3000015), 
following the manufacturers’ protocol. The plasmids were mixed in a ratio of 1:1.5:2 
(envelope:packaging:transfer) by using 2.5μg of VSVG, 3.75μg of d8.9, and 5μg of either 
pCW57.1-GFP-3xFlag-TRF1-FokI or pCW57.1-GFP-3xFlag-TRF1-FokI(D450A). In the 
morning after the transfection, medium was removed from HEK293FT cells, and 10ml of fresh 
medium without antibiotics was added (note: melanocyte culture medium was added). Culture 
medium containing viral particles was harvested 24 hours later (i.e. 48 hours after transfection), 
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then filtered through a 0.45μm pore PVDF filter and mixed with polybrene (10μg/ml final 
concentration). The medium was then added to NHEM melanocytes at 70% confluency (note: 
different dilutions of viral particles were added, which ranged from 0 to 2). After 24 hours, 
fresh culture medium was added to NHEM melanocytes. The following day, selection of 
transduced cells was carried out by treating NHEM melanocytes with 1.5μg/ml Puromycin for 
5 days.  
 Flow cytometry 
Prior to use, the flow cytometer (Partec, http://www.partec.com) was calibrated using 
fluorescent microbeads in order to ensure optimum performance and reproducibility. Each 
measurement was performed in triplicate and 1 x 104 cells were analysed per measurement. 
2.9.1. Dihydroethidium 
Dihydroethidium (DHE) is a blue fluorescent dye, and upon oxidation by superoxide anions, it 
is converted into a red fluorescent product, which intercalates within the cell’s DNA. 
Melanocytes were harvested and centrifuged at 1600 RPM for 2 minutes. Supernatant was 
discarded and approximately 2.5 x 105 live cells were incubated with 10 M of DHE 
(Invitrogen, D1168) in serum-free MGM4 for 30 minutes at 37°C in the dark. Following another 
centrifugation at 1600 RPM for 2 minutes, supernatant was discarded, and cell pellet was 
resuspended in 2ml serum-free MGM-4. DHE median fluorescence intensity was then 
determined by flow cytometry using the red fluorescence channel (FL3 channel). An FSC/SSC 
dot plot was used to define the population of live cells and apoptotic cells and debris were 
excluded by gating.  
2.9.2. MitoSOX 
MitoSOX is a red fluorescent dye, which is used as a mitochondrial superoxide indicator. 
MitoSOX permeates the membrane of live cells and is selectively targeted to mitochondria, 
where it is oxidised by superoxide anions, exhibiting red fluorescence. Mitochondrial 
superoxide levels were determined using the same protocol as for DHE, however, cells were 
incubated with 5M MitoSOX Red (Invitrogen, M36008) for 10 minutes at 37°C in the dark. 
MitoSOX median fluorescence intensity was determined by flow cytometry using the red 
fluorescence channel (FL3 channel). 
  Subjects 
Young subjects consisted of white British subjects, ranging in age from 22 to 31 years. Skin 
punch biopsies of 4mm were obtained from the sun-protected site of the upper inner arm of 
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each donor, and were taken by a qualified dermatologist in 2007. The study was approved by 
the Colworth Ethics Committee (UCR2007-07), and subjects gave informed written consent 
prior to inclusion in this study. Data from 14 randomly selected Colworth donors were used in 
this study, with an age range from 22.8 to 31.8 years.  
Skin samples from older subjects were obtained from the Leiden Longevity Study (LLS). Study 
design and methodologies of the LLS have been previously described (Schoenmaker et al., 
2006). Briefly, the LLS consisted of men and women aged above 89 and 91 years, respectively, 
with at least one sibling who matches the same age criterion. The offspring of either long-lived 
sibling and the partners of the offspring were recruited to participate in the study. Skin punch 
biopsies of 4mm were taken from the sun-protected part of the upper-inner arm of each donor. 
The study protocol was approved by the Medical Ethics Committee of the Leiden University 
Medical Centre (following the declaration of Helsinki), and participants gave informed written 
consent. Data from 31 randomly selected LLS participants were used in this study, with an age 
range from 54.9 to 76.8 years. 
Skin biopsies were fixed in formalin (Sigma) overnight (18-24 hours), followed by washing 
and dehydration. Samples were then embedded in paraffin wax, cut into 4m sections and 
mounted onto glass slides. 
  Culture of human epidermal equivalents  
MelanoDerm (MatTek Corp., Ashland, MA) comprises normal human epidermal keratinocytes 
(NHEK) co-cultured with melanocytes (NHEM), which develop into a multi-layered, highly 
differentiated model of human epidermis.  
For this study, two different types of MelanoDerms were produced by MatTek Corporation 
(Ashland, MA), which contained neonatal human keratinocytes and either proliferating or UV-
induced senescent melanocytes. Tissues were then fixed in 10% neutral buffered formalin at 0, 
10 and 21 days post epidermal differentiation, followed by PBS washes and dehydration. 
Samples were paraffin embedded, cut into 4μm sections and mounted onto glass slides.   
  Immunofluorescence 
2.12.1. Immunocytochemistry (ICC) on fixed cells 
Cells grown on coverslips were fixed with 2% paraformaldehyde (PFA) (VWR, 9713.9010) in 
PBS for 5 minutes at room temperature. PFA was discarded, cells were washed with PBS twice, 
and stored at -80C for long term storage. Following permeabilisation in 1ml PBG-Triton for 
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45 minutes at room temperature, cells were incubated with primary antibody (Table 2.2) diluted 
in PBG-Triton overnight at 4C in a humidified chamber. Cells were then washed three times 
with PBG-Triton for 5 minutes and incubated with fluorescein-conjugated secondary antibody 
(Table 2.3) for 1 hour at room temperature in the dark with gentle shaking. Cells were washed 
three times in PBS for 5 minutes followed by mounting on to glass microscope slides with 
ProLong Gold Antifade Mountant with DAPI (Invitrogen, P36935). Slides were imaged using 
a Leica DM5500B microscope and images were captured with a DFC360FX camera using 
LASAF software (Leica). 
2.12.2. Immuno-FISH (γH2A.X-TeloFISH) on fixed cells  
Cells grown on coverslips were fixed and immunocytochemistry for γH2A.X was performed 
as described above. Subsequent to secondary antibody incubation, cells were washed twice in 
PBS and fluorescence in situ hybridisation (FISH) was performed.  
Cells were incubated in 1ml of fixative (methanol: acetic acid, 3:1) for 30 minutes, followed by 
dehydration in graded cold ethanol solutions (70, 90, 100%) for 2 minutes each. The samples 
were then incubated in PBS at 37°C for 5 minutes, and fixed in 4% PFA at 37°C for 2 minutes. 
Following a PBS wash, cells were dehydrated again with cold ethanol solutions (70, 90, 100%) 
for 2 minutes each, and were left to air dry. Coverslips were then placed onto glass slides 
containing 10μl of hybridisation buffer with PNA probe (Table 2.1) and samples were then 
denatured for 10 minutes at 80°C. Coverslips were incubated for 2 hours at room temperature 
in a humidified chamber in the dark to allow hybridisation to occur. Samples were then 
transferred back into a 12 well plate and washed three times in FISH wash buffer (Table 2.1) 
for 10 minutes, followed by three washes in 0.05% TBS-Tween for 5 minutes. Cells were then 
dehydrated in graded cold ethanol solutions (70, 90, 100%), and left to air dry before they were 
mounted onto glass microscope slides with ProLong Gold Antifade Mountant with DAPI 
(Invitrogen, P36935). Cells were imaged using a Leica DM5500B microscope and images were 
captured with a DFC360FX camera using LASAF software (Leica), or using a Leica DMi8 
wide field fluorescence microscope (inverted) equipped with a Hamamatsu C11440-22 camera 
using LASX software. In depth Z stacking was used (a minimum of 35 optical slices with 63x 
objectives), and quantification of DNA damage foci and telomere-associated foci was 
performed blinded using ImageJ software.  
 
 
Chapter 2   Materials and Methods 
66 
 
Antibody Species Specificity Dilution 
Anti-Ki67 (Abcam, 
ab15580) 
Rabbit polyclonal Human 
Mouse 
1:250 
Anti-phospho-
histone H2A.X 
(H2A.X) (Ser139) 
(Millipore, 05-636) 
Mouse monoclonal Human 1:200 
Anti-p16 (CINTec 
Histology, Roche, 
9511) 
Mouse monoclonal Human As provided in the 
kit 
Anti-p21 (Cell 
Signalling, 2947S) 
Rabbit monoclonal Human 
Monkey 
1:400 
Anti-MelanA 
(Santa Cruz, sc-
28871) 
Rabbit polyclonal Human 
Mouse 
Rat 
1:50 
Anti-CXCR3 
(Abcam, ab64714) 
Mouse monoclonal Human 1:400 
Table 2.2 – Primary antibodies used for immunofluorescence on fixed cells. 
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Antibody Species Specificity Dilution 
Anti-rabbit 
Fluorescein-
conjugated 
secondary antibody 
Alexa Fluor 594 
(Invitrogen, 
A11012) 
Goat Rabbit 1:4000 
Anti-rabbit 
Fluorescein-
conjugated 
secondary antibody 
Alexa Fluor 647 
(Invitrogen, 
A21244) 
Goat Rabbit 1:4000 
Anti-mouse 
Fluorescein-
conjugated 
secondary antibody 
Alexa Fluor 488 
(Invitrogen, 
A21042) 
Goat Mouse 1:4000 
Anti-mouse 
Fluorescein-
conjugated 
secondary antibody 
Alexa Fluor 594 
(Invitrogen, 
A11005) 
Goat Mouse 1:4000 
Table 2.3 – Secondary antibodies used for immunofluorescence on fixed cells. 
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2.12.3. Immunohistochemistry on paraffin embedded tissues 
Skin sections cut at 3m were deparaffinised in Histoclear (National Diagnostics, HS-200) 
twice for 5 minutes each, followed by hydration in a graded ethanol series: twice in 100% 
ethanol for 5 minutes, once in 90% for 5 minutes and once in 70% for 5 minutes, and two 
washes in distilled H2O for 5 minutes. Antigen retrieval was performed by incubating sections 
in 0.01M citrate buffer (pH 6.0) for 5 minutes at high power (800W) in a microwave oven, 
followed by 10 minutes at medium power (400W). Sections were placed on ice and allowed to 
cool to room temperature, followed by two washes in distilled H2O for 5 minutes. Next, sections 
were incubated in blocking reagent (normal goat serum (NGS) (Vector lab, PK-6101) diluted 
1:60 in 0.1% bovine serum albumin (BSA) (Sigma, A9418)) for 30 minutes at room 
temperature, followed by incubation with primary antibody (diluted in blocking reagent) 
overnight at 4C (Table 2.4). The next day, sections were washed three times in PBS for 5 
minutes, and then incubated with secondary antibody (diluted in blocking reagent) for 30 
minutes at room temperature (Table 2.5). For H2A.X staining, sections were incubated with a 
goat anti-rabbit biotinylated secondary antibody (1:200, diluted in blocking solution) (Vector 
Labs, VECTASTAIN, PK-6101) for 30 minutes at room temperature, and then washed three 
times with PBS for 5 minutes before being incubated with fluorescin avidin DCS (1:500) 
(Vector Lab, A-2011) (1:500, diluted in PBS) for another 30 minutes at room temperature. 
Following three PBS washes for 5 minutes, sections were mounted with ProLong Gold Antifade 
Mountant with DAPI (Invitrogen, P36935). Images were taken using a Leica DM5500B 
microscope and captured with a DFC360FX camera using LASAF software (Leica). Image 
analysis was performed using ImageJ software.  
2.12.4. Immuno-FISH (γH2AX-TeloFISH) staining on paraffin embedded tissues 
Following immunofluorescence for H2A.X, as described above, sections were washed three 
times in PBS, and then cross-linked by incubation in 4% PFA in PBS for 20 minutes at room 
temperature. Sections were washed in PBS three times for 5 minutes, and then dehydrated in 
graded ethanol solutions (70%, 90%, 100%, for 3 minutes each). Sections were allowed to air 
dry prior to being denatured in hybridisation buffer (Table 2.1) for 10 minutes at 80C, and 
then incubated for 2 hours at room temperature in a dark humidified chamber to allow 
hybridisation to occur. Sections were then washed for 10 minutes in FISH wash buffer (Table 
2.1), followed by a 10-minute wash in 2x SSC and another 10-minute wash in PBS. Sections 
were then mounted with ProLong Gold Antifade Mountant with DAPI (Invitrogen, P36935). 
Slides were imaged using a Leica DM5500B microscope and images were captured with a 
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DFC360FX camera using LASAF software (Leica), or using a Zeiss Spinning Disk confocal 
microscope equipped with a QuantEM 5125C camera and Axiovision software (Zeiss). In depth 
Z-stack was used (a minimum of 40 optical slices with 63x or 100x oil objective). DNA damage 
and telomere-associated foci were analysed in a blinded fashion using ImageJ software. 
 
Antibody Species Specificity Dilution 
Anti-Ki67 (Abcam, 
ab15580) 
Rabbit 
polyclonal 
Human 
Mouse 
1:250 
Anti-phospho-histone 
H2A.X (H2A.X) (Cell 
Signalling, 9718) 
Rabbit 
monoclonal 
Human 
Mouse 
1:400 
Anti-SIRT1 (Abcam, 
ab13749) 
Rabbit 
polyclonal 
Human 
Cow 
1:100 
Anti-MelanA (Dako, 
M7196) 
Mouse 
monoclonal 
Human 1:20 
Anti-8-oxoG (Millipore, 
MAB3560) 
Mouse 
monoclonal 
Human 
Rat 
Mouse 
Monkey 
1:100 
Anti-p16 (CINTec 
Histology, Roche, 
9511) 
Mouse 
monoclonal 
Human As provided in kit 
Anti-MelanA (Santa 
Cruz, sc-28871) 
Rabbit 
polyclonal 
Human 
Mouse 
Rat 
1:50 
Anti-CXCR3 (Abcam, 
ab64714) 
Mouse 
monoclonal 
Human 1:400 
Table 2.4 – Primary antibodies used for immunofluorescence in tissue. 
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Antibody Species Specificity Dilution 
Anti-rabbit Fluorescein-
conjugated secondary 
antibody Alexa Fluor 
488 (Invitrogen, 
A11008) 
Goat Rabbit 1:1000 
Anti-rabbit Fluorescein-
conjugated secondary 
antibody Alexa Fluor 
594 (Invitrogen, 
A11012) 
Goat Rabbit 1:1000 
Anti-mouse 
Fluorescein-conjugated 
secondary antibody 
Alexa Fluor 488 
(Invitrogen, A21042) 
Goat Mouse 1:1000 
Anti-mouse 
Fluorescein-conjugated 
secondary antibody 
Alexa Fluor 594 
(Invitrogen, A11005) 
Goat Mouse 1:1000 
Anti-mouse 
Fluorescein-conjugated 
secondary antibody 
Alexa Fluor 647 
(Invitrogen, A21235) 
Goat Mouse 1:1000 
Anti-rabbit IgG 
biotinylated 
(VECTASTAIN Elite 
ABC Kit) (Vector lab, 
PK-6101) 
Goat Rabbit 1:200 
Table 2.5 – Secondary antibodies used for immunofluorescence in tissue. 
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2.12.5. Q-FISH 
Quantitative-FISH (Q-FISH) analysis of telomere-FISH intensity was performed on fixed cells 
and paraffin-embedded tissue following immuno-FISH staining (as described above). Image 
analysis was performed using ImageJ software, where Z projections were created for each 
individual image and the oval tool was used to measure the integrated density of each individual 
telomere signal.  
  Haematoxylin and Eosin (H&E) staining 
Sections mounted onto glass slides were deparaffinised in Histoclear (National Diagnostics, 
HS-200) for 5 minutes, followed by re-hydration in a graded ethanol series: twice in 99% 
ethanol and once in 95% ethanol for 1 minute each, and then washed in distilled H2O for 5 
minutes. Sections were immersed in Harris Haematoxylin (6765003; Thermo Scientific) for 1 
minute, and rinsed in running tap water for 2-3 minutes. Sections were then counterstained in 
Eosin-Y (6766007; Thermo Scientific) for 2 minutes followed by washes under running tap 
water until clear. Next, sections were dehydrated through a graded ethanol series: once in 95% 
ethanol and twice in 99% ethanol for 1 minute each, then cleared in Histoclear and mounted in 
Di-N-Butyle Phthalate in Xylene (DPX) (Thermo Scientific, LAMB-DPX). 
Slides were imaged using a Nikon widefield microscope and images were captured with a Leica 
DFC420 camera using the LAS software (Leica) using a 20x objective. 
 Senescence-associated--galactosidase (Sen--Gal) staining in fixed cells 
Cells grown on glass coverslips were washed with PBS and fixed with 0.2% glutaraldehyde in 
2% PFA in PBS for 5 minutes. Cells were incubated in Sen--Gal staining solution (pH 6.0) 
(Table 2.1) overnight at 37C in the dark, followed by three 5-minute PBS washes, and were 
then mounted onto glass microscope slides using ProLong Gold Antifade Mountant with DAPI 
(Invitrogen, P36935). A minimum of 10 random fields were imaged (20x objective) using a 
Leica DM5500B microscope and captured with a Leica DFC420 camera using LASAF software 
(Leica). Cells were scored either positive (dark blue staining) or negative for Sen--Gal 
staining, and quantification was done using ImageJ software. 
  EdU incorporation  
In order to assess cell proliferation, cells were cultured in the presence of 10M EdU (diluted 
in fresh growth medium) for 24 hours. Cells were then washed twice in PBS for 5 minutes at 
37C, and then fixed with 2% PFA in PBS for 5 minutes (at this point, cells can be stored at -
80C for long term storage). Following two washes in 3% BSA in PBS for 5 minutes, cells were 
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permeabilised with 0.5% Triton X-100 for 20 minutes at room temperature, with gentle shaking 
on an orbital shaker.  
All subsequent EdU detection steps were carried out according to the manufacturer’s 
instructions (Click-iT EdU AlexaFluor Imaging Kit, ThermoFisher Scientific).  
Cells were imaged using a Leica DM5500B microscope and captured with a DFC360FX 
camera using LASAF software (Leica). Images were analysed using ImageJ software.  
  Morphometric skin measurements  
2.16.1. Skin biopsies 
The measurements of skin morphology characteristics have been previously described (Waaijer 
et al., 2012a). Briefly, two sections of each biopsy were stained with Orcein dye, and imaged 
for morphology analysis. Images were analysed semi-automatically using an image analysis 
software, and the measurements are shown in Figure 2.2. Epidermal thickness was obtained by 
dividing the area covered by the epidermis (area between yellow and blue lines) by the length 
of the epidermal-dermal junction (EDJ) (blue line) in micrometres. Moreover, curvature of the 
epidermis was derived from the ratio of a straight horizontal line between the margins of the 
epidermis (white line) over the length of the epidermal-dermal junction (blue line).      
     
 
Figure 2.2 – Morphometric measurements of the epidermis. Epidermal measures include 
thickness and curvature of the epidermis. Image adapted from (Waaijer et al., 2012a). 
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2.16.2. MelanoDerm epidermal thickness 
Haematoxylin and eosin staining was performed in human epidermal equivalent sections, which 
were then imaged (20x objectives) using a Nikon E800 widefield microscope and captured with 
a Leica DFC420 camera using LASAF software (Leica). For each section, the full length of the 
epidermis was imaged. Epidermal thickness was measured throughout the section using five 
randomly selected areas for each field by applying a randomly offset grid overlay on ImageJ. 
Mean per field and then mean per section were calculated. Data are plotted as mean thickness 
(μm) per section +/- SEM.  
 Analysis of pro-inflammatory cytokine release 
2.17.1. Luminex assay 
This assay involves microspheres which have been colour-coded with different concentrations 
of two fluorescent dyes (red and infra-red) at distinct ratios to create up to 100 distinct bead 
regions. Each microsphere is then coated with a specific capture antibody, which detects 
specific analytes in a test sample. Multiple conjugated beads can be added to each sample, 
allowing the detection of many different analytes in a single sample. The captured analytes are 
then detected by biotinylated detection antibodies, followed by addition of phycoerythrin (PE)-
conjugated streptavidin, which acts as a reporter molecule, binding to the biotinylated 
antibodies, and completing the reaction on the surface of each microsphere. The beads are then 
read on a dual-laser flow-based detection instrument, where one laser identifies the bead 
according to its colour-coding, and determines the identity of the analyte being analysed. The 
second laser determines the fluorescence intensity of the PE-derived signal, which is directly 
proportional to the amount of analyte bound, providing a concentration of each analyte of 
interest.  
In this study, detection of cytokines and chemokines in cell culture supernatants was performed 
using the following commercially available kits: Milliplex Human Cytokine/Chemokine 
Magnetic Bead Panel – Premixed 41 Plex (Merck Millipore, HCYTMAG-60K-PX41), and two 
custom panels (14-plex assay, LXSAHM-14; 3-plex assay, LXSAHM-03, R&D Systems), 
which were designed based on results obtained from the proteome profiler explained above. 
Protocol was followed according to manufacturer’s instructions. Assays were analysed using a 
Luminex 200 reader.      
  Gene expression analysis 
Gene expression analysis was performed on cultured normal human epidermal melanocytes. 
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2.18.1. RNA extraction 
Cells were trypsined and centrifuged at 150g for 5 minutes at 4°C. Following a PBS wash, cells 
were again centrifuged at 150g for 5 minutes at 4°C, and supernatant was then discarded. RNA 
extraction of cell pellets was carried out using the RNeasy Mini Kit (QIAGEN, Cat. Number 
74106), according to the manufacturer’s instructions. RNA quality and quantification was 
performed using Nanodrop® 1000 spectrophotometer (Thermo Scientific).  
2.18.2. cDNA synthesis 
For cDNA synthesis, 0.5g of RNA was used per reverse transcription reaction, and the High-
Capacity cDNA Reverse Transcription Kit (ThermoFisher Scientific, 4368814) was used, 
according to the manufacturer’s instructions. 
2.18.3. Real Time Polymerase Chain Reaction (RT-PCR) 
Each RT-PCR well contained 10l of Real time PCR reaction mix, which consisted of 4l of 
cDNA (200-800ng), 5l Power Syber® Green PCR Master Mix (Invitrogen, Cat. Number 
4367659), 0.2l of 10M reverse and forward primers, and 0.8l deionised H2O. See Table 2.6 
for primer sequences used. Each sample was run in triplicates in a C1000TM Thermal Cycler, 
CFX96TM Real-Time System (Bio-Rad) and Bio-Rad CXF Manager software. The 
thermocycler conditions were the following: 
1. 95C for 10 minutes 
2. 95C for 15 seconds   
3. 65C for 30 seconds  
4. Repeat 39X steps 2 and 3.  
Primer specificity was confirmed using a dissociation step with calculation of a melting curve. 
Quantification of mRNA expression was determined by normalising to the levels of an internal 
control mRNA (18S in this case). mRNA expression was calculated using the ΔΔC(t) method. 
Gene Species Sequence 
p16 Human Forward 5’-CGGTCGGAGGCCGATCCAG 
Reverse 5’-GCGCCGTGGAGCAGCAGCAGCT 
18S Human Forward 5’-GGCCCTGTAATTGGAATGAGTC 
Reverse 5’-CCAAGATCCAACTACGAGCTT 
Table 2.6 – Primer sequences for cDNA real-time PCR. 
Chapter 2   Materials and Methods 
75 
 
  Protein expression analysis 
2.19.1. Protein extraction 
Primary human melanocytes were washed with ice-cold PBS before addition of ice-cold RIPA 
buffer (Table 2.1) in order to lyse the cells. Samples were then stored at -80C until further 
analysis. 
2.19.2. Protein quantification 
Cell lysates were thawed on ice and centrifuged for 10 minutes at 16100g at 4C. In order to 
quantify sample protein concentration, a colorimetric Bio-Rad DC Protein Assay kit (Bio-Rad; 
Reagent A, 500-0113, Reagent B, 500-0114) was used according to the manufacturer’s 
instructions. Absorbance readings were measured using the Fluostar Omega plate reader (BMG 
Labtech). Protein concentration of each sample was then calculated and normalised by mixing 
specific volumes of protein lysate and loading buffer (950l of 2x Laemmli buffer (Bio-Rad, 
161-0737) and 50l of mercaptoethanol (Sigma, M6250)). Protein denaturation was carried out 
by incubating samples at 100C for 5 minutes, and samples were then placed on ice and used 
immediately for western blotting. 
2.19.3. Western blotting 
A running gel was prepared according to the size of the proteins of interest being analysed and 
poured into a cassette to allow polymerisation to occur (Invitrogen, NC2015 or NC2010) (see 
Table 2.7 for gel preparation). Subsequently, a 5% acrylamide staking gel was prepared, poured 
into the cassette and again allowed to polymerise. Gels were then placed in an XCell 
SureLockTM Mini-Cell Electrophoresis System (Invitrogen) and covered in Tris-Glycine 
running buffer (250M Tris, 1.92mM Glycine and 0.1% SDS). Samples were loaded in adjacent 
wells alongside a protein standard (Bio-Rad, 161-0374), followed by electrophoresis carried 
out at 120V, 35mA for 90 minutes. 
Proteins were then transferred from the gel onto a 0.45m polyvinylidene difluoride (PVDF) 
membrane (Millipore, IPVH00010) by placing both the membrane and the gels between 
transfer pads (VWR, 732-0594), which were soaked in transfer buffer (250M Tris, 1.93mM 
Glycine). Transfer was carried out using the Trans-Blot® SD Semi-Dry Transfer Cells (BioRad) 
at 20 volts for 1 hour. Following transfer, a Ponceaux red solution (0.5% Ponceaux and 5% 
acetic acid in H2O) was used to stain membranes and facilitate identification of protein bands.  
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The membrane was then blocked in blocking buffer (5% milk in 0.05% PBS-Tween) for 1 hour 
at room temperature with gentle shaking, followed by incubation with primary antibody (diluted 
in blocking buffer) overnight at 4C with gentle shaking (see Table 2.8 for primary antibodies 
used). Note that antibodies against phosphorylated proteins were diluted in 5% BSA in 0.05% 
PBS-Tween. Followed by three washes in distilled H2O, membranes were incubated with 
secondary antibody diluted in blocking buffer for 1 hour at room temperature, again with gentle 
shaking (see Table 2.9 for secondary antibodies). Membranes were washed three times with 
distilled H2O, once in 0.05% PBS-Tween for 5 minutes, and then again washed in distilled H2O 
(3-5 times) to remove excess Tween.  
Membranes were incubated with chemiluminescence agent ClarityTM Western ECL substrate 
(Bio-Rad, 170-5060) for 5 minutes, and visualised using Fuji film Intelligent Dark box II and 
Image Reader Las-1000 Software. Each protein of interest was confirmed by comparing the 
size of each protein band to the protein standard loaded. Signal intensity of protein bands was 
analysed using ImageJ analysis software. Background subtraction was applied, and signal 
intensity of the protein of interest was normalised to a loading control. 
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1x Stacking Gel (5ml) 5%     
Sterile H2O 3.4ml     
30% Acrylamide 850l     
1.5M Tris (pH 6.8) 1.3ml     
10% SDS 50l     
10% Ammonium 
persulphate (w/v in 
dH2O) 
50l     
TEMED 4l     
1x Running Gel 
(10ml) 
5% 8% 10% 12% 15% 
Protein Size (kDa) >250 250-120 120-40 20-15 <20 
Sterile H2O 6.8ml 5.1ml 4ml 3.3ml 2.3ml 
30% Acrylamide 1.7ml 2.6ml 3.3ml 4ml 5ml 
1.5M Tris (pH 8.8) 2.5ml 2.5ml 2.5ml 2.5ml 2.5ml 
10% SDS 100l 100l 100l 100l 100l 
10% Ammonium 
persulphate (w/v in 
dH2O) 100l 100l 100l 100l 100l 
TEMED 8l 4l 4l 4l 4l 
Table 2.7 - Running and stacking gels for Western blotting. 
 
 
 
 
 
 
 
 
Chapter 2   Materials and Methods 
78 
 
Antibody Species Specificity Dilution 
Anti-Akt (Cell Signalling, 
9272) 
Rabbit polyclonal Human 
Mouse 
1:1000 
Anti-p-Akt (S473) (Cell 
Signalling, 9271) 
Rabbit polyclonal Human 
Mouse 
1:1000 
Anti-Erk1/2 (p44/42 
MAPK) (Cell Signalling, 
9102)  
Rabbit polyclonal Human 
Mouse 
1:1000 
Anti-phospho ERK1/2 (p-
44/42 MAPK) 
(Thr202/Tyr204) (Cell 
Signalling, 9101) 
Rabbit polyclonal Human 
Mouse 
1:1000 
Anti-GAPDH (Cell 
Signalling, 5174) 
Rabbit monoclonal Human 
Mouse 
1:5000 
Anti-Lamin B1 (Abcam, 
ab16048) 
Rabbit polyclonal Human 
Mouse 
1:1000 
Anti-p16 (BD Pharmingen, 
550834) 
Mouse monoclonal Human 1:500 
Anti-p21 (Cell Signalling, 
2947) 
Rabbit polyclonal Human 
Mouse 
1:1000 
Anti-p70S6K (Cell 
Signalling, 9202) 
Rabbit polyclonal Human 
Mouse 
1:1000 
Anti-p70S6K (T389) (Cell 
Signalling, 9205) 
Rabbit polyclonal Human 
Mouse 
1:1000 
Anti-S6 (Ser235/236) (Cell 
Signalling, 2211) 
Rabbit monoclonal Human 
Mouse 
1:1000 
Anti-α-tubulin (Abcam, 
ab7291) 
Mouse monoclonal Human 
Mouse 
1:2000 
Anti-β-actin 
(Cell Signalling, 4970) 
Rabbit monoclonal Human 
Mouse 
Rat 
1:1000 
Table 2.8 – Primary antibodies used for Western blotting. 
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Antibody Species Specificity Dilution 
IgG-HRP 
conjugated (Sigma 
Aldrich, A0545) 
Goat Rabbit 1:5000 
IgG-HRP 
conjugated (Sigma 
Aldrich, A2554) 
Goat Mouse 1:5000 
Table 2.9 – Secondary antibodies used for Western blotting. 
 
 Statistical analysis 
Data are expressed as the, mean ± S.E.M. In instances where data were normally distributed, 
significant differences between two groups were analysed using an independent samples two-
tailed t-test, and multi-group comparison was assessed using a one- or two-way ANOVA. When 
a one-way ANOVA was used, a Tukey’s multiple comparison post-hoc test was also performed. 
In some cases, a two-way ANOVA was also performed to analyse significance between groups 
and a Bonferroni post-hoc test was used, unless stated otherwise. If data were not normally 
distributed, statistical analysis was carried out using the Mann-Whitney U test. P values less 
than 0.05 were considered statistically significant. Data were analysed using the following 
softwares: GraphPad Prism version 5.0 and 7.0, GraphPad software, San Diego, California, 
USA, www.graphpad.com; IBM SPSS statistics version 19; and SigmaPlot version 12.5 from 
Systat Software, Inc., San Jose, California, USA, www.systasoftware.com.  
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Chapter 3: Melanocytes accumulate telomere-associated DNA damage 
during human skin ageing 
Senescent cells have been shown to accumulate in human skin with age (Dimri et al., 1995; 
Ressler et al., 2006), and evidence suggests that accumulation of these cells contributes to age-
associated skin changes by compromising regeneration and structure (Adamus et al., 2014; 
Velarde et al., 2015). However, the majority of studies so far have focused on dermal fibroblasts 
and keratinocytes, whilst the contribution of senescent melanocytes to the skin ageing process 
remains poorly understood. It has been demonstrated that p16-positive melanocytes accumulate 
in human skin with age, and this correlated with increased facial wrinkles, higher perceived 
age, and age-associated elastin morphology (Waaijer et al., 2012b; Waaijer et al., 2016b), 
suggesting that senescent melanocytes might contribute to skin ageing characteristics. 
Furthermore, the role of telomere dysfunction in melanocyte senescence has also not been fully 
investigated. Although several studies have previously shown that telomere length decreases in 
human skin with age (Lindsey et al., 1991; Butler et al., 1998; Friedrich et al., 2000; Nakamura 
et al., 2002), very few reports have investigated whether telomeres trigger a DNA damage 
response in skin cells in vivo.  
Therefore, the aims of this study were to investigate the expression of senescence markers in 
melanocytes in human skin with age, in particular the involvement of telomere dysfunction in 
this process. In addition, I also aimed to investigate whether senescent melanocytes could act 
in a cell non-autonomous manner, and impact surrounding cells in the epidermis in vivo. 
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 Investigating the expression of senescence markers in melanocytes in human skin 
with age in vivo 
In order to characterise melanocyte senescence in vivo, I performed immunofluorescence to 
analyse the expression of a range of senescence markers in skin biopsies from young (22.8 to 
31.8 years old; mean age = 26.65) and older (55.6 to 67.5 years old; mean age = 61.6) human 
donors (Table 3.1). A marker for a melanocytic cell surface protein, known as melan-A, was 
also used to allow identification of each marker specifically in melanocytes. Firstly, in 
agreement with previous data (Gilchrest et al., 1979), the number of melanocytes significantly 
decreases with age, as shown by an approximate 2-fold decrease in the number of melan-A-
positive cells in the aged epidermis (P=0.002) (Figure 3.1 A, D, F).  
The cyclin-dependent kinase inhibitor, p16, is an important cell-cycle regulator, and has been 
shown to be highly expressed in senescent cells both in vitro and in vivo (Serrano et al., 1997; 
Lin et al., 1998; Herbig et al., 2006). Indeed, I found that there is a significant increase in the 
percentage of melanocytes positive for p16 in aged skin compared to younger donors (p=0.004) 
(Figure 3.1 B). Moreover, Sirtuin1 (SIRT1) is an NAD+-dependent protein deacetylase, which 
regulates p53 function and silences the expression of genes such as NF-κB through its histone 
deacetylase activity (Vaziri et al., 2001; Yeung et al., 2004; Oberdoerffer et al., 2008), and a 
decline in SIRT1 has been associated with ageing and senescence (Sasaki et al., 2006; Imai and 
Guarente, 2014). Immunofluorescence analysis of SIRT1 revealed a significant decrease in 
SIRT1 expression in melanocytes from older donors in vivo (P<0.0001) (Figure 3.1 C). 
Furthermore, I analysed the expression of the proliferation marker, Ki-67, demonstrating that 
the average number of proliferating melanocytes is low in both young and older skin (Figure 
3.1 D). Unexpectedly, I found that the number of Ki-67-positive melanocytes in aged epidermis 
is slightly higher when compared to younger skin; however, this difference is not statistically 
significant (P=0.23) (Figure 3.1 D, E).  
Together, these results demonstrate that melanocytes express senescence markers with age, 
indicating that senescent melanocytes accumulate in the epidermis of aged human skin in vivo.  
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 Group 
Young Older 
Age range 22.8 to 31.8 55.6 to 67.5 
Age (mean ± SD) 26.7 ± 2.9 61.6 ± 3.2 
Gender (M/F) 6/8 6/6 
Table 3.1 – Age range and gender of young and older subjects involved in this study. 
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Figure 3.1 – Expression of senescence markers in melanocytes in human skin in vivo. Skin 
biopsies obtained from young and older human donors were stained by immunofluorescence to 
analyse the expression of different markers of senescence. A marker for the melanocytic 
protein, melan-A, was also used to identify melanocytes. Dot plots show (A) mean number of 
melan-A-positive cells per field, (B) percentage of p16-positive melanocytes, (C) percentage 
of SIRT1-positive melanocytes and (E) mean number Ki-67-positive melanocytes per field for 
each individual donor. The horizontal line represents the mean for each group. Representative 
images of (D) SIRT1 (red) and (F) Ki67 (red) immunofluorescence staining together with the 
melanocyte marker melan-A (green) in young and older skin. White arrows indicate 
melanocytes. SIRT1 and Ki-67 images were taken using a 40x and 20x objective, respectively. 
Statistical significance was determined using a two-tailed unpaired t-test, **P<0.01, 
***P<0.001. (Analysis of p16 expression was done in collaboration with Jeff Pawlikowski and 
Peter Adams, and Ki-67 quantification was done in collaboration with Anthony Lagnado). 
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 Telomeres become dysfunctional with age in melanocytes in vivo  
In order to investigate whether telomere dysfunction is a feature of melanocyte senescence in 
vivo, I performed immuno-FISH combining immunofluorescence against γH2AX (a marker of 
DNA damage) and in situ hybridisation for telomeric specific PNA probe in skin biopsies from 
young and older donors. Firstly, to determine whether global DNA damage increases in 
melanocytes with age, I quantified the number of γH2AX foci, a well-established marker of 
DNA double stranded-breaks, in melanocytes. I found that there is a significant increase in the 
number of DNA damage foci in aged melanocytes when compared to those in younger skin (P 
= 0.04) (Figure 3.2 A). Next, in order to establish whether activation of a DDR at telomeres 
occurred with age, I analysed co-localisation of γH2AX with telomeres, which is also known 
as telomere-associated foci, or TAF. Melanocytes in aged skin have, on average, higher 
numbers of telomeres signalling a DNA damage response (P<0.0001) (Figure 3.2 B, D). I also 
found that a significantly higher percentage of melanocytes contain TAF in the skin of older 
donors (P = 0.0002), where 87% of aged melanocytes contain damaged telomeres compared to 
53% of young pigment cells, suggesting that telomere dysfunction plays a role in melanocyte 
ageing in vivo (Figure 3.2 C).  
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Figure 3.2 – Telomeres become dysfunctional in melanocytes in human skin with age. 
Immuno-FISH was performed in skin biopsies from young and older donors to analyse the 
DNA damage protein, γH2AX, and TAF. Dot plots show (A) mean number of γH2AX foci, (B) 
mean number of telomere-associated foci in melanocytes, and (C) the percentage of 
melanocytes containing TAF for each individual subject, which were obtained by analysing Z-
stacks of each skin section. The horizontal line represents the mean of each group. Statistical 
significance was analysed by using a two-tailed unpaired t-test, *P<0.05, ***P<0.001 (D) 
Representative immuno-FISH image in melanocytes (pink) in young and older skin sections. 
Telomeres are shown in red, and γH2AX foci are shown in green. Co-localisation of the two is 
indicative of TAF, which are indicated by the arrows and amplified on the right. Images are 
Huygen (SVI) deconvolved Z projections and were taken using a 100x oil objective.  
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Since a DNA damage response can be activated at telomeres as result of extensive attrition 
(Takai et al., 2003; Herbig et al., 2004), and telomere shortening has been shown to occur with 
ageing in many tissues, including the skin (Lindsey et al., 1991; Butler et al., 1998; Friedrich 
et al., 2000; Nakamura et al., 2002), I wanted to determine whether telomere damage in 
melanocytes occurred as a consequence of shortening. By performing quantitative fluorescent 
in situ hybridisation (Q-FISH) in skin biopsies from human donors and analysing individual 
telomere signal intensity, I found no significant difference in median telomere length between 
melanocytes from young and older skin (P=0.382) (Figure 3.3 A), suggesting that these cells 
do not undergo significant telomere shortening with age in vivo. To further investigate whether 
there was a shift in the length of telomeres in melanocytes with age, I divided FISH signal 
intensities into tertiles, where the first tertile represents lower intensities, and quantified the 
percentage of telomeres within each tertile for each donor. As seen in Figure 3.3 B, the majority 
of telomeres lie within the first tertile in both young and old donors, with no statistical 
significance between both groups in any tertile (P = 0.98), indicating that the range of telomere 
lengths remains the same in melanocytes with age. Moreover, I also analysed whether 
melanocytes of older donors contained more critically short telomeres by setting a threshold, 
such that anything below 10% of the highest FISH signal intensity was considered a very short 
telomere. Consistently, I did not find a significant difference in the percentage of very short 
telomeres in melanocytes in young and aged skin (P=0.52) (Figure 3.3 C), again demonstrating 
that there is no significant shortening with age. Interestingly, analysis of FISH intensity of 
individual telomeres revealed that telomeres co-localising with the DNA damage protein, 
γH2AX were significantly longer than γH2AX-negative ones (P<0.001) (Figure 3.3 D, E, F), 
suggesting that damage preferentially accumulates in longer telomeres in melanocytes in vivo.    
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Figure 3.3 – Longer telomeres are preferentially damaged in melanocytes in vivo. 
Quantitative FISH was performed in skin biopsies from young and older human donors, and 
FISH intensity of individual telomeres were analysed as a measure of length. Histograms 
showing (A) telomere signal intensities in melanocytes from young and older skin sections, and 
(D) intensity of γH2AX-negative and γH2AX-positive telomeres in melanocytes of both young 
and older biopsies. Red dotted line indicates median intensity. Statistical significance was 
determined by using a Mann-Whitney U test. (B) Percentage of telomeres in tertiles of FISH 
signal intensity, where the first tertile represents the lowest intensities. Statistical significance 
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was determined by a two-tailed unpaired T-test. Data are mean ± S.E.M. of percentage of 
telomeres in each tertile per donor. (C) Percentage of very short telomeres in melanocytes of 
young and old skin sections. A two-tailed unpaired T-test was performed for statistical analysis. 
Data are mean ± S.E.M. of percentage of very short telomeres per donor. (E) Representative 
immuno-FISH image (red: telomeres; green: γH2AX) of a melanocyte in the skin of an older 
donor (top), showing a longer telomere co-localising with γH2AX (a) and a shorter one which 
is γH2AX-negative (b). Images are Huygen (SVI) deconvolved Z projections and were taken 
using a 100x oil objective. (F) Graphs showing the quantification of telomere intensity of 
γH2AX-positive (a) and γH2AX-negative (b) telomeres. Red line indicates telomere intensity, 
and green shows γH2AX intensity. 
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 Investigating telomere dysfunction in melanocytes as a biomarker for age-related 
skin characteristics 
Since I showed that telomere dysfunction increases with age in melanocytes in human skin in 
vivo, I wanted to determine whether TAF in melanocytes could be used as a predictor of 
parameters associated with skin ageing. For this part of this study, I used skin biopsies from 22 
older donors, ranging from 54.9 to 76.8 years old (average age = 64.8 years). Amongst the 
morphometric skin characteristics available for these donors were epidermal thickness and 
curvature (provided by Unilever), two parameters which are known to be affected with age.  
In agreement with previous reports (Marks, 1981; Lavker et al., 1987; Grove, 1989; Farage et 
al., 2007), I found that epidermal thickness significantly decreases with age (P=0.04) (Figure 
3.4 A, C). Moreover, the curvature of the epidermis is also significantly lost with age (P=0.02) 
(Figure 3.4 B), giving the epidermal-dermal junction a flatter appearance, as shown in Figure 
3.4 C.  
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Figure 3.4 – Epidermal thickness and curvature decreases with age in older donor cohort. 
Graphs showing correlation between (A) epidermal thickness and age, (B) epidermal curvature 
and age for each individual donor. Note that a curvature value closer to 1 denotes a flatter EDJ. 
Correlation was determined using a Pearson’s correlation test. (C) Images showing thinning of 
the epidermis (blue arrows) and the loss in epidermal curvature (red-dotted lines) with age. Red 
dotted line represents the epidermal-dermal junction.  
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3.3.1. TAF in melanocytes does not correlate with epidermal thinning in skin of 
older donors 
To determine whether telomere dysfunction in melanocytes in vivo was a useful predictor of 
epidermal thinning in age skin, I performed immuno-FISH in skin biopsies of the older cohort 
of donors to analyse γH2AX co-localisation with telomeres. I found that the mean number of 
γH2AX foci in melanocytes did not correlate with the age-dependent decrease in epidermal 
thickness (P=0.6) (Figure 3.5 A). Moreover, although there is a slight tendency for epidermal 
thinning with increased TAF in melanocytes, this correlation was not statistically significant 
(P=0.4) (Figure 3.5 B). In addition, the percentage of melanocytes containing TAF in the 
epidermis of aged skin does not significantly correlate with decreased epidermal thickness 
(Figure 3.5 C), suggesting that telomere dysfunction in melanocytes does not successfully 
predict changes in epidermal thickness with age.  
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Figure 3.5 – Telomere dysfunction in melanocytes does not correlate with epidermal 
thinning. Immuno-FISH was performed in skin biopsies of 22 older donors. Graphs showing 
correlation between (A) the number of γH2AX foci, (B) number of TAF in melanocytes, and 
(C) percentage of melanocytes containing TAF, and epidermal thickness for each individual 
donor. Correlation was determined using a Pearson’s correlation test. When accounting for age, 
the statistical significance of each correlation was (A) P=0.1, (B) P=0.35, and (C) P=0.23.   
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3.3.2. Telomere dysfunction in melanocytes correlates with loss of epidermal 
curvature in aged skin  
Next, I found that the mean number of DNA damage foci in melanocytes positively correlates 
with flattening of the epidermis in the skin of older donors (P=0.02) (Figure 3.6 A). Moreover, 
loss of epidermal curvature positively correlates with the mean number of TAF in melanocytes 
(P=0.002) (Figure 3.6 B), and the percentage of melanocytes containing dysfunctional 
telomeres in the epidermis also shows a positive correlation with epidermal flattening in aged 
skin (P=0.0004) (Figure 3.6 C). These correlations remained statistically significant even when 
accounting for confounders such as subject age. In fact, the proportion of melanocytes 
containing TAF is the factor that correlates most strongly with the loss in epidermal curvature, 
suggesting that accumulation of TAF in melanocytes may be a potential marker of epidermal 
flattening in aged skin.  
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Figure 3.6 – TAF in melanocytes correlates with epidermal flattening in aged skin. 
Immuno-FISH was performed in skin biopsies of 22 older donors. Graphs showing correlations 
between (A) the number of γH2AX foci, (B) number of TAF in melanocytes, and (C) 
percentage of melanocytes containing TAF, and epidermal curvature for each individual donor. 
Correlation was determined using a Pearson’s correlation test. When accounting for subject 
age, the statistical significance for these correlations was (A) P=0.004, (B) P=0.007, and (C) 
P=0.001.  
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 Evidence for paracrine telomere damage induction by senescent melanocytes in 
human skin in vivo 
It has been shown that senescent cells can affect their environment and induce senescence in 
neighbouring cells via the secretion of pro-inflammatory cytokines and ROS (Nelson et al., 
2012; Acosta et al., 2013). Given this and the observation that telomere damage in melanocytes 
correlates with epidermal flattening, I wanted to investigate whether melanocytes containing 
dysfunctional telomeres (and are likely senescent) could induce paracrine damage in 
surrounding epidermal cells. Consequently, this could affect keratinocyte function and 
proliferation, and contribute to skin ageing phenotypes, such as epidermal flattening. 
I allocated melanocytes containing 0 to 3 TAF into separate groups, and analysed the amount 
of telomeres signalling a DDR in keratinocytes located in the immediate vicinity of each 
melanocyte, as demonstrated in Figure 3.7 C. In general, keratinocytes in the skin of older 
individuals have significantly more DNA damage foci when compared to cells in younger skin 
(P<0.01 and P<0.001 for cells around melanocytes with 0 and 1 TAF, respectively) (Figure 3.7 
A). Similarly, there is a significantly higher number of TAF in keratinocytes of older donors, 
suggesting that these cells also accumulate dysfunctional telomeres with age (P<0.05 for 
keratinocytes around melanocytes with 0 and 2 TAF, and P<0.001 for those around melanocytes 
with 1 TAF) (Figure 3.7 B).  
However, although the mean number of DNA damage foci tends to be higher in keratinocytes 
surrounding melanocytes with more TAF in both young and older skin sections, this increase 
is not statistically significant within each group (Figure 3.7 A). On the other hand, I found that 
telomeric damage is significantly higher in epidermal cells neighbouring melanocytes with a 
higher number of dysfunctional telomeres in both young and older skin (Figure 3.7 B). In the 
skin of young donors, cells in the vicinity of melanocytes containing 2 TAF have on average a 
significantly higher number of telomeres signalling a DDR when compared to cells surrounding 
melanocytes with 0 or 1 TAF (P<0.001). Similarly, in older skin, melanocytes with 3 TAF 
appear to induce significantly more telomere damage in surrounding cells when compared to 
melanocytes with 1 or no TAF (P=0.006) (Figure 3.7 C). In fact, there is an approximate 3-
fold increase in the amount of telomere-associated foci in cells in the vicinity of melanocytes 
containing 2 and 3 TAF (in young and old skin, respectively) in relation to those surrounding 
pigment cells without dysfunctional telomeres.  
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Figure 3.7 – Senescent melanocytes may induce paracrine TAF in neighbouring cells in 
vivo. (A) Mean number of γH2AX foci and (B) mean number of TAF in keratinocytes adjacent 
to melanocytes containing 0 to 3 TAF in young and older skin. Note that melanocytes with 3 
TAF were not found in young skin sections. Data are mean ± SEM, where N=7 donors per 
group. At least 30 keratinocytes were counted per subject. Statistical significance was 
determined using a two-way ANOVA. *P<0.05, **P<0.01, ***P<0.001. (C) Representative 
immuno-FISH images of keratinocytes around melanocytes with 0 TAF (top panel) and 3 TAF 
(bottom panel). Melanocytes are circled in yellow, and keratinocytes analysed are circled in 
red. White arrows represent co-localisation between γH2AX and telomeres, which are 
amplified on the right. Images are Z projections taken using a 100x oil objective.  
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In order to ensure that the differences in keratinocyte TAF were not due to subject-to-subject 
variability, we carried out an ordinal logistic model accounting for subject, and found that the 
increase in TAF in keratinocytes neighbouring melanocytes with more dysfunctional telomeres 
was still highly significant (P<0.0001) (Figure 3.8 A). Moreover, we separated the number of 
TAF in keratinocytes into tertiles, such that 1 indicates low numbers, 2 denotes medium and 3 
high numbers of TAF, and showed that increased number of TAF in keratinocytes is 
significantly associated with higher frequency of telomere damage in melanocytes (P<0.0001) 
(Figure 3.8 B). 
Together, these results suggest that melanocytes with more TAF, and likely senescent, may 
exert a bystander effect in vivo, inducing paracrine telomeric damage in neighbouring epidermal 
cells, and possibly contributing to skin ageing characteristics. 
 
 
Figure 3.8 – Paracrine damage induction by melanocytes accounting for subject 
variability. (A) Mean number of TAF in keratinocytes around melanocytes containing 0 to 3 
TAF accounting for subject. The horizontal line in each box indicates the median value. (B) 
Mean number of TAF in keratinocytes were divided into tertiles, where 1 = low, 2 = 
intermediate, and 3 = high numbers of TAF. Each point represents the average number of 
keratinocyte TAF for the corresponding category (i.e. number of melanocyte TAF) per subject. 
The blue line in both graphs joins the mean values for each category in the x-axis. Statistical 
significance was determined by an effect likelihood ratio test.     
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 Discussion 
In this study, we observed that the number of melanocytes decreases by around 2-fold in the 
epidermis of older human skin. This is in line with previous studies, which have shown that the 
number of melanocytes decreases by 10-20% every decade after the age of 30 years (Whiteman 
et al., 1999). This has been suggested to be a result of increased apoptosis that occurs due to 
ROS accumulation and decreased levels of the anti-apoptotic protein, Bcl-2, in aged 
melanocytes, which contributes to melanocyte loss with age (Sermadiras et al., 1997; Kauser 
et al., 2011; Cichorek et al., 2013).    
Although there has been a number of studies reporting the accumulation of senescent cells in 
the skin with age, very few have investigated the expression of senescence-associated markers 
specifically in melanocytes in human skin. We have shown that p16 expression is significantly 
increased in melanocytes in the epidermis of older donors, which is in agreement with other 
reports showing an accumulation of p16-positive melanocytes in older human skin (Waaijer et 
al., 2012b; Waaijer et al., 2016b). Furthermore, we report for the first time that SIRT1 
expression is downregulated in melanocytes with age in vivo. Although activation of SIRT1 by 
resveratrol treatment was shown to prevent UVB-induced senescence of dermal fibroblasts in 
mouse skin (Chung et al., 2015), no previous reports have demonstrated an age-dependent 
association between this histone deacetylase and melanocytes in human skin in vivo. Indeed, 
loss of SIRT1 has been associated with senescence in human and mouse fibroblasts in vitro 
(Sasaki et al., 2006), and inhibition of SIRT1 was shown to induce senescence in human 
melanoma cells (Ohanna et al., 2014). SIRT1 modulates p53 deacetylation, inhibiting its 
transcriptional activity, and thus plays a role in controlling cell-cycle progression (Vaziri et al., 
2001). Additionally, SIRT1 has been shown to deacetylate histones in promoter regions of 
genes such as IL-6 and IL-8, repressing the expression of SASP components (Hayakawa et al., 
2015). Since a stable proliferation arrest is a hallmark of senescence, we also analysed 
expression of Ki-67; however, we did not find a significant difference in the number of 
proliferating melanocytes in young and old skin. Although there was a slight increase in Ki-67-
positive melanocytes in skin sections from older donors, this difference was not statistically 
significant. This is in line with previous work, which failed to detect differences in the 
proportion of Ki-67-positive cells in human epidermis with age (Ressler et al., 2006). 
Importantly, the number of Ki-67-positive melanocytes were very low in both groups, 
supporting the observation that differentiated melanocytes have low proliferative capacity in 
vivo (Jimbow et al., 1975). Taken together, these data show an age-dependent increase in 
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senescence markers in melanocytes, indicating that senescent melanocytes accumulate in the 
epidermis of aged human skin in vivo.  
The association of telomeres with DDR proteins in melanocytes in human skin has been poorly 
explored, with only one study showing that telomere dysfunction occurs in melanocytic nevi, 
which are cancer precursor lesions (Suram et al., 2012). Here, we show for the first time that 
the frequency of damaged telomeres is significantly higher in melanocytes in aged skin, 
suggesting a role for telomere dysfunction in melanocyte senescence in vivo. Although several 
reports have shown that telomere length decreases with age in human skin (Lindsey et al., 1991; 
Butler et al., 1998; Friedrich et al., 2000; Nakamura et al., 2002), we found no significant 
difference in telomere length between melanocytes in young and aged skin, suggesting that 
damage does not occur primarily as a result of telomere shortening in melanocytes in vivo. The 
absence of significant telomere shortening might be explained by the fact that these cells rarely 
divide in vivo, as shown by aforementioned studies and also corroborated by our data showing 
low levels of Ki-67 positivity in melanocytes of both young and older skin. Interestingly, our 
data suggests that longer telomeres preferentially accumulate damage in melanocytes in human 
skin, shown by the significant increase in median signal intensity of γ-H2AX-positive telomeres 
as determined by Q-FISH. The accumulation of DDR proteins in telomeres that are not critically 
short has been previously reported in non-dividing cells, such as hippocampal neurons and liver 
hepatocytes of old baboons (Fumagalli et al., 2012), and in mouse hepatocytes (Hewitt et al., 
2012). In fact, it has been proposed that long telomeres may provide a more abundant target for 
DNA damage to occur (Fumagalli et al., 2012). Consistent with this, human cancer cells with 
very long telomeres following enforced elongation were more sensitive to ionising irradiation, 
suggesting that telomeres above a critical length are more likely to accumulate DSBs (Fairlie 
and Harrington, 2015).  However, we cannot completely rule out the contribution of short 
telomeres in DDR activation in melanocyte senescence in vivo. It is possible that Q-FISH is not 
sensitive enough to detect very short telomeres, resulting in a biased enrichment of DNA 
damage proteins at longer telomeres. Another possibility is that intense FISH signals might 
represent multiple dysfunctional telomeres aggregating within one DDR focus, as it has been 
shown to occur in human fibroblasts in vitro (Kaul et al., 2011), and these cannot be 
distinguished by the microscopy methods used in this study. Therefore, more sensitive methods 
such as super resolution microscopy could be used in order to confirm these results. Moreover, 
in order to determine whether telomere fusions occur in melanocyte senescence, immuno-FISH 
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against γH2AX and telomeres could be performed in melanocyte metaphase spreads, allowing 
visualisation of individual chromosome ends.  
Another mechanism by which telomeres can activate a DNA damage response is due to loss of 
shelterin components, or uncapping, with ageing. It is thought that extensive telomere attrition 
leads to displacement of shelterin proteins, exposing chromosome ends which are then 
recognised as DSBs by the DNA repair machinery (O'Sullivan and Karlseder, 2010). 
Accordingly, senescent human endothelial cells in vitro have shorter telomeres and decreased 
levels of shelterin proteins, such as TIN2, POT1, TRF2 and TRF1, whereas these were 
maintained in high passage telomerase-immortalised cells (Hohensinner et al., 2016). 
Furthermore, expressing a dominant-negative TRF2 allele in human fibroblasts triggers 
uncapping and leads to activation of a DDR at telomeres, supporting the idea that uncapped 
telomeres resemble DNA lesions (Takai et al., 2003). Since our data suggests that telomeres do 
not shorten significantly in senescent melanocytes in vivo, it is unlikely that telomere 
deprotection would occur as a result of extensive loss of telomeric repeats. However, it has been 
shown that oxidative damage at telomeres disrupts the binding of TRF1 and TRF2 (Opresko et 
al., 2005), possibly providing a length-independent mechanism for loss of shelterin 
components. One possibility is that oxidative stress is increased during melanocyte senescence 
in vivo, and this in turn displaces shelterin proteins, leading to activation of a DDR at telomeres 
with age. Indeed, ROS has been implicated as both an initiator and effector of the senescent 
phenotype (Macip et al., 2002; Saretzki et al., 2003; Passos et al., 2007; Passos et al., 2010), 
and enhanced ROS generation is involved in oncogene-induced melanocyte senescence 
(Kaplon et al., 2013; Leikam et al., 2014). Nonetheless, other studies have provided evidence 
that TRF2 was still retained at a fraction of telomeres signalling a DDR in stress-induced 
(Fumagalli et al., 2012), replicative senescence (Kaul et al., 2011), and in melanocytic nevi, 
which are a model of OIS (Suram et al., 2012), suggesting that loss of shelterin proteins does 
not necessarily precede DDR activation at telomeres. In order to further investigate whether 
telomere dysfunction occurs as a result of uncapping in melanocyte senescence in vivo, telomere 
FISH should be performed together with immunofluorescence against γH2AX, a shelterin 
protein such as TRF2, and a melanocyte marker, allowing us to observe co-localisation between 
γH2AX-positive telomeres and TRF2 in human skin.  
Increasing evidence now suggests that persistent DDR signalling at telomeres plays an 
important role in the establishment of senescence. It has been shown that DNA damage at 
telomeres is less efficiently repaired compared to non-telomeric damage due to the presence of 
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shelterin proteins, which inhibit components of the DNA repair machinery (Kruk et al., 1995; 
Bombarde et al., 2010; Fumagalli et al., 2012; Hewitt et al., 2012). Consistently, live-cell 
imaging studies have demonstrated that the majority of long-lived DNA damage foci co-localise 
with telomeres in stress-induced senescence (Hewitt et al., 2012). Such irreparable DNA 
damage generates persistent DDR signalling at telomeres, which is believed to be important for 
the initiation and maintenance of the senescent state (Fumagalli et al., 2012; Hewitt et al., 
2012). Indeed, telomere dysfunction accumulates in human fibroblasts during replicative (Kaul 
et al., 2011), stress- (Fumagalli et al., 2012; Hewitt et al., 2012), and oncogene-induced 
senescence (Suram et al., 2012), and was shown to occur independently of length in all cases. 
Length-independent telomere damage has also been reported in many tissues in mice and 
primates with age (Fumagalli et al., 2012; Hewitt et al., 2012; Jurk et al., 2014), suggesting that 
telomere dysfunction may also contribute to age-related decline in tissue function. Given these 
data, it is possible that the observed age-associated increase in telomere-associated damage in 
melanocytes contributes to melanocyte senescence in human skin in vivo. However, in order to 
confirm this, immunofluorescence staining against p16, γH2AX, and a melanocyte marker 
together with FISH for telomeres need to be performed; this would then allow us to determine 
whether p16-positive melanocytes contain more TAF than p16-negative ones. Although we also 
observed an increase in the number of γH2AX foci in aged melanocytes, the increase in both 
number of TAF and the percentage of melanocytes containing TAF in older skin is more highly 
significant, suggesting that TAF may serve as a more robust marker of melanocyte senescence 
in vivo.  
Skin ageing is accompanied by many morphological changes, including epidermal thinning and 
loss of epidermal curvature (Waaijer et al., 2012a). In accordance to this, we observed a 
significant decrease in epidermal thickness and loss in epidermal curvature with age in the older 
donor cohort. Since accumulation of senescent cells has been shown to contribute to tissue 
dysfunction with age (Baker et al., 2011; Baker et al., 2016), we investigated whether increased 
TAF in melanocytes (used as a proxy for senescence) was associated with age-related skin 
characteristics. In this study, we did not find a significant correlation between TAF in 
melanocytes and epidermal thinning, although there is a trend for decreased epidermal thickness 
with increased number of TAF. It is possible that our cohort was too small to detect any 
significance, and thus this should be confirmed using a larger number of subjects. However, 
this finding is in agreement with previously published data showing that p16-positivity in the 
epidermis, which arises mainly from melanocytes, does not associate with age-related 
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epidermal morphology (Waaijer et al., 2016b). In contrast, we observed a highly significant 
association between increased TAF in melanocytes and flattening of the epidermal-dermal 
junction, suggesting that accumulation of melanocytes with dysfunctional telomeres, which are 
likely senescent, contributes to this skin ageing phenotype. Flattening of the EDJ occurs 
primarily as a result of the retraction of the rete ridges, which consist of epidermal invaginations 
into the dermis (indicated by the red dotted line in Figure 3.4 C). Physiologically, a flattened 
dermal-epidermal interface means that the epidermis is less resistant to shearing forces, since 
these projections not only increase the surface area to maximise nutrient exchange across the 
junction but they also provide mechanical support to the epidermis (Briggaman and Wheeler, 
1975; Lavker, 1979). Flattening of the epidermal-dermal junction reduces the exchange surface 
between the epidermis and dermis, and thus compromises nutrient supply to the epidermis. This 
has been suggested to contribute to reduced keratinocyte proliferation with ageing (Lavker et 
al., 1989). Furthermore, it has been shown that epidermal stem cells reside within rete ridges 
(Ghazizadeh and Taichman, 2005), therefore, retraction of these structures might also 
compromise epidermal turnover with age by affecting keratinocyte differentiation and 
proliferation. Although it is not known whether flattening of the EDJ is a direct consequence of 
senescent melanocyte accumulation, our results implicate TAF as a potential marker for 
epidermal flattening that occurs during skin ageing. Interestingly, accumulation of p16-positive 
melanocytes has been associated with increased facial wrinkling, higher perceived age, and age-
associated elastin morphology, suggesting that senescent melanocytes are a robust marker of 
global skin ageing (Waaijer et al., 2016b).  
Senescent cells have been shown to induce paracrine DNA damage and senescence in healthy 
neighbouring cells via mechanisms involving secretion of SASP factors and increased ROS 
(Nelson et al., 2012; Acosta et al., 2013). In agreement with this, our data showed that 
keratinocytes surrounding melanocytes with more TAF, a marker of senescence, also had 
significantly more telomere damage, providing evidence for a possible bystander effect of 
senescent melanocytes in human skin in vivo. It is possible that senescent melanocytes affect 
neighbouring keratinocytes by the secretion of pro-inflammatory factors, similarly to that 
reported in senescent fibroblasts (Hubackova et al., 2012; Acosta et al., 2013). It has been 
proposed that molecules secreted by senescent cells, such as IL-1 and TGF-β family ligands, 
stimulate the expression of Nox4, an NADPH oxidase that contributes to ROS generation, in 
neighbouring cells. Accumulation of ROS can then induce oxidative DNA damage in these 
cells, activating a DDR that contributes to the establishment of senescence (Hubackova et al., 
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2012). Another study has provided evidence that senescent cells can also activate a DDR in 
neighbouring cells through gap junction-mediated cell-cell contact, where ROS generation in 
bystander cells was shown to be a major contributor to damage induction (Nelson et al., 2012). 
In fact, ROS has been implicated in a positive feedback loop that replenishes DNA damage 
foci, stabilising the senescence growth arrest through continuous activation of p21 (Passos et 
al., 2010). Although the mechanisms involved in paracrine damage induction in the context of 
melanocyte senescence will be further investigated in the following chapters, increased ROS 
generation has been shown to contribute to skin ageing phenotypes in vivo. Deletion of Sod2, a 
mitochondrial antioxidant enzyme, increases mitochondrial oxidative stress, and was shown to 
induce DNA damage and cellular senescence in mouse skin. Moreover, Sod2 deficiency also 
resulted in skin ageing phenotypes, such as epidermal thinning (Velarde et al., 2012). 
Consistently, inducing mitochondrial oxidative stress specifically in keratinocytes by Sod2 
deletion delayed wound closure and accelerated epidermal thinning in old mice, phenotypes 
associated with depletion of epidermal stem cells (Velarde et al., 2015). This was proposed to 
be due to senescence of rapidly dividing transit-amplifying (TA) cells, which arise from stem 
cells, and are required for epidermal expansion. It is though that mitochondrial oxidative stress 
induces senescence of TA cells, which in turn increases the demand for stem cells, leading to 
exhaustion of the stem cell pool with ageing, and consequently causing epidermal thinning and 
delayed wound healing (Velarde et al., 2015). Therefore, oxidative stress appears to be a major 
driver of keratinocyte senescence and a contributor to skin ageing characteristics.   
Studies suggest that senescence can also be transmitted to surrounding cells in vivo. For 
example, clusters of senescent hepatocytes have been observed in mouse liver with age (Nelson 
et al., 2012), and in a mouse model of chronic inflammation, which shows accelerated ageing 
phenotypes (Jurk et al., 2014). Further evidence was shown by studies in mouse models of OIS, 
where inducing OIS in hepatocytes in vivo resulted in accumulation of immune cells around 
senescent hepatocytes which also displayed markers of senescence, such as p21 and p16 
(Acosta et al., 2013). Moreover, p21-positive stromal cells were observed in the vicinity of 
human colon sessile serrated adenoma (SSAs), pre-malignant lesions which arise from BRAF 
mutations that trigger OIS (Acosta et al., 2013). These results support a role for a bystander 
effect of senescent cells in mice and human in vivo. Although we show evidence for paracrine 
damage induction by senescent melanocytes in vivo, immunohistochemical staining for SASP 
factors will need to be done in order to elucidate the involvement of the SASP in this process 
in human skin. Moreover, markers of oxidative DNA damage, such as 8-oxo-dG, could shed 
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light on the accumulation of oxidative DNA lesions in keratinocytes in vivo. However, studies 
involving genetic manipulation of antioxidant enzymes in mice specifically in keratinocytes are 
needed to establish the role of oxidative stress in paracrine damage induction.  
Although we did not investigate the consequences of telomere damage accumulation in 
keratinocytes, it has been shown that telomere dysfunction induces senescence in human 
keratinocytes in culture (Minty et al., 2008). Interestingly, senescent keratinocytes display high 
macro-autophagic activity that targets components such as the nucleus and mitochondria, 
resulting in cell death in vitro (Gosselin et al., 2009). It is possible that paracrine telomere 
damage initially induces senescence in keratinocytes but this later results in cell death, probably 
explaining the low levels of p16-positive epidermal cells (around 8%)  previously reported in 
aged human skin (Ressler et al., 2006; Nassour et al., 2016). In fact, these cells are mainly 
located in the basal layer of the epidermis, and have been shown to co-localise with melanocytes 
(Waaijer et al., 2012b; Waaijer et al., 2016b), suggesting that melanocytes are the major 
senescent cell population in the epidermis of human skin.  In order to further investigate this, 
other senescence markers, such as p21, have to be analysed in our donor cohort to confirm the 
seldom accumulation of senescent keratinocytes in human skin with age. This would suggest 
that the age-associated changes in the epidermal compartment are, in part, due to death of 
senescent keratinocytes rather than their accumulation. Since epidermal regeneration and 
homeostasis is highly dependent on the capacity of stem/ progenitor cells to proliferate and 
repopulate the tissue, it will also be important to consider the impact of senescent melanocyte 
bystander effects on epidermal stem cells, a subpopulation of which are located in the basal 
layer of the epidermis (Zouboulis et al., 2008), similarly to melanocytes. Indeed, it has been 
recently shown that increased secretion of inflammatory factors in the epidermis of aged mice 
contributes to hair follicle stem cell function decline with age (Doles et al., 2012).  
Furthermore, from this study, we cannot exclude the possibility that senescent keratinocytes 
might also affect melanocytes in a paracrine manner. In fact, an intricate network of paracrine 
signalling exists between melanocytes and keratinocytes, where the latter secretes pro-
inflammatory cytokines and growth factors in response to different stimuli that control growth 
and survival of melanocytes (Wang et al., 2016). However, the high turnover rate of 
keratinocytes in the epidermis, as well as their propensity to undergo cell death when becoming 
senescent, makes the possibility of these cells having long-term detrimental effects on 
melanocytes less likely. 
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In summary, we have shown that senescent melanocytes accumulate in human skin with age, 
and that telomere dysfunction independently of shortening is involved in this process. We have 
also provided evidence that senescent melanocytes might induce paracrine telomere damage in 
surrounding keratinocytes, which can contribute to skin ageing phenotypes by affecting 
keratinocyte proliferation and function, although further experiments are necessary confirm this 
hypothesis. Moreover, our data also suggests that TAF in melanocytes is a potential biomarker 
of epidermal-dermal flattening, a characteristic of skin ageing. 
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Chapter 4: Characterisation of in vitro models of melanocyte senescence 
Melanocytes are neural crest-derived cells located in the basal layer of the epidermis, and are 
responsible for synthesising melanin in response to solar ultraviolet light (Bandyopadhyay et 
al., 2001). Unlike fibroblasts and other cell types, melanocyte senescence in vitro has been 
reported to be mainly dependent on the p16/pRb pathway, whereas p21 expression was 
decreased as these cells reached their proliferative capacity (Bandyopadhyay and Medrano, 
2000; Bandyopadhyay et al., 2001). Moreover, overexpression of the catalytic subunit of 
telomerase (hTERT) considerably extended the lifespan of melanocytes in culture, suggesting 
that telomere attrition plays a role in melanocyte senescence (Bandyopadhyay et al., 2001).  
However, the majority of studies involving melanocyte senescence in vitro focus on replicative 
and oncogene-induced senescence (Bennett and Medrano, 2002; Bansal and Nikiforov, 2010), 
whereas stress-induced senescence remains relatively understudied.    
Previous work from our group and others demonstrated that stress-induced senescence involved 
the activation of an unresolved DDR at telomeres irrespectively of length (Fumagalli et al., 
2012; Hewitt et al., 2012). This was shown in human lung fibroblast lines such as IMR90 
(Fumagalli et al., 2012) and MRC5 (Hewitt et al., 2012), however not in melanocytes. Given 
the fact that we observed that melanocytes acquire TAF irrespectively of length in vivo (chapter 
3), I wanted to investigate whether exposure to DNA damaging agents, such as X-ray and UV 
irradiation, in vitro would contribute to persistent damage at telomeres, and consequently, 
senescence. Moreover, in this study, I also aimed to investigate whether telomere-specific 
damage was irreparable in melanocytes and contributed to the establishment of senescence. To 
this end, I transduced melanocytes with an endonuclease which causes telomere-specific 
breaks. Finally, in order to investigate the mechanisms mediating bystander DNA damage 
induction by senescent melanocytes, which will be further explored in chapter 5, I aimed to 
establish and characterise different models of melanocyte senescence in vitro, including the 
molecular profile of their secretory phenotype. 
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 Replicative senescence  
4.1.1. Markers of senescence increase as melanocytes reach their proliferative 
capacity 
The first model investigated in this study was replicative senescence, where melanocytes were 
serially passaged until they reached the end of their proliferative capacity. Lightly pigmented 
neonatal melanocytes were cultured for 180 days, during which time they performed around 16 
population doublings before withdrawing from the cell cycle (Figure 4.1 A). Indeed, at this PD, 
there is a 5-fold decrease in the percentage of proliferating melanocytes, shown by a reduction 
in Ki-67 expression (Figure 4.1 C, D). Consistent with previous reports (Bandyopadhyay and 
Medrano, 2000), only around 19% of melanocytes are positive for Ki-67 at early passages, 
reflecting their slow proliferation rate. This is also highlighted when comparing proliferation 
rates of human melanocytes and MRC5 human lung fibroblasts (Figure 4.1 B). The latter 
undergo 46 PDs and reach the Hayflick limit at approximately 120 days in culture. In fact, 
MRC5 fibroblasts undergo, on average, 0.35 population doublings/day compared to 0.12 
PDs/day observed for human melanocytes. Therefore, the latter replicate approximately 3 times 
slower than MRC5 fibroblasts, reiterating their slow proliferative rate. Moreover, Sen-β-Gal 
activity, which is a commonly used senescence marker, was also increased in late passage 
melanocytes, indicating that these cells have reached senescence (Figure 4.1 E, F).  
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Figure 4.1 – Melanocytes reach replicative senescence in culture after 16 population 
doublings. (A) Growth curve of melanocytes serially passaged until they reached replicative 
senescence. (B) Graph comparing growth curves of normal human melanocytes (orange) and 
MRC5 human lung fibroblasts (green). (C) Percentage of Ki-67-positive melanocytes at early 
and later passages. Data are mean of at least 10 random planes, and a minimum of 65 cells per 
group (N=1). (D) Representative Ki-67 immunocytochemistry images for early and late passage 
melanocytes in vitro. Ki-67 is shown in red, and DAPI is shown in blue. Images were taken 
using a 40x objective. (E) Percentage of Sen-β-Gal positive melanocytes at early and late 
passages. Data are mean of 10 random planes, with 217 cells (PD 5) and 141 cells (PD 16) 
(N=1). (F) Representative Sen-β-Gal (blue) images for early and late passage melanocytes. 
Images were taken using a 20x objective.   
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To further characterise the phenotype of replicative senescent melanocytes, I analysed the 
expression of CDK inhibitors commonly up-regulated during senescence. Since previous 
studies have suggested that melanocyte senescence is mainly regulated by the p16-pRb 
pathway, (Bandyopadhyay and Medrano, 2000; Bandyopadhyay et al., 2001), I analysed the 
expression of p16 by quantitative PCR, and found a 2-fold increase in p16 mRNA levels in 
senescent melanocytes (Figure 4.2 A). Increased p16 expression was also confirmed at the 
protein level by Western blotting analysis (Figure 4.2 B), corroborating the involvement of p16 
during the growth arrest. In contrast to previously published data, the levels of p21 were also 
significantly up-regulated in senescent melanocytes, as demonstrated by Western blotting 
(Figure 4.2 B) and corroborated by immunocytochemistry, which showed an increase in the 
percentage of p21-positive melanocytes at PD 16 (Figure 4.2 B, C, D). Therefore, these results 
suggest that increased p21 is also associated with melanocyte senescence. Furthermore, I also 
examined the expression of the nuclear envelope protein, lamin B1, which has been shown to 
decrease in senescent human and mouse fibroblasts (Freund et al., 2012; Sadaie et al., 2013). 
Although I found that lamin B1 was down-regulated in replicative senescent melanocytes, this 
decrease appears to be small (Figure 4.2 B), suggesting that mild changes in nuclear integrity 
occur during melanocyte senescence. However, these results need to be independently 
confirmed. 
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Figure 4.2 – Characterisation of senescence markers during replicative melanocyte 
senescence. (A) Fold change in p16 mRNA levels from early passage and senescent 
melanocytes in culture, as determined by q-PCR. Data are normalised to proliferating (PD 3) 
cells (N=1). (B) Western blot showing analysis of lamin B1, p21, and p16 expression in young 
and senescent melanocytes (N=1). β-actin was used as the loading control. (C) Percentage of 
p21-positive melanocytes at early and later passages. Data are mean of 15 random planes, with 
60 cells (PD 5) and 90 cells (PD 16) (N=1). (D) Representative p21 immunocytochemistry 
image of melanocytes at PDs 5 and 16. Images were taken using a 40x objective. Red denotes 
p21, whereas blue shows DAPI staining.  
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4.1.2. mTOR activity is up-regulated during melanocyte replicative senescence  
The protein kinase, mTOR, is a central nutrient and energy sensor in the cell, and is an important 
regulator of cellular responses such as cell growth and metabolism (Xu et al., 2014a). Increased 
activation of mTOR signalling has been implicated in many aspects of the senescence 
phenotype. In fact, pharmacological inhibition of mTOR by rapamycin treatment has been 
shown to extend replicative lifespan of fibroblasts in culture, and also attenuate senescence-
associated characteristics, such as decreased p21 expression and secretion of pro-inflammatory 
cytokines involved in the SASP (Demidenko and Blagosklonny, 2008; Kolesnichenko et al., 
2012; Laberge et al., 2015). However, the role of mTOR during melanocyte senescence remains 
understudied, although studies suggest that up-regulation of mTOR activity is involved in OIS 
escape and melanoma formation (Souroullas and Sharpless, 2015).  
To investigate whether melanocyte replicative senescence was accompanied by enhanced 
mTOR activity, cells were serially passaged in culture, and protein lysates were collected at the 
exponential growth phase (PD 2 – 6) and at the time when proliferation had ceased (PD 16). 
Western blot analysis of proliferating and senescent melanocytes revealed an increase in the 
levels of p70S6 kinase phosphorylated at threonine 389 (T389) in senescent melanocytes, which 
is indicative of increased mTOR activity (Figure 4.3 A, B). Although total p70S6 kinase was 
also slightly upregulated with replicative exhaustion (Figure 4.3 A, C), the ratio of 
phosphorylated p70S6 kinase over total p70S6K is 2.5-fold higher in senescent melanocytes 
compared to proliferating cells (Figure 4.3 D), suggesting that mTOR activity is up-regulated 
in melanocyte replicative senescence.  
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Figure 4.3 – Melanocyte replicative senescence is accompanied by increased mTOR 
activation. Melanocytes were grown in culture and protein extracts were collected from cells 
at early (PD 2 and 6) and later (PD 16) passages. (A) Western blot showing expression levels 
p70S6K(T389), p70S6K, and GAPDH as a loading control. Graphs show quantification of 
Western blots for (B) p70S6K(T389), (C) p70S6K, and (D) the ratio of p70S6K(T389) over 
p70S6K. Values were normalised against GAPDH, and the data represent fold change relative 
to PD 2 (N=1).    
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4.1.3. Oxidative stress increases in late passage melanocytes in vitro 
Reactive oxygen species have been shown to play a role in the induction of senescence, as 
increased ROS levels have been reported in replicative-, stress-induced and oncogene-induced 
senescence (Saretzki et al., 2003; Passos et al., 2007; Ogrunc et al., 2014). Moreover, ROS 
have also been implicated as effector molecules during the senescence, and are essential for 
reinforcing the growth arrest (Macip et al., 2002; Passos et al., 2010). Although increased 
oxidative stress has been reported to occur in oncogene-induced melanocyte senescence 
(Leikam et al., 2008; Kaplon et al., 2013; Leikam et al., 2014), the involvement of ROS during 
replicative melanocyte senescence remains poorly explored.  
In order to investigate whether ROS was involved in the establishment of replicative 
senescence, melanocytes were grown in culture, and cells were collected at the proliferative 
state, after 3 and 4 cumulative population doublings (early passage), and at later passages, 
following 12 and 13 cumulative PDs, when they were near the end of their replicative lifespan. 
I then measured ROS production by flow cytometry using ROS-indicator dyes, DHE and 
MitoSOX, which detect whole cell superoxide anion and mitochondrial superoxide anion 
levels, respectively. Firstly, there is a significant increase in DHE fluorescence intensity in late 
passage melanocytes compared to proliferating controls (P=0.006) (Figure 4.4 A), suggesting 
that superoxide production is enhanced in cells approaching senescence. Since mitochondria 
have been implicated as a major source of ROS during senescence (Saretzki et al., 2003; Passos 
et al., 2007; Sahin et al., 2011; Correia-Melo et al., 2016), I wanted to investigate whether 
mitochondrial ROS was also increased in melanocytes at later passages. Indeed, our results 
show a significant increase in mitochondrial superoxide levels in older melanocytes, as 
demonstrated by a 1.5-fold increase in MitoSOX fluorescence intensity in late passage cells 
(P=0.04) (Figure 4.4 B). These data suggest that mitochondrial ROS production is also 
enhanced as melanocytes approach replicative senescence.  
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Figure 4.4 – Oxidative stress is increased in melanocytes approaching replicative 
senescence. Cells were serially passaged in culture and were collected at early (PDs 3 and 4) 
and late passages (PDs 12 and 13) for ROS measurements by flow cytometry. Graphs show 
percentage fold change in fluorescence intensity of (A) DHE and (B) MitoSOX compared to 
younger controls. Data are mean ± S.E.M of N=3 technical repeats. Statistical significance was 
analysed by an unpaired t-test. *P<0.05, **P<0.01.     
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4.1.4. Telomere-associated damage accumulates in senescent melanocytes 
The majority of senescence-inducing stimuli leads to the activation of a DNA damage response, 
which in turn activates downstream pathways that lead to the up-regulation of the CDK 
inhibitors p16 and p21, mediating the senescence-growth arrest (Campisi and d'Adda di 
Fagagna, 2007a; Zhang et al., 2012). In particular, telomeric damage has been shown to 
increase during senescence and ageing, and persistent DDR signalling at telomeres is believed 
to be important to maintain the senescence phenotype (Fumagalli et al., 2012; Hewitt et al., 
2012). Studies have demonstrated that the lifespan of melanocytes in culture can be extended 
by overexpressing telomerase, suggesting that telomere shortening is involved in melanocyte 
senescence (Bandyopadhyay et al., 2001). However, the association of DNA damage proteins 
at telomeres in senescent melanocytes has not been extensively explored.  
To determine whether telomeres became dysfunctional during melanocyte replicative 
senescence, cells were grown in culture and were collected during the exponential growth phase 
(PD 5), and when they reached senescence (PD 16). I then performed immunofluorescence 
against the DNA damage protein, γH2AX, coupled with in situ hybridisation for a telomere 
specific probe (immuno-FISH), where co-localisation between γH2AX and telomeres indicates 
telomere-associated foci, or TAF. Although senescent melanocytes have a slightly higher 
number of DNA damage foci compared to proliferating controls, this difference is very small 
(Figure 4.5 A). On the other hand, senescent melanocytes show a significant increase in the 
frequency of telomere damage, approximately 3-fold higher in relation to younger melanocytes 
(Figure 4.5 B). In addition, the percentage of cells containing dysfunctional telomeres increases 
as melanocytes become senescent (Figure 4.5 C), suggesting an association between DNA 
damage signalling at telomeres and melanocyte replicative senescence.  
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Figure 4.5 – Telomeres become dysfunctional during melanocyte replicative senescence. 
Cells were extensively passaged in culture and were collected during the proliferative phase 
(PD 5) and once they reached senescence (PD 16). Graphs indicate (A) mean number of γH2AX 
foci, (B) mean number of TAF, and (C) percentage of melanocytes containing TAF at PDs 5 
and 16. Data are mean of 20 random planes of at least 40 cells per condition (N=1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4   Characterisation of in vitro models of melanocyte senescence 
117 
 
4.1.5. Telomere damage occurs independently of length  
Telomere dysfunction can arise as a result of telomere shortening, which occurs with each round 
of cell division due to the so called “end-replication problem”, whereby DNA polymerases 
cannot fully synthesise the lagging strand of DNA, leading to loss of telomeric repeats each 
time a cell divides (Olovnikov, 1971; Watson, 1972). Indeed, extensive telomere attrition has 
been shown to occur during replicative senescence in human cells (Harley, 1991; Bodnar et al., 
1998). In order to investigate whether telomere shortening occurs in melanocytes undergoing 
replicative senescence, I performed Q-FISH, and analysed individual telomere signal intensity 
as a measure of telomere length in both proliferating (PD 5) and senescent melanocytes (PD 
16). Indeed, I found that telomere length was significantly shorter in senescent cells when 
compared younger controls (P<0.001) (Figure 4.6 A). In fact, telomeres in senescent 
melanocytes are approximately 15% shorter than those in proliferating cells. Moreover, to 
investigate whether there was a shift in the distribution of telomere lengths between young and 
senescent melanocytes, I divided FISH signal intensity into tertiles, where the first tertile 
comprises telomeres of lower intensities, and quantified the percentage of telomeres in each 
tertile for proliferating and growth-arrested cells. As seen in Figure 4.6 B, although the majority 
of telomeres lie within the first tertile for both young and senescent cells, the latter show a slight 
enrichment in the percentage of telomeres with the lowest signal intensities. Moreover, 
proliferating melanocytes have a higher number of telomeres in the second and third tertiles of 
FISH intensity, suggesting that proliferating melanocytes have, on average, longer telomeres. 
This was further corroborated by setting a threshold to consider very short telomeres as those 
with intensities below 10% of the highest FISH signal intensity, which demonstrated that 
senescent melanocytes have a higher percentage of critically short telomeres (Figure 4.6 C). 
These results suggest that telomere shortening that occurs with repeated rounds of replication 
might contribute to telomere dysfunction during melanocyte senescence. 
Although telomere attrition contributes to DDR activation at telomeres, telomere dysfunction 
has also been shown to occur independently of length in human fibroblasts undergoing 
replicative senescence (Kaul et al., 2011). To determine whether damage occurred 
preferentially at shorter telomeres, I compared FISH signal intensity of telomeres signalling a 
DDR (γH2AX-positive) to those that were not associated with γH2AX (γH2AX-negative). I 
found that there was no significant difference between the length of γH2AX-positive and 
γH2AX–negative telomeres (P=0.64) (Figure 4.6 D, E, F), suggesting that telomere 
dysfunction occurs irrespectively of length during melanocyte senescence.   
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Figure 4.6 – Telomere damage occurs independently of length in senescent melanocytes. 
Quantitative FISH was performed in proliferating (PD 5) and senescent (PD 16) melanocytes, 
and FISH intensity of at least 900 individual telomeres was analysed as a measure of length. 
Histograms show (A) telomere signal intensities in proliferating and senescent melanocytes in 
culture, and (D) intensity of γH2AX-negative and γH2AX-positive telomeres in both young 
and old melanocytes. Red dotted line indicates median intensity. Statistical significance was 
Chapter 4   Characterisation of in vitro models of melanocyte senescence 
119 
 
determined by performing a Mann-Whitney U test. (B) Percentage of telomeres in tertiles of 
FISH signal intensity, where the first, second and third tertiles represent the lowest, intermediate 
and highest signal intensities, respectively. Data are mean percentage for each population 
doubling (N=1). (C) Percentage of very short telomeres in proliferating and senescent 
melanocytes. Data are mean percentage for each population doubling (N=1). (E) Representative 
immuno-FISH image (red: telomeres; green: γH2AX) of a melanocyte containing telomeres of 
similar lengths, one which (a) co-localises with γH2AX and the other (b) is γH2AX-negative. 
Images were taken using a 63x oil objective. (F) Graphs showing the quantification of telomere 
intensity of γH2AX-positive (a) and γH2AX-negative (b) telomeres. Red line indicates 
telomere intensity, and green shows γH2AX intensity. 
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4.1.6. Senescent melanocytes secrete pro-inflammatory factors that are involved in 
the SASP 
It is known that senescent cells develop a distinct secretory phenotype, also known as the SASP, 
which comprises the upregulation of a number of pro-inflammatory cytokines, chemokines, 
growth factors and proteases (Malaquin et al., 2016). Although the composition of the SASP is 
dependent on cell type and on senescence-inducing stimuli (Coppe et al., 2008; Coppe et al., 
2010b), the secretion of such signalling proteins is thought to have evolved as a way for 
senescent cells to communicate with the surrounding environment, including the immune 
system, to facilitate their clearance (Xue et al., 2007; Krizhanovsky et al., 2008). The 
development of a pro-inflammatory secretory phenotype has been reported in melanocytes 
undergoing senescence in response to BRAFV600E oncogene activation (van Tuyn et al., 2017); 
however, the composition of the SASP arising from other senescence-inducing stimuli in 
melanocytes has not been extensively explored. 
To investigate whether melanocytes undergoing replicative senescence developed a secretory 
phenotype, melanocytes were serially passaged in culture and conditioned medium (CM) was 
collected from cells at the exponential growth phase (cumulative PDs 8-10) and after they 
entered the senescence program (cumulative PDs 16-17). Melanocytes were cultured in CM for 
24 hours before media was collected for analysis. I then performed a cytokine array in 
conditioned media collected from young and senescent cells, which simultaneously analyses 
the relative abundance of 42 secreted cytokines and chemokines; however, out of this panel, 
only 9 proteins were present at detectable levels in CM from cultured melanocytes (Figure 4.7 
A). Nonetheless, there was an increase in secretion of known SASP factors, such as IL-8, IL-6, 
and RANTES in 3 independent experiments (Figure 4.7 A-J). However, due to the high 
variability between experiments, no significant differences were found. Therefore, increasing 
the number of experiments could help determine the cytokines which are significantly up-
regulated during replicative melanocyte senescence.   
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Figure 4.7 – Secretory phenotype of replicative senescent melanocytes. (A) Heatmap 
showing cytokines detected in CM from young and senescent melanocytes. Blue represents low 
expression, whereas red denotes high expression. Each column represents one independent 
experiment for the corresponding condition. Heatmap was generated using Prism 7.0. 
Concentration values are expressed as pg/ml/cell. Graphs showing the concentration of (B) IL-
8, (C) Gro-α, (D) IL-6, (E) PDGF-AA, (F) RANTES, (G) FGF-2, (H) MIP-1α, (I) IL-4 and (J) 
MCP-1 secreted by melanocytes. Values were normalised by cell number. Data are mean ± 
S.E.M. of N=3 experiments. Statistical significance was determined by a two-tailed unpaired t-
test. N.S. = not significant.  
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 Stress-induced senescence (X-ray) 
There are several pitfalls to the use of replicative senescent melanocytes in my studies: firstly, 
they take almost 200 days to obtain, which impacted on my ability to conduct multiple 
independent experiments. Secondly, since melanocytes divide very slowly from the beginning, 
it makes it difficult to acquire enough senescent cells. For that reason, I decided to explore 
alternative methods to induce senescence, including a model of stress-induced senescence by 
exposure to X-ray irradiation currently used by many labs in the senescence field (Passos et al., 
2010; Laberge et al., 2015). This model is deemed advantageous for investigating senescence 
for the following reasons: i) it is a fast and reliable way to generate a homogenous population 
of senescent cells; ii) it requires only one dose of X-ray irradiation to induce senescence in the 
majority of cells with negligible cell death; iii) it allows the investigation of mechanisms 
underlying the induction of senescence kinetically, from the induction of damage to the 
establishment of the SASP (Coppe et al., 2008; Passos et al., 2010). However, one evident 
pitfall is that it is not physiological since it is unlikely that humans are exposed to high levels 
of X-ray irradiation.  
4.2.1. 10 Gy X-ray irradiation induces senescence in melanocytes in vitro 
In order to induce senescence in melanocytes in culture, cells at the exponential growth phase 
were irradiated using 10 Gy X-ray irradiation, and were then cultured for an additional 10 days 
following irradiation before they were collected for the analysis of senescence markers (Figure 
4.8 A). Since the hallmark of senescence is a stable cell-cycle arrest, I firstly analysed the 
proliferation status of proliferating and irradiated cells by EdU incorporation. I found a 
significant decrease in EdU-positive melanocytes 10 days after 10 Gy X-ray irradiation 
(P=0.006) (Figure 4.8 B, C), suggesting that the majority of cells are arrested in the cell cycle. 
Next I carried out a biochemical assay for the detection of Sen-β-Gal activity, and found that 
irradiated melanocytes had significantly higher levels of Sen-β-Gal staining, with 
approximately 80% of cells showing Sen-β-Gal positivity 10 days following X-ray irradiation 
(P=0.0005) (Figure 4.8 D, E).  
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Figure 4.8 – Stress-induced melanocyte senescence is induced by X-ray irradiation. (A) 
Scheme representing the experimental procedure. (B) Percentage of EdU-positive melanocytes 
at control, proliferating conditions (No IR) and 10 days after 10 Gy X-ray irradiation. Data are 
mean ± S.E.M. of N=3 independent experiments. (C) Representative immunofluorescence 
images of EdU staining of non-irradiated melanocytes and cells 10 days after X-ray irradiation 
(red: EdU; blue: DAPI). Images were taken using a 20x objective. (D) Percentage of Sen-β-
Gal-positive untreated and irradiated melanocytes. Data are mean ± S.E.M. of N=3 independent 
experiments. (E) Representative Sen-β-Gal (blue) images of non-irradiated melanocytes and 
cells 10 days following X-ray irradiation. Images were taken using a 20x objective. Statistical 
significance was determined by performing a two-tailed unpaired t-test. **P<0.01, ***P<0.001. 
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Although decreased proliferation and increased Sen-β-Gal activity are indicative of senescence, 
other markers need to be analysed in order to fully ascertain if irradiated melanocytes are in a 
state of permanent growth arrest. Therefore, I performed immunofluorescence for the CDK 
inhibitor, p16, and found that at 10 days following irradiation melanocytes expressed 
significantly higher levels of p16 compared to young, proliferating controls (P=0.002) (Figure 
4.9 A, B). Moreover, I also examined the expression of p21 at 3 and 10 days following 
irradiation. I found that p21 expression was up-regulated at 3 days after irradiation, 
approximately 2-fold higher when compared to non-irradiated controls, likely reflecting the 
initial arrest to allow cells to repair X-ray-induced DNA damage. However, due to the 
variability between experiments, this increase was not statistically significant. Although there 
is a slight decrease in p21 expression at day 10, this was not statistically significant, and p21 
levels remain higher in melanocytes 10 days after irradiation when compared to untreated 
controls. However, this did not reach statistical significance likely due to the variation between 
experiments (Figure 4.9 C, D). These results suggest that mechanisms involving p16 and, to 
some extent, p21, are associated with stress-induced melanocyte senescence. 
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Figure 4.9 – Stress-induced melanocyte senescence involves up-regulation of both p16 and 
p21. Melanocytes were irradiated using 10 Gy X-ray irradiation and were collected 3 and 10 
days after irradiation for characterisation of senescence markers. (A) Percentage of p16-positive 
untreated and irradiated melanocytes 10 days after the initial exposure. Data are mean ± S.E.M. 
of N=3 independent experiments. Statistical significance was determined by using a two-tailed 
unpaired t-test; **P<0.01. (B) Representative p16 immunofluorescence image of non-irradiated 
and senescent (10d 10Gy) melanocytes (Red: p16; blue: DAPI). Images were taken using a 40x 
objective (done in collaboration with Jessica Halim). (C) Representative Western blot to 
analyse the expression of p21 in untreated melanocytes, and 3 and 10 days following X-ray 
irradiation. GAPDH was used as a loading control. (D) Quantification of Western blot, showing 
fold change of p21 levels compared to non-irradiated (No IR) controls. p21 values were 
normalised by GAPDH. Data are mean ± S.E.M. of N=3 independent experiments. Statistical 
significance was determined by a one-way ANOVA. FC = fold change.   
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4.2.2. mTOR activity is unchanged in stress-induced melanocyte senescence 
As previously mentioned, mTOR activity has been implicated in the senescent phenotype. 
Indeed, it has been demonstrated that mTOR activity is up-regulated in human fibroblasts in 
response to X-ray irradiation, which was shown to contribute to senescence by stimulating 
mitochondrial biogenesis and maintaining the DDR through ROS generation (Correia-Melo et 
al., 2016).  
Since I observed an increase in mTOR activation in replicative senescent melanocytes, I wanted 
to investigate whether this also occurred during stress-induced melanocyte senescence. For that, 
I irradiated melanocytes using 10 Gy X-ray irradiation, and collected protein lysates at 3 and 
10 days following irradiation. Western blot analysis revealed a decrease in phosphorylated 
p70S6 kinase (T389) levels in melanocytes at 3 days after irradiation when compared to 
proliferating cells. However, this decrease was not statistically significant. This was shown to 
remain lower in senescent melanocytes (10d 10Gy) when compared to non-irradiated controls, 
although it also did not reach statistical significance (Figure 4.10 A, B). I also observed that 
the levels of total p70S6 kinase did not change significantly following irradiation of 
melanocytes across three independent experiments (Figure 4.10 C). Moreover, the ratio of 
p70S6K(T389) over total p70S6K, which is indicative of mTOR activity, was not increased in 
senescent melanocytes in relation to proliferating control cells (Figure 4.10 D), suggesting that 
mTOR activation is not involved in stress-induced senescence in melanocytes, or at least not at 
the time points analysed.     
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Figure 4.10 – mTOR activity is not up-regulated in stress-induced melanocyte senescence. 
Cells were irradiated using 10 Gy X-ray irradiation, and protein lysates were collected at 3 and 
10 days following irradiation, when melanocytes are senescent. (A) Representative Western 
blot showing expression levels of p70S6K(T389), p70S6K, and GAPDH as a loading control. 
Graphs are quantification of Western blots showing fold change of (B) p70S6K(T389), (C) 
p70S6K, and (D) the ratio of p70S6K(T389) over p70S6K, compared to non-irradiated (No IR) 
control. Values were normalised against GAPDH. Data are mean ± S.E.M. of N=3 independent 
experiments. Statistical significance was determined by a one-way ANOVA. FC = fold change.   
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4.2.3. Mitochondrial ROS generation increases in stress-induced melanocyte 
senescence 
Studies have demonstrated that mitochondrial dysfunction and increased ROS generation occur 
as a result of stress-induced senescence in human fibroblasts, which generates a dynamic 
positive feedback loop, maintaining a DDR and contributing to the stability of the cell-cycle 
arrest (Passos et al., 2010). Moreover, it has been shown that clearance of mitochondria in 
human fibroblasts reduced intracellular ROS levels and ameliorated the senescence phenotype 
of these cells, suggesting that mitochondrial-derived ROS contributes to the development of 
senescence (Correia-Melo et al., 2016). Although mitochondrial oxidative stress has reported 
to occur during OIS in melanocytes (Kaplon et al., 2013), a role for mitochondrial ROS 
generation during stress-induced melanocyte senescence remains poorly explored. 
To determine whether mitochondrial ROS increased in irradiated melanocytes, cells were 
exposed to 10 Gy X-ray irradiation, and mitochondrial superoxide levels were measured by 
flow cytometry 3 days after irradiation using the fluorescent dye MitoSOX. Measurements were 
conducted at 3 days, since it has been previously shown that ROS levels increase from 2 days 
after X-ray irradiation, and remain stable from this time onwards, even when cells become 
senescent (Passos et al., 2010). I found that the levels of mitochondrial superoxide were 
significantly higher in melanocytes 3 days after irradiation, showing a 2-fold increase compared 
to proliferating controls (P=0.03) (Figure 4.11 A). These results suggest that increased 
mitochondrial ROS production occurs as a consequence of senescence induction. 
Next, in order to investigate whether mitochondrial ROS was an inducer of melanocyte 
senescence, X-ray irradiated melanocytes were treated with the mitochondria-targeted 
antioxidant, MitoQ, for 10 days following irradiation. Although MitoQ successfully prevented 
the increase in mitochondrial ROS production that occurs upon senescence induction (P<0.05) 
(Figure 4.11 B), scavenging mitochondrial ROS was not sufficient to significantly reduce Sen-
β-Gal activity in senescent melanocytes (10 days after X-ray irradiation) (Figure 4.11 C). 
Therefore, it appears that mitochondrial ROS is not involved in the induction of Sen-β-Gal, 
although other senescence markers need to be analysed in order to fully assess the role of ROS 
in the establishment of melanocyte senescence.  
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Figure 4.11 – Mitochondrial superoxide production is enhanced following X-ray 
irradiation of melanocytes. Cells were exposed to 10 Gy X-ray irradiation and mitochondrial 
superoxide levels were measured 3 days later by flow cytometry. (A) Graph shows percentage 
fold change in fluorescence intensity of MitoSOX in irradiated melanocytes compared to 
untreated controls. Data are mean ± S.E.M. of N=3 independent experiments. Statistical 
significance was analysed by an unpaired t-test. *P<0.05. (B) Percentage fold change in 
MitoSOX fluorescence intensity in irradiated melanocytes (3 days after irradiation) with and 
without MitoSOX compared to non-irradiated controls. (C) Percentage of Sen-β-Gal-positive 
melanocytes at the conditions indicated. Sen-β-Gal activity was evaluated 10 days after 
irradiation. Data are mean ± S.E.M. of N=3 independent experiments. Statistical significance 
was determined by a one-way ANOVA. *P<0.05, **P<0.01, ***P<0.001. (MitoSOX 
experiments were done in collaboration with Jessica Halim). 
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4.2.4. Stress-induced senescent melanocytes have increased telomere dysfunction  
It has been shown that telomere damage increases in stress-induced senescence in fibroblasts 
in vitro, with approximately half of the DNA damage foci co-localising with telomeres 
(Fumagalli et al., 2012; Hewitt et al., 2012). Moreover, damage at telomeres was shown to be 
long-lived, contributing to a persistent DDR signalling which is believed to be important for 
maintaining the senescent phenotype (Hewitt et al., 2012). Nevertheless, no previous studies 
have reported DNA damage signalling at telomeres during stress-induced melanocyte 
senescence. 
To establish whether telomere dysfunction was a consequence of stress-induced senescence, 
melanocytes were irradiated using 10 Gy X-ray irradiation, and were allowed to progress into 
senescence for a period of 10 days. Immuno-FISH was then performed using an antibody 
against γH2AX coupled with a telomere specific probe, to allow visualisation of γH2AX foci 
at telomeres, which is indicative of TAF. Firstly, I observed that irradiation resulted in an 
increase in the number of DNA damage foci at 3 days, which was reduced at 10 days. Although 
DNA damage remained higher in senescent cells when compared to non-irradiated controls 
(Figure 4.12 A), these results suggest that melanocytes are capable of repairing a fraction of 
DNA lesions induced by irradiation. Similarly, the number of dysfunctional telomeres also 
increased 3 days following irradiation; however, the number of TAF did not decrease at 10 
days, and remained higher compared to proliferating melanocytes (Figure 4.12 B, E), 
suggesting that there is no significant repair of telomeric DNA damage. A similar pattern was 
observed when analysing the percentage of melanocytes containing dysfunctional telomeres 
after irradiation (Figure 4.12 C). Moreover, the frequency of melanocytes containing more than 
one telomere signalling a DDR increases 3 days following irradiation, and is considerably 
higher even after 10 days, when melanocytes are senescent (Figure 4.12 D). Overall, these data 
suggest that telomere dysfunction is a feature of stress-induced melanocyte senescence. 
However, in order to establish statistical significance, these results need to be independently 
confirmed.  
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Figure 4.12 – Telomere dysfunction increases in stress-induced melanocyte senescence. 
Melanocytes were irradiated using 10 Gy X-ray irradiation, and DNA and telomere damage 
were analysed at the time points indicated. Graphs show (A) mean number of γH2AX foci, (B) 
mean number of TAF, (C) percentage of melanocytes containing TAF, and (D) percentage of 
melanocytes containing more than 1 TAF. Data are mean of 30 cells obtained from a minimum 
of 10 random planes (N=1). (E) Representative immuno-FISH images of proliferating (top) and 
senescent (bottom) melanocytes. Telomeres are shown in red, γH2AX is depicted in green, and 
DAPI is shown in blue. Arrows indicate co-localisation between γH2AX and telomeres, which 
is amplified on the right. Images were taken using a 63x oil objective. 
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4.2.5. Telomere damage occurs irrespectively of length 
A number of studies have demonstrated that genotoxic stress that induces senescence can 
initiate DDR signalling at telomeres that are not critically short both in vitro and in vivo 
(Fumagalli et al., 2012; Hewitt et al., 2012). Although length-independent telomere damage 
has been shown to occur in melanocytic nevi in vivo, which are growth arrested due to oncogene 
activation (Suram et al., 2012), it is not known whether longer telomeres can also signal a DNA 
damage response in stress-induced melanocyte senescence.  
To determine whether DNA damage occurred at telomeres irrespectively of length in stress-
induced senescence, I performed Q-FISH, and analysed the signal intensity of individual 
telomeres as a measure of length in both proliferating and irradiated melanocytes. Next, I 
compared FISH signal intensity of telomeres signalling a DDR (γH2AX-positive) to those that 
were not associated with γH2AX (γH2AX-negative), and found that dysfunctional telomeres 
were not significantly shorter than γH2AX-negative telomeres (P=0.158) (Figure 4.13 A). In 
fact, I observed that in a single cell, telomeres of similar lengths can either signal a DDR or 
remain undamaged following irradiation (Figure 4.13 B, C), suggesting that damage occurs 
independently of telomere length during stress-induced melanocyte senescence. 
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Figure 4.13 – Telomere damage occurs independently of length during stress-induced 
senescence. Quantitative FISH was performed in proliferating and irradiated melanocytes (3 
and 10 days following IR), and FISH intensity of at least 800 individual telomeres was analysed 
as a measure of length. (A) Histograms showing intensity of γH2AX-negative and γH2AX-
positive telomeres in both proliferating and irradiated melanocytes. Red dotted line indicates 
median intensity. Statistical significance was determined by performing a Mann-Whitney U 
test. (B) Representative immuno-FISH image (red: telomeres; green: γH2AX) of a melanocyte 
containing telomeres of similar lengths, one which (a) co-localises with γH2AX and the other 
(b) is γH2AX-negative. Images were taken using a 63x oil objective. (C) Graphs showing the 
quantification of telomere intensity of γH2AX-positive (a) and γH2AX-negative (b) telomeres. 
Red line indicates telomere intensity, and green shows γH2AX intensity. 
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4.2.6. Pro-inflammatory secretory phenotype of stress-induced senescent 
melanocytes 
Having established that melanocytes become senescent in response to genotoxic stress caused 
by X-ray irradiation in culture, I then wanted to determine whether this senescence-inducing 
stimulus also triggered the secretion of pro-inflammatory cytokines and chemokines, as 
observed in replicative-induced senescent melanocytes.  
To characterise the secretory phenotype of stress-induced senescent melanocytes, conditioned 
medium was collected from proliferation efficient and senescent cells (10 days following X-ray 
irradiation). Melanocytes in each condition were cultured in CM for 24 hours prior to media 
collection for analysis. A cytokine array was then carried out in CM obtained from proliferating 
and senescent melanocytes. I found that out of the panel of 42 cytokines that can be detected 
by this assay, 15 proteins were present at detectable levels in CM of cultured melanocytes 
(Figure 4.14 A). Moreover, more detailed analysis of the pro-inflammatory profile of these 
cells revealed that RANTES (Figure 4.14 B) and IP-10 (Figure 4.14 C) were significantly 
increased in CM from senescent melanocytes, with a 10- and 4.5-fold increase in concentration 
levels, respectively, when compared to young (non-irradiated) cells (P=0.0006 and P=0.0001, 
respectively). Although senescent melanocytes also secreted higher levels of IL-6 and IL-8, this 
was not statistically significance (P=0.08 and P=0.09, respectively) (Figure 4.14 D, E). 
Nevertheless, these results show that senescent melanocytes develop a distinct secretory 
phenotype, suggesting that stress-induced senescence is also accompanied by a SASP. 
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Figure 4.14 – Secretory phenotype of stress-induced melanocytes. (A) Heatmap showing 
cytokines detected in CM from young (non-irradiated) and senescent (10 days after irradiation) 
melanocytes. Blue represents low expression, whereas red denotes high expression. Each 
column represents one independent experiment for the corresponding condition. Heatmap was 
generated using Ingenuity Pathway Analysis (IPA). Graphs showing the concentration of (B) 
RANTES, (C) IP-10, (D) IL-6, and (E) IL-8. Data are mean ± S.E.M. of N=3 independent 
experiments. Statistical significance was determined by a two-tailed unpaired t-test. **P<0.01, 
***P<0.001, N.S. = not significant. (Cytokine array was done in collaboration with Duncan 
Talbot from Unilever).   
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 Stress-induced senescence (UV irradiation) 
4.3.1. Repeated UV exposure induces senescence in melanocytes in vitro 
In order to establish a more physiologically relevant model of melanocyte senescence, I next 
aimed to investigate the use of UV radiation as another stimulus to trigger stress-induced 
senescence. Firstly, to determine a suitable UV dose to induce senescence, lightly-pigmented 
human neonatal melanocytes were exposed to different doses of both UVA and UVB radiation 
once a day for five consecutive days, and cells were then collected 4 days following the last 
exposure for the analysis of senescence markers (Figure 4.15 A). Amongst the doses tested, 
0.1 J/cm2 UVA and UVB radiation induced a small but significant increase in Sen-β-Gal 
activity, as shown by an approximate 2-fold increase in Sen-β-Gal-positive cells compared to 
non-irradiated, proliferating controls (P<0.05) (Figure 4.15 B, C). Although a small increase 
in p16 expression was also achieved with this dose, this was not statistically significant (P>0.05) 
(Figure 4.15 D, E), suggesting that 0.1 J/cm2 does not efficiently induce melanocyte senescence 
in vitro. On the other hand, repeated exposure to 0.4 J/cm2 UVA and UVB radiation resulted in 
a 7-fold increase in Sen-β-Gal activity, where 82% of irradiated melanocytes were positive for 
Sen-β-Gal when compared to proliferating controls (P<0.001) (Figure 4.15 B, C). Moreover, 
this dose significantly increased p16 expression in relation to control cells (P<0.001), with 74% 
of melanocytes expressing p16 following 0.4 J/cm2 UVA+B exposure, which is also a 
significantly higher proportion in comparison to 0.1 J/cm2 irradiated cells (P<0.001) (Figure 
4.15 D, E). Therefore, these results suggest that repeated exposure to 0.4 J/cm2 UVA+B is 
sufficient to induce senescence in human melanocytes in culture. 
 
Chapter 4   Characterisation of in vitro models of melanocyte senescence 
137 
 
 
Figure 4.15 – Stress-induced senescence is achieved by repeated exposure of melanocytes 
to 0.4J/cm2 UVA and UVB radiation. (A) Scheme showing the experimental procedure. 
Proliferation efficient melanocytes were exposed to different doses of both UVA and UVB 
radiation once a day for five consecutive days. Cells were collected 4 days following the last 
exposure. Graphs showing (B) the percentage of Sen-β-Gal- and (D) p16-positive melanocytes 
following exposure to UVA+B radiation at the indicated doses. Data are mean ± S.E.M. of N=3 
technical repeats. Statistical significance was determined by a one-way ANOVA. *P<0.05, 
**P<0.01, ***P<0.001. Representative images of (C) Sen-β-Gal (blue) and (E) p16 (green) 
immunofluorescence (blue: DAPI) of proliferating and UV irradiated melanocytes. Images 
were taken using a 20x objective.  
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Having established a suitable UV dose that significantly up-regulates markers of senescence in 
melanocytes, I then wanted to determine whether the cell-cycle arrest was indeed permanent 
and not a mere transient arrest to allow repair UV-induced DNA damage. For that, melanocytes 
were exposed to 0.4 J/cm2 of UVA+B radiation once a day for five consecutive days, and cells 
were collected both at 4 and 18 days following the last exposure. Firstly, I analysed the 
proliferation status of untreated (no IR) and irradiated melanocytes by EdU incorporation. I 
found a 3.2-fold decrease in the percentage of proliferating melanocytes 4 days after the last 
UV exposure when compared to control cells, although this did not reach statistical significance 
(P>0.05) (Figure 4.16 A, B). Moreover, there is a further 2.6-fold decrease in proliferation 
between 4 and 18 days after irradiation, albeit not statistically significant (P>0.05), suggesting 
that there is continued progression towards a cell-cycle arrest at later time points (Figure 4.16 
A). Nonetheless, the percentage of proliferating melanocytes is significant lower at 18 days 
following UV exposure when compared to proliferating controls (P<0.05) (Figure 4.16 A, B), 
confirming that melanocytes do not resume proliferation after repeated UV irradiation. Next, to 
further characterise the growth arrest I performed immunofluorescence for the CDK inhibitor, 
p16. In accordance to my previous data, I observed a significant increase in p16 expression 4 
days after irradiation (P<0.05), which remained significantly higher at 18 days when compared 
to proliferating cells (P<0.01), with 87.5% of melanocytes expressing p16 at this time point 
(Figure 4.16 C). Therefore, these results corroborate the observation that repeated UVA and 
UVB exposure at 0.4 J/cm2 is sufficient to induce a stable proliferation arrest and melanocyte 
senescence in vitro.  
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Figure 4.16 – A stable cell-cycle arrest in achieved by UV exposure of melanocytes in vitro. 
Melanocytes were exposed to 0.4 J/cm2 UVA and UVB radiation once a day for five 
consecutive days, and then collected at 4 and 18 days for the analysis of senescence markers. 
(A) Graph showing the percentage of EdU-positive melanocytes at the time points indicated. 
Data are mean ± S.E.M. of N=3 independent experiments. (B) Representative EdU 
immunofluorescence images of proliferating and irradiated melanocytes (4 and 18 days post-
IR) (red: EdU; blue: DAPI). Images were taken using a 20x objective. (C) Percentage of p16-
positive melanocytes at the time points indicated as determined by immunofluorescence. Data 
are mean ± S.E.M. of N=3 independent experiments. Statistical significance was determined by 
a one-way ANOVA. *P<0.05, **P<0.01.  
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4.3.2. Telomere damage increases in UV-induced senescent melanocytes  
Given that all models of melanocyte senescence studied so far have suggested a role for 
telomere dysfunction the process, I aimed to investigate whether telomere damage also occurred 
as a result of UV-induced senescence. Although telomeres have been shown to be 
hypersensitive to UV-induced damage, which is also less efficiently, if at all, repaired in human 
fibroblasts in culture, (Kruk et al., 1995; Rochette and Brash, 2010), the relationship between 
telomere damage following UV exposure and senescence in human melanocytes has been 
understudied.  
To determine whether DNA damage accumulates at telomeres as a result of UV-induced 
senescence, melanocytes were exposed to UV irradiation as previously described, and collected 
at 4 days following the last exposure, when cells were shown to be senescent. I then performed 
immunofluorescence against the DNA damage protein, γH2AX, coupled with in situ 
hybridisation for a telomere specific probe, which allowed me to visualise telomere-associated 
damage or TAF. Firstly, I found that senescent melanocytes had a significantly higher number 
of DNA damage foci in comparison to proliferating cells, rising by 6-fold after repeated 
exposure to UV radiation.  (P=0.0007) (Figure 4.17 A, D). Moreover, as seen in other models 
of melanocyte senescence, telomeric damage was significantly increased in UV-induced 
senescent cells. In fact, the frequency of damaged telomeres was 4.5-fold higher in senescent 
melanocytes compared to non-irradiated controls (P=0.0005) (Figure 4.17 B, D). I also found 
that, following repeated UV exposure, the percentage of melanocytes containing dysfunctional 
telomeres significantly increased, with 60% of senescent melanocytes containing at least one 
telomere signalling a DDR (P=0.001) (Figure 4.17 C). These results suggest that both non-
telomeric and telomeric DNA damage are associated with the phenotype of UV-induced 
senescent melanocytes.  
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Figure 4.17 – Non-telomeric and telomeric DNA damage increase as a result of UV-
induced melanocyte senescence. Melanocytes were exposed to 0.4J/cm2 UVA and UVB 
radiation once a day for five consecutive days, and DNA and telomere damage were analysed 
at the time points indicated. Graphs show (A) mean number of γH2AX foci, (B) mean number 
of TAF, (C) percentage of melanocytes containing TAF. Data are mean ± S.E.M. of N=3 
independent experiments. Statistical significance was determined by a two-tailed unpaired t-
test. ***P<0.001. (E) Representative immuno-FISH images of proliferating (top) and senescent 
(bottom) melanocytes. Telomeres are shown in red, γH2AX is depicted in green, and DAPI is 
shown in blue. Arrows indicate co-localisation between γH2AX and telomeres, which is 
amplified on the right. Images were taken using a 63x oil objective. 
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4.3.3. Telomere damage occurs irrespectively of length in UV-induced senescent 
melanocytes 
As previously mentioned, telomere damage independently of length has been shown to occur 
in human cells during replicative-, stress- and oncogene-induced senescence (Kaul et al., 2011; 
Hewitt et al., 2012; Suram et al., 2012). However, it is not yet known whether longer telomeres 
also signal a DDR in human melanocytes in response to repeated UV irradiation. In fact, it is 
possible that UV exposure would cause single-stranded breaks preferentially at telomeres, 
accelerating telomere shortening (von Zglinicki et al., 2000).  
To investigate whether length-independent telomere damage also occurred during UV-induced 
melanocyte senescence, I performed Q-FISH in both proliferating and senescent cells, and 
analysed individual telomere signal intensity as a measure of length. By comparing FISH signal 
intensity of γH2AX-positive and –negative telomeres, I found that the median length of 
dysfunctional telomeres was very similar to those not signalling a DDR, with no statistically 
significant difference between their lengths (P=0.55) (Figure 4.18 A). Moreover, it is possible 
to find two telomeres of similar lengths in one cell, one which is associated with γH2AX 
whereas the other remains undamaged following repeated exposure to UVA+B radiation 
(Figure 4.18 B, C), suggesting that DNA damage occurs irrespectively of length in UV-induced 
senescent melanocytes.  
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Figure 4.18 – Length-independent telomere damage occurs in UV-induced senescent 
melanocytes. Quantitative FISH was performed in proliferating and senescent melanocytes (4 
days following the last exposure to 0.4J/cm2 UVA and UVB IR), and FISH intensity of at least 
1,800 individual telomeres was analysed as a measure of length. (A) Histograms showing 
intensity of γH2AX-negative and γH2AX-positive telomeres in both proliferating and senescent 
melanocytes. Red dotted line indicates median intensity. Statistical significance was determined 
by performing a Mann-Whitney U test. (B) Representative immuno-FISH image (red: 
telomeres; green: γH2AX) of a melanocyte containing telomeres of similar lengths, one which 
(a) co-localises with γH2AX and the other (b) is γH2AX-negative. Images were taken using a 
63x oil objective. (C) Graphs showing the quantification of telomere intensity of γH2AX-
positive (a) and γH2AX-negative (b) telomeres. Red line indicates telomere intensity, and green 
shows γH2AX intensity. 
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4.3.4. Senescence-associated secretory phenotype of UV irradiated melanocytes 
Given that repeated exposure to UV irradiation induces senescence in melanocytes in vitro, I 
next wanted to determine if this phenotype was also accompanied by increased secretion of pro-
inflammatory cytokines and chemokines, as observed with replicative and X-ray-induced 
senescence. 
The development of a SASP in response to UV irradiation has not been extensively reported by 
previous studies. Moreover, given that the secretory phenotype is a dynamic process which 
develops over time following senescence induction (Coppe et al., 2010a), I collected 
conditioned medium from senescent melanocytes at different time points after the last UV 
irradiation (6 and 18 days) in order to kinetically investigate the development of the secretory 
phenotype of these cells. Melanocytes were cultured in CM for 24 hours before media were 
collected for analysis. Different panels of cytokine arrays were performed, which overall 
detected the relative abundance of 58 cytokines and chemokines present in CM of proliferating 
and senescent cells. From the proteins analysed in these arrays, 14 were present at detectable 
levels in CM collected from cultured melanocytes (Figure 4.19 A). I observed that a distinct 
secretory phenotype significantly develops in senescent melanocytes at day 18, whereas at day 
6 the secretion of the majority of proteins analysed remain similar to proliferating cells (Figure 
4.19 A). These results suggest that the SASP progressively matures following the induction of 
UV-induced melanocyte senescence. Moreover, although there was an increase in secretion of 
pro-inflammatory factors by senescent melanocytes (Figure 4.20 A-L), statistical significance 
was only reached for IL-8, MCP-1, MIP-1α, MMP-3, and serpin E1 (Figure 4.20 B-D, J, K) 
likely due to the variability between experiments. Nonetheless, repeated UV exposure drives 
melanocyte senescence in vitro which is also accompanied by the development of a distinct 
pro-inflammatory secretory phenotype.  
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Figure 4.19 – Characterisation of the secretory phenotype of UV-induced senescent 
melanocytes. Heatmap showing cytokines detected in CM from young (non-irradiated) and 
senescent melanocytes (6 and 18 days after UVA+B irradiation). Blue represents low 
expression, whereas red denotes high expression. Concentration values are expressed as 
pg/ml/cell. Each column represents one independent experiment for the corresponding 
condition. Heatmap was generated using Prism 7.0. (Cytokine array analysis was done in 
collaboration with Duncan Talbot from Unilever).  
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Figure 4.20 – Cytokines and chemokines up-regulated in UV-induced senescent 
melanocytes accounting for cell number. Graphs showing concentrations of (A) Gro-α, (B) 
IL-8, (C) MCP-1, (D) MIP-1α, (E) Park7, (F) Emmprin, (G) Angiogenin, (H) Cystatin C, (I) 
TIMP-1, (J) MMP-3, (K) Serpin E1 and (L) DPP-IV secreted by melanocytes at the time points 
indicated. The concentration of each protein was normalised by cell number. Data are mean ± 
S.E.M. of N=3 independent experiments. Statistical significance was determined by a one-way 
ANOVA. *P<0.05, **P<0.01. 
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 Expression of a telomere-specific endonuclease (TRF1-FokI) induces melanocyte 
senescence in vitro 
So far, I have shown that telomere dysfunction occurs as a result of replicative and stress-
induced (X-ray and UV irradiation) melanocyte senescence; however, it is not possible to 
establish causality between telomere damage and senescence from these observations. 
Therefore, to investigate whether dysfunctional telomeres were a cause or a mere consequence 
of senescence, we expressed a FLAG-tagged telomeric protein, TRF1, fused to the catalytic 
domain of FokI nuclease in melanocytes (TRF1-FokI), which has been shown to induce DSBs 
specifically at telomeres (Tang et al., 2013; Cho et al., 2014). In order to control the amount of 
telomeric DNA damage being induced, we cloned the TRF1-FokI fusion protein into a 
doxycycline (DOX) inducible lentiviral backbone, such that expression is only switched on in 
the presence of DOX. Melanocytes expressing a nuclease inactive TRF1-FokI-D450A mutant 
were used as controls (done in collaboration with Alison Howard and Gisela Otten).  
Contrary to previous observations, new evidence has emerged suggesting that double-stranded 
breaks at telomeres can be repaired in proliferating cells (Doksani and de Lange, 2016; Mao et 
al., 2016). Therefore, to determine whether telomeric DSBs could be repaired after the 
induction of TRF1-FokI, melanocytes expressing the fusion protein were treated with 
doxycycline for 6 hours, which was determined to be the optimal time of TRF1-FokI induction 
by DOX (data not shown). Following DOX removal, cells were cultured for an additional 3 and 
7 days after induction (Figure 4.21 A), and immuno-FISH combining immunofluorescence for 
γH2AX and in situ hybridisation using a telomere specific probe was performed in order to 
analyse telomere DNA damage (in collaboration with Anthony Lagnado). I observed that the 
number of DNA damage foci gradually increased in melanocytes expressing TRF1-FokI at 3 
and 7 days after induction compared to control cells in which the nuclease was not induced (no 
DOX) (Figure 4.21 B). Moreover, DNA damage was higher in TRF1-FokI melanocytes at 7 
days in comparison to 3 days after induction, suggesting that additional DNA lesions are formed 
in a time-dependent manner. TRF1-FokI melanocytes also have increased DNA damage when 
compared to cells expressing the mutant TRF1-FokI(D450A) protein (Figure 4.21 B), 
indicating that a fraction non-telomeric DNA damage is also induced as a result of TRF1-FokI 
expression in melanocytes. Therefore, based on these results, it cannot be concluded that TRF1-
FokI is telomere specific, and a comprehensive kinetic study needs to be performed in order to 
further elucidate its specificity.  
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Furthermore, TRF1-FokI-expressing cells have a higher frequency of telomere damage at both 
3 and 7 days after induction when compared to melanocytes without nuclease induction (no 
DOX) (Figure 4.21 C), showing that TRF1-FokI activation indeed causes DNA damage at 
telomeres. Importantly, TRF1-FokI melanocytes display higher numbers of TAF when 
compared to cells expressing the nuclease inactive TRF1-FokI(D450A), confirming the 
functionality of the TRF1-FokI fusion protein. Interestingly, the amount of dysfunctional 
telomeres in TRF1-FokI melanocytes at day 7 was significantly higher when compared to day 
3 (Figure 4.21 C). Given this time-dependent increase in telomere damage, these data suggest 
that telomeric DSBs are not repaired in melanocytes in vitro. Alternatively, it is also possible 
that secondary TAF are being generated following the DSBs caused by the fusion protein. 
However, in order to corroborate these findings, these experiments need to be independently 
confirmed.  
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Figure 4.21 – Melanocytes expressing TRF1-FokI have increased non-telomeric and 
telomeric DNA damage. Melanocytes expressing TRF1-FokI or the nuclease inactive TRF1-
FokI(D450A) mutant were incubated with DOX for 6 hours and collected at the time points 
indicated. (A) Scheme representing the experimental procedure. Graphs showing (B) mean 
number of γH2AX foci and (C) mean number of TAF in melanocytes expressing TRF1-
FokI(D450A) or TRF1-FokI without nuclease induction (no DOX), and 3 and 7 days following 
induction by DOX. Data are mean of 17 – 35 cells obtained from at least 6 random planes 
(N=1).  
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Next, I wanted to determine whether induction of DNA damage by TRF1-FokI was sufficient 
to induce melanocyte senescence in vitro. For that, I analysed Sen-β-Gal activity in TRF1-FokI 
melanocytes at 3 and 7 days after nuclease induction. Although TRF1-FokI(D450A) cells 
showed an increase in Sen-β-Gal activity at 7 days, only 30% of TRF1-FokI(D450A) 
melanocytes showed Sen-β-Gal positivity, whereas this was increased to 80% in TRF1-FokI 
melanocytes (Figure 4.22 A). Moreover, an increase in Sen-β-Gal activity is observed only at 
7 days following TRF1-FokI induction in melanocytes (Figure 4.22 A). To further corroborate 
the induction of senescence in these cells, I also carried out immunofluorescence for p16. 
Although TRF1-FokI melanocytes had higher basal levels of p16 prior to nuclease induction 
compared to TRF1-FokI(D450A) cells, I found that, at 7 days, TRF1-FokI melanocytes showed 
elevated p16 expression compared to TRF1-FokI cells at day 3 and without nuclease induction 
(Figure 4.22 B). Moreover, p16 expression was higher in TRF1-FokI melanocytes at all 
observed time points when compared to TRF1-FokI(D450A)-expressing cells (Figure 4.22 B). 
These results suggest that accumulation of DSBs leads to melanocyte senescence in vitro. 
However, given that non-telomeric damage was also observed upon TRF1-FokI induction, it 
cannot be concluded that senescence is a result of dysfunctional telomeres in this system. 
Therefore, these data need to be independently confirmed, and further experiments are needed 
to implicate telomeres are drivers of melanocyte senescence.  
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Figure 4.22 – Accumulation of DNA DSBs induces senescence in human melanocytes. (A) 
Percentage of Sen-β-Gal-positive melanocytes expressing TRF1-FokI(D450A) or TRF1-FokI 
without nuclease induction, and at 3 and 7 days after induction. (B) Percentage of p16-positive 
melanocytes expressing TRF1-FokI(D450A) or TRF1-FokI without nuclease induction, and at 
3 and 7 days after induction (in collaboration with Anthony Lagnado). Data are mean of positive 
cells in 6 random fields (N=1). 100-200 cells were analysed for Sen-β-Gal activity, and a 
minimum of 27 cells were counted for p16 analysis.  
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 Discussion 
In this study, we exploited different stimuli to induce human melanocyte senescence in vitro in 
order to establish a suitable model to be used for the investigation of mechanisms of bystander 
DNA damage, which will be discussed in further detail in the following chapter. A summary of 
the phenotypes involved in replicative-, X-ray-, and UV irradiation-induced senescence can be 
seen in Table 4.1. We found that the CDK inhibitor, p16, was up-regulated in all three models 
of senescence studied. This is agreement with previously published data, demonstrating that 
melanocyte senescence, both by replicative exhaustion and by stimulation of melanin synthesis, 
is mediated primarily by an increase in p16 (Bandyopadhyay and Medrano, 2000; 
Bandyopadhyay et al., 2001). The latter binds to and inhibits the cyclin-dependent kinases 4 
and 6, in turn preventing Rb phosphorylation. Non-phosphorylated Rb remains bound to E2F 
transcription factors, and thus E2F target genes, which are important for G1/S transition, cannot 
be transcribed, promoting cell-cycle arrest (Rayess et al., 2012). Indeed, melanocyte senescence 
is accompanied by Rb dephosphorylation, down-regulation of CDK-4 activity, and increased 
association of E2F4 with Rb (Bandyopadhyay and Medrano, 2000; Bandyopadhyay et al., 
2001). In fact, mutations in the CDKN2A gene, which encodes for p16, accounts for a large 
number of cases of familial melanoma, indicating that p16 is a major regulator of melanocyte 
growth arrest (Aoude et al., 2015). The importance of the p16-pRb pathway in melanocyte 
senescence is corroborated by studies showing that a heterozygous deletion in the Ink4a-Arf 
locus, which affects both p16 and Arf, delayed senescence in mouse melanocytes in culture 
(Sviderskaya et al., 2002), whilst no effects were observed on mouse fibroblast senescence 
(Serrano et al., 1996). Accordingly, two strains of human melanocytes with deletions or 
mutations in both p16 alleles, had extended replicative lifespan in vitro, and became senescent 
after around 50 population doublings, whilst normal adult human melanocytes normally reach 
senescence after 10 PDs (Sviderskaya et al., 2003). Interestingly, senescence in p16-deficient 
melanocytes was accompanied by elevated levels of p53 and p21, whereas this was not 
observed in normal melanocyte senescence, suggesting that p16 is the primary mediator of 
normal human melanocyte senescence, and that the p53-p21 pathway acts as a second barrier 
to promote growth arrest (Sviderskaya et al., 2003).  
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Senescence-inducing stimulus 
 Replication X-ray irradiation UV irradiation 
p16 ↑ ↑ ↑ 
p21 ↑ ↑ N.D. 
mTOR activity ↑ ± N.D. 
ROS ↑ ↑ N.D. 
TAF ↑ ↑ ↑ 
IL-8 ↑ ↑ ↑ 
Gro-α ↑ ↓ ↑ 
PDGF-AA ↑ ↓ ± 
MIP-1α ↑ ↓ ↑ 
MCP-1 ↑ ↓ ↑ 
IL-6 ↑ ↑ Not detectable 
RANTES ↑ ↑ Not detectable 
IL-4 ↑ ↓ Not detectable 
FGF-2 ↑ Not detectable Not detectable 
IP-10 Not detectable ↑ Not detectable 
EGF Not detectable ↓ Not detectable 
MCP-3 Not detectable ↓ Not detectable 
G-CSF Not detectable ↓ Not detectable 
VEGF Not detectable ↓ Not detectable 
MDC Not detectable ± Not detectable 
IL-5 Not detectable ± Not detectable 
TIMP-1 Not detectable Not detectable ↑ 
MMP-3 Not detectable Not detectable ↑ 
Park7 N.D. N.D. ↑ 
Emmprin N.D. N.D. ↑ 
Angiogenin N.D. N.D. ↑ 
Cystatin C N.D. N.D. ↑ 
Serpin-E1 N.D. N.D. ↑ 
DPP-IV N.D. N.D. ↑ 
Dkk-1 N.D. N.D. ± 
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Table 4.1 – Comparison of phenotypes of melanocyte senescence induced by different 
stimuli. Table summarising the phenotypes of replicative, X-ray- and UV-induced melanocyte 
senescence. ↑: indicates increased levels, ±: indicates no change, N.D.: not determined.  
Our results also demonstrated that p21 levels increase in both replicative and stress-induced (X-
ray) senescent melanocytes, contrary to previously published data showing that p21 is down-
regulated during melanocyte senescence (Bandyopadhyay and Medrano, 2000; Bandyopadhyay 
et al., 2001; Sviderskaya et al., 2003). However, the regulation of melanocyte senescence has 
been shown to be dependent on the culture medium composition, with different groups not only 
reporting a wide range of lifespans depending on the media used, but also different expression 
patterns of CDK inhibitors, such as p21, at the time of senescence (Bennett, 2003). Although 
p16 was always up-regulated in senescent melanocytes regardless of the growth medium 
(Haddad et al., 1998; Bandyopadhyay et al., 2001), cells cultured in the presence of cAMP 
agonists, such as cholera toxin (CT), senesced with low levels of p21 (Bennett, 2003), whereas 
p21 up-regulation was observed in melanocytes senescing without supplementation of cAMP 
agonists (Haddad et al., 1998). In fact, the growth medium used in this study did not contain 
cAMP agonists, possibly explaining our observation that p21 levels increase in replicative and 
stress-induced (X-ray) senescent melanocytes. Moreover, interferon-γ (IFN-γ) treatment was 
shown to induce melanocyte senescence with a concomitant increase in p21 levels (Wang et 
al., 2014), and UVB irradiation induces a p21-dependent G1 growth arrest in melanocytes 
(Medrano et al., 1995), suggesting that different senescence-inducing stimuli can also affect the 
expression of CDK inhibitors. Therefore, it is possible that p21 up-regulation observed in our 
model of stress-induced (X-ray) melanocyte senescence is a result of the type of stimulus. 
Although previous studies have demonstrated that p21 is important for senescence induction in 
other cells types, such as fibroblasts (Brugarolas et al., 1995; Brown et al., 1997), we cannot 
establish a causal role for p21 in melanocyte senescence from our studies. Therefore, future 
experiments could be performed using p21 knockdown melanocytes in order to further 
investigate the involvement of p21 in melanocyte senescence. 
We have also shown that lamin B1 is down-regulated in melanocytes during replicative 
senescence. In agreement, a reduction in lamin B1 levels has been reported in replicative 
senescent human fibroblasts and BRAF-induced senescent human melanocytes (Shimi et al., 
2011; Sadaie et al., 2013). Lamin B1 is a nuclear envelope protein that is important for nuclear 
stability, and also plays a role in transcription and chromatin remodelling (Spann et al., 2002; 
Shimi et al., 2008). Interestingly, a reduction in lamin B1 during senescence was shown to lead 
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to spatial repositioning of perinuclear heterochromatin, which was proposed to contribute to 
SAHF formation, heterochromatic regions that silence genes required for cell-cycle progression 
(Narita et al., 2003; Sadaie et al., 2013). Therefore, loss of lamin B1 might contribute to the 
proliferation arrest during melanocyte replicative senescence. In fact, heterochromatic changes 
have been proposed to occur in replicative senescent melanocytes (Bandyopadhyay et al., 
2002). Down-regulation of the p300/CBP histone acetyltransferase was shown to promote 
deacetylation and silencing of the cyclin E gene, a cyclin that controls progression through S 
phase (Bandyopadhyay et al., 2002). It is believed that loss of acetylation contributes to 
formation of repressive heterochromatin, thus silencing genes associated with proliferation, and 
contributing to melanocyte senescence (Bandyopadhyay et al., 2002). However, it is important 
to note that we only observed a mild decline in lamin B1 levels in our study. Therefore, these 
experiments will need to be independently confirmed in order to achieve further conclusions 
regarding the role of lamin B1 during melanocyte senescence.  
The observation that mTORC1 activity is upregulated in replicative melanocyte senescence is 
consistent with studies showing that mTOR inhibition by rapamycin extends the replicative 
lifespan of human and murine fibroblasts in culture (Kolesnichenko et al., 2012; Pospelova et 
al., 2012), implicating mTORC1 in the senescence process. Although the mechanisms leading 
to mTOR activation during senescence are still not fully understood, mTOR is thought to 
contribute to the senescence phenotype by promoting translation of pro-inflammatory factors 
involved in the SASP (Herranz et al., 2015; Laberge et al., 2015). One study demonstrated that 
mTOR inhibition diminished the SASP in fibroblasts undergoing replicative, oncogene- and 
stress-induced senescence (Herranz et al., 2015). It was shown that mTOR regulates the 
translation of the kinase MK2, which in turn phosphorylates the RNA-binding protein 
ZFP36L1, inhibiting the degradation of transcripts of proteins involved in the SASP (Herranz 
et al., 2015). Furthermore, inhibiting mTOR was also shown to decrease translation of the pro-
inflammatory protein, IL-1α, in senescent cells, in turn reducing the transcriptional activity of 
NF-κB, which regulates the transcription of many SASP genes (Laberge et al., 2015). 
Interestingly, supressing mTORC1 activity inhibited the SASP without reversing the growth 
arrest, suggesting that the effects of mTOR on the pro-inflammatory secretory phenotype are 
dissociated from the cell-cycle arrest (Herranz et al., 2015; Laberge et al., 2015). Others have 
suggested that mTORC1 signalling stimulates mitochondria biogenesis during senescence, and 
contributes to the maintenance of a DDR through increased ROS production (Correia-Melo et 
al., 2016), which is important for the induction of senescence and the SASP (Rodier et al., 
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2009; Passos et al., 2010). It is also possible that mTORC1 activation mediates growth arrest 
in response to a DDR by directly interacting with components of the DNA damage response, 
such as Mdm2, a negative regulator of p53 (Lai et al., 2010). Upon DNA damage induction, it 
was shown that S6K1, a downstream target of mTORC1, forms a complex with Mdm2, 
inhibiting p53 ubiquitination, thus stabilising p53, which can then mediate cell cycle arrest (Lai 
et al., 2010). However, in this study, such interactions were reported to occur a few hours after 
a DDR, which does not explain how a stable arrest in maintained in the context of senescence.  
In contrast to replicative senescence, our results suggest that mTORC1 activity remains 
unchanged in stress-induced (X-ray) senescent melanocytes. One possibility is that mTOR 
activation occurs early following genotoxic stress, and returns to basal levels after a few days, 
providing an explanation for the constant levels of mTOR activity observed in melanocytes at 
3 and 10 days following X-ray irradiation. Indeed, studies have shown that mTORC1 activity 
peaks at 4 hours after induction of DNA damage in mouse fibroblasts, and gradually decreases 
at 8 and 24 hours after damage (Lai et al., 2010). Consistent with this, X-ray irradiation of 
human fibroblasts results in mTOR activation during the first 24 hours after the induction of 
stress, and then decreases at 3 days, albeit not to control levels (Correia-Melo et al., 2016). A 
slight increase in mTOR activity has also been reported in human oral keratinocytes 24 hours 
post-irradiation, and inhibition of mTOR by rapamycin was shown to reduce a DDR and 
markers of senescence in these cells (Iglesias-Bartolome et al., 2012). It is possible that mTOR 
is involved in the early stages of induction of melanocyte senescence in response to genotoxic 
stress but this is not detected in this study as we have only analysed mTOR activity at 3 and 10 
days following irradiation. Therefore, in order to obtain a better understanding of the role of 
mTORC1 in stress-induced melanocyte senescence, it is important to analyse its activity in the 
first few hours following genotoxic stress. Nonetheless, mTORC1 down-regulation has been 
reported in BRAF-induced growth arrested melanocytes in mice in vivo, suggesting that mTOR 
activation can also depend on the nature of the senescence-inducing stimulus (Damsky et al., 
2015). However, it is unlikely that mTORC1 is not involved in the senescent phenotype of 
melanocytes, since its inhibition diminished the SASP during stress-induced (X-ray) 
melanocyte senescence, which will be discussed in the following chapter.   
Further characterisation of the senescent phenotype of human melanocytes revealed that both 
replicative and stress-induced (X-ray) senescence are accompanied by increased oxidative 
stress, in accordance with previously published data showing that increased ROS is involved in 
fibroblast senescence in response to genotoxic stress or replicative exhaustion (Saretzki et al., 
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2003; Passos et al., 2007; Passos et al., 2010). Consistent with a role for oxidative stress in 
melanocyte senescence, early studies have demonstrated that melanocyte proliferation is 
impaired when these cells are cultured in hyperoxic conditions (Horikoshi et al., 1991). 
Increased intracellular ROS has been reported in IFN-γ-induced melanocyte senescence, and 
treatment with the antioxidant N-acetylcysteine (NAC) resulted in decreased p21 and IL-6 
release, and prevented melanocyte senescence (Wang et al., 2014). Although MitoQ has been 
shown to extend the replicative lifespan of fibroblasts under conditions of mild oxidative stress 
(Saretzki et al., 2003), our results demonstrated that scavenging mitochondrial ROS by MitoQ 
treatment was not sufficient to prevent Sen-β-Gal activity in senescent melanocytes. Therefore, 
from these results, we cannot conclude that enhanced ROS generation mediates melanocyte 
senescence. However, other senescence markers need to be analysed in MitoQ-treated 
senescent melanocytes in order to further investigate the impact of ROS in this process. 
Moreover, overexpression and knockdown of antioxidant enzymes in melanocytes could also 
shed light on the involvement of oxidative stress in melanocyte senescence. 
Nonetheless, in agreement with our findings that senescent melanocytes display higher levels 
of ROS, oncogene-induced melanocyte senescence has also been shown to involve mechanisms 
leading to increased ROS generation (Leikam et al., 2008; Kaplon et al., 2013). For example, 
melanocyte senescence induced by N-RAS activation is accompanied by enhanced ROS 
production and DNA damage, and senescence can be prevented by NAC treatment (Leikam et 
al., 2008). Moreover, increased ROS generation was shown to occur in BRAF-induced 
senescence as a result of increased mitochondrial respiration (Kaplon et al., 2013). More 
specifically, BRAF(V600E) expression, an oncogene commonly associated with melanocytic 
nevi, led to activation of the mitochondrial gatekeeper enzyme pyruvate dehydrogenase, which 
increased the use of pyruvate in the citric acid cycle, resulting in enhanced respiration and 
oxidative stress (Kaplon et al., 2013). Although the mechanisms leading to increased ROS 
generation in replicative and stress-induced senescent melanocytes are not fully understood, it 
has been shown that ROS can be induced downstream of a DDR, whereby continuous activation 
of p21 induces mitochondrial dysfunction and ROS generation through signalling pathways 
involving GADD45-p38MAPK-TGFβ (Passos et al., 2010). The ensuing oxidative stress 
causes further DNA damage, maintaining a positive feedback loop between a DDR, p21 and 
ROS which stabilises the senescence growth arrest (Passos et al., 2010). Indeed, overexpression 
of p21 results in increased ROS and cell-cycle arrest in fibroblasts (Macip et al., 2002). More 
recently, it has been proposed that a DDR induces PGC-1β-dependent mitochondrial biogenesis 
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through mechanisms involving ATM, Akt and mTOR, contributing to increased ROS 
production, which maintains a DDR and stabilises the senescence phenotype (Correia-Melo et 
al., 2016). In addition, increased ROS as a result of extensive telomere attrition has been 
reported. It was shown that p53 activated in response to telomere shortening induces 
mitochondrial dysfunction by repressing PGC-1α and PGC-1β promoters, which impairs 
mitochondrial biogenesis and function, and in turn elevates ROS levels (Sahin et al., 2011). In 
fact, our results show that telomere shortening occurs during melanocyte replicative 
senescence; therefore, it is possible that short telomeres activate such downstream signalling, 
contributing to increased ROS production in senescent melanocytes. However, telomerase 
would need to be expressed in melanocytes in vitro in order to further investigate the role of 
telomere shortening in the induction of ROS during melanocyte senescence.  
Although we did not investigate whether ROS generation is enhanced in UV-induced 
melanocyte senescence, it is well established that induction of ROS is one of the main effects 
of UV irradiation (Klotz et al., 1999; Maziere et al., 2001; Heck et al., 2003; Cotter et al., 
2007). Therefore, it is possible that oxidative stress is also associated with the phenotype of 
UV-induced senescent melanocytes. One obvious response to UV irradiation is increased 
melanin production, which offers protection against UV-induced DNA damage (Kobayashi et 
al., 1998; Smit et al., 2001). Paradoxically, melanin synthesis is a highly oxidative process, 
although its confinement to melanosomes protects cellular components from oxidative damage 
(Denat et al., 2014). Nevertheless, tyrosine-induced melanogenesis has been shown to increase 
intracellular ROS and decrease levels of the antioxidant glutathione in lightly-pigmented 
melanocytes (Smit et al., 2008). Moreover, in some cases, melanin has been shown to act as a 
pro-oxidant, contributing to oxidative stress. For example, it has been shown that melanocytes 
with higher content of the red pigment pheomelanin are more sensitive to UVA-induced single-
stranded DNA breaks (Wenczl et al., 1998). It was suggested that oxidative stress was 
significantly enhanced by increased pheomelanin content, contributing to UVA sensitivity 
(Wenczl et al., 1998). Indeed, it is known that ROS production is stimulated upon UV 
irradiation of pheomelanin pigments, a characteristic owed to its chemical structure (Napolitano 
et al., 2014). Consistently, another study demonstrated that melanocytes with a higher 
pheomelanin: eumelanin ratio had increased levels of UVB-induced oxidative DNA lesions 
(Smit et al., 2001). Therefore, it appears that the balance between the pro-oxidant and protective 
properties of melanin depends on the ratio of eumelanin to pheomelanin in the cell. 
Interestingly, senescent melanocytes have been shown to have increased melanin content 
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(Horikoshi et al., 1991; Bandyopadhyay and Medrano, 2000). Moreover, dysplastic nevi cells, 
which are melanoma precursors, are more pigmented than normal melanocytes from the same 
donor. These cells were shown to contain a higher pheomelanin to eumelanin ratio, and 
senesced prematurely when compared to normal melanocytes (Smit et al., 2008). Therefore, it 
is possible that melanin contributes to elevated ROS production in normal human senescent 
melanocytes. Although it is not known whether the ratio of pheomelanin to eumelanin increases 
in these cells, this would be an interesting topic for further investigation.  
As well acting as effector molecules downstream of the activation of senescence signalling 
pathways, increased ROS generation can also contribute to the induction of senescence by 
directly inducing DNA damage. For example, premature senescence can be induced in 
fibroblasts by treatment with sub-lethal concentrations of H2O2 (Chen et al., 1998). 
Interestingly, mild oxidative stress causes SSBs to preferentially accumulate at telomeres, 
which results in an accelerated rate of telomere shortening and premature senescence (von 
Zglinicki et al., 1995; von Zglinicki, 2000; von Zglinicki, 2002). Accordingly, reducing 
intracellular ROS levels, either by the use of antioxidants or by overexpression of antioxidant 
enzymes, prevents telomere shortening and extends replicative lifespan of human fibroblasts 
(Saretzki et al., 2003; Serra et al., 2003). Indeed, telomeres are believed to be highly susceptible 
to oxidative stress due to their high content of guanine triplets, which are extremely sensitive 
to oxidative modifications (Oikawa and Kawanishi, 1999). In fact, our results demonstrate that 
the frequency of telomere damage increases during replicative and stress-induced (X-ray and 
UV) melanocyte senescence. Although it is not clear whether telomere dysfunction in these 
models occurs as a direct result of increased ROS generation, it is possible that ROS contributes 
to the formation of telomeric DNA damage during melanocyte senescence. In order to 
corroborate this hypothesis, it will be important to analyse DNA damage in senescent 
melanocytes treated with MitoQ.  
Interestingly, we observed that telomere damage occurs independently of length in replicative, 
X-ray-, and UV-induced melanocyte senescence, suggesting that longer telomeres are also able 
to signal a DDR in response to stress. This is consistent with previous studies showing that 
length-independent telomere dysfunction can occur in cells undergoing replicative and stress-
induced senescence in vitro (Kaul et al., 2011; Hewitt et al., 2012), and has also been 
demonstrated in human melanocytic nevi (Suram et al., 2012), as well as in many tissues of 
mice with age (Hewitt et al., 2012; Jurk et al., 2014). It has been previously proposed that 
damage occurs at long telomeres as they represent a more abundant target for break formation 
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(Fumagalli et al., 2012). This is supported by studies showing that forced elongation of telomere 
length sensitises cancer cells to ionising radiation, suggesting that DSBs preferentially 
accumulate at telomeres exceeding a critical length (Fairlie and Harrington, 2015). However, 
our in vitro data does not support the idea that longer telomeres accumulate more damage than 
shorter ones. In fact, consistent with previously published data (Hewitt et al., 2012; Suram et 
al., 2012), we have not identified a significant difference in length between dysfunctional and 
non-damaged telomeres. Indeed, it is possible that the method used to analyse individual 
telomere length in this study is not sensitive enough to detect very short telomeres, thus making 
it difficult to accurately identify significant differences in length between damaged and non-
damaged telomeres. Therefore, in order to confirm these results, super resolution microscopy 
could be used as a more sensitive method, which would likely detect weaker FISH signal 
intensities when compared to wide-field or confocal microscopy.  
It is also possible that telomeres become dysfunctional due to loss of shelterin proteins, or 
uncapping, in senescent melanocytes. For example, during replicative senescence, extensive 
telomere shortening is believed to lead to displacement of shelterin proteins, which in turn 
exposes telomeric ends that are then recognised as DSBs by the DNA repair machinery 
(O'Sullivan and Karlseder, 2010). In support of this, fibroblasts expressing a dominant-negative 
allele of TRF2, which triggers uncapping, have increased numbers of dysfunctional telomeres, 
indicating that uncapped telomeres activate a DDR (Takai et al., 2003). Given that our results 
show significant loss of telomeric repeats during replicative melanocyte senescence in vitro, it 
is possible that uncapping contributes to DDR activation at telomeres in this process. 
Furthermore, studies have shown that oxidative DNA damage disrupts the binding of TRF1 and 
TRF2 at telomeres (Opresko et al., 2005), which would provide a mechanism for length-
independent loss of shelterin. This would be consistent with our results demonstrating increased 
ROS and length-independent telomere damage in senescent melanocytes. However, telomere 
dysfunction in the presence of TRF2 has been previously reported in stress-induced (Fumagalli 
et al., 2012) and replicative senescence (Kaul et al., 2011), as well as in melanocytic nevi 
(Suram et al., 2012), suggesting that  DDR activation can occur independently of telomere 
uncapping. An additional possibility has been proposed by Cesare et al., suggesting that 
telomeres can also exist in an intermediary state of capping, whereby a DDR is activated but 
sufficient TRF2 or other shelterin components are retained to suppress NHEJ, leading to a 
persistent DDR at telomeres irrespectively of length (Cesare et al., 2009). In order to further 
investigate whether uncapping contributes to telomere damage during melanocyte senescence, 
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telomere FISH should be performed together with immunofluorescence against γH2AX, and a 
shelterin protein such as TRF2, to allow analysis of co-localisation between γH2AX-positive 
telomeres and TRF2 in cultured melanocytes. 
Our data also suggest that telomere dysfunction is associated with melanocyte senescence, since 
telomere damage was shown to accumulate in replicative, X-ray and UV-induced senescent 
melanocytes. As previously mentioned, telomeres are highly sensitive to oxidative stress when 
compared to the rest of the genome (Petersen et al., 1998). In addition, damage occurring at 
telomeres is less efficiently repaired (Kruk et al., 1995; Rochette and Brash, 2010), mainly 
because components of the shelterin complex inhibit proteins of the DNA repair machinery 
(Bombarde et al., 2010; Fumagalli et al., 2012). This contributes to persistent DNA damage 
signalling at telomeres, which is important for the initiation and maintenance of senescence 
through continuous activation of p21 and p16 (d'Adda di Fagagna et al., 2003; Takai et al., 
2003; Jacobs and de Lange, 2004). In accordance to this, our results demonstrate that following 
X-ray irradiation, non-telomeric DNA damage appears to be repaired at 10 days, whilst 
telomere-associated damage remains high, suggesting that DDR signalling at telomeres is 
indeed persistent. Future analysis of telomere damage at later time points after UV irradiation 
of melanocytes should also reveal whether telomere-associated foci are persistent following 
repeated UV exposure. Consistent with our observations, dysfunctional telomeres have been 
shown to accumulate in human fibroblasts during replicative (Kaul et al., 2011), stress- 
(Fumagalli et al., 2012; Hewitt et al., 2012), and oncogene-induced senescence (Suram et al., 
2012). Moreover, the majority of long-lived DNA damage foci were shown to co-localise with 
telomeres in stress-induced senescent fibroblasts (Hewitt et al., 2012), supporting the idea that 
persistent telomere-associated damage contributes to the senescence phenotype. However, from 
our results, we cannot establish that a persistent DDR at telomeres is in fact an inducer of 
melanocyte senescence. Although expression of TRF1-FokI induced markers of senescence in 
melanocytes, the fusion endonuclease generated both telomeric and non-telomeric DNA 
damage, and thus we cannot conclude that senescence was induced specifically as a result of 
telomere dysfunction. Moreover, a fraction of melanocytes expressing mutant TRF1-FokI also 
displayed a small increase in senescence markers, suggesting that the transduction could have 
contributed to induction of senescence in some cells. Although previous studies suggest that 
persistent DNA damage plays a role in the induction and maintenance of the senescence 
phenotype (d'Adda di Fagagna et al., 2003; Passos et al., 2010; Fumagalli et al., 2014), further 
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experiments involving the inhibition of DDR signalling will need to be performed in order to 
corroborate that this is also the case in melanocyte senescence. 
Recent studies have challenged the irreparability of telomeres, providing evidence that 
telomeric DSBs are repaired by mechanisms involving homologous recombination and 
alternative (alt)-NHEJ (Doksani and de Lange, 2016; Mao et al., 2016). This is in contrast with 
our results demonstrating that telomere damage induced by transient expression of TRF1-FokI 
remained high even one week after induction. Although these data suggest that TAF are not 
repaired by melanocytes, we cannot exclude the possibility secondary telomere damage is also 
being induced following TRF1-FokI induction. One possible scenario is that activation of a 
DDR at telomeres causes an increase in intracellular ROS, which in turn would generate further 
breaks at telomeres. An increase in oxidative stress could also explain the induction of non-
telomeric DNA damage seen in melanocytes expressing TRF1-FokI. In support of this, 
secondary DNA damage as a result of telomere dysfunction has been reported in fibroblasts 
expressing a dominant-negative TRF2 allele and in fibroblasts from late-generation TERC-/- 
mice (Passos et al., 2010). These cells displayed high levels of mitochondrial ROS, and 
antioxidant treatment reduced DNA damage foci induction (Passos et al., 2010). However, 
further experiments are needed to confirm that this occurs in TRF1-FokI melanocytes. Firstly, 
levels of intracellular ROS should be measured by flow cytometry to ascertain if induction of 
the fusion protein increases generation of ROS. Moreover, antioxidant treatment following 
TRF1-FokI induction would allow us to determine if a further increase in both telomeric and 
non-telomeric damage could be prevented by scavenging excess ROS. Another explanation for 
the increase in non-telomeric DNA damage in TRF1-FokI melanocytes is that TRF1 could be 
located in genomic sites other than telomeres, similarly to TRF2 and RAP1 (Bradshaw et al., 
2005; Martinez et al., 2010). However, studies in mice have not identified extra-telomeric TRF1 
(Garrobo et al., 2014), and other studies using TRF1-FokI have reported exclusive localisation 
at telomeres (Tang et al., 2013; Doksani and de Lange, 2016), making this possibility less likely. 
Overall, based on our results, we cannot conclude that TRF1-FokI induces telomere-specific 
DSBs, and a more comprehensive kinetic study will need to be performed in order to investigate 
its specificity. Nonetheless, we have demonstrated that telomeres are irreparable in melanocytes 
independently in one experiment. 
It is important to note that, in one study, damage repair at telomeres was only observed in 
proliferating cells, such as BJ fibroblasts and HeLa cells (Mao et al., 2016). Interestingly, HeLa 
cells, which are faster dividing cells, display a faster repair kinetics compared to slower dividing 
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fibroblasts, suggesting that proliferation rate is an important determinant of telomeric DSB 
repair (Mao et al., 2016). On the other hand, when senescence was induced in fibroblasts either 
by genotoxic stress or replicative exhaustion, no significant repair was detected at telomeres 
(Mao et al., 2016). By using the CRISPR-Cas9 system to specifically target telomeric repeats, 
the authors were able to induce DSBs specifically at telomeres in HEK cells, and provided 
evidence for telomere damage repair by homologous recombination (Mao et al., 2016). Another 
group also expressed the fusion protein TRF1-FokI to induce telomere-specific damage in 
mouse embryonic fibroblasts (Doksani and de Lange, 2016). Consistent with our observations 
in melanocytes, TRF1-FokI expression induced significant telomere damage in MEFs, which 
was accompanied by activation of ATM-dependent kinase signalling in S-phase; however, 
these breaks were shown to be efficiently repaired by mechanisms involving both HR and alt-
NHEJ (Doksani and de Lange, 2016). The aforementioned studies suggest that in dividing cells, 
particularly in S phase, telomeric breaks can be repaired via HR; however, this does not occur 
in senescent cells. This could be a consequence of heterochromatin changes that occur during 
senescence (Narita et al., 2003), making telomeric DNA less accessible for the repair 
machinery, explaining the persistent DDR signalling at telomeres observed in senescent cells 
(Mao et al., 2016). However, further studies are required to confirm this hypothesis. Another 
possibility is that that senescence-inducing stimuli are likely to cause a large amount of damage, 
which might be greater than the repair capacity of cells, resulting in accumulation of telomere 
damage which cannot be repaired, and contributing to senescence (Mao et al., 2016). Although 
these studies suggested that generating telomeric DSBs did not lead to senescence, this was 
only shown in immortalised cells (Doksani and de Lange, 2016; Mao et al., 2016). On the 
contrary, our results indicate that TRF1-FokI expression induces senescence in normal human 
melanocytes. However, since both non-telomeric and telomeric damage were induced by the 
fusion protein, we cannot conclude that senescence occurred as a result of telomere damage 
specifically. Therefore, these experiments will need to be independently confirmed once the 
specificity of TRF1-FokI used in our study is corroborated. Additionally, future work should 
also involve expression of TRF1-FokI in melanoma cell lines to confirm whether telomere 
damage can be repaired in rapidly dividing, transformed cells. One possible scenario is that, in 
these cells, dysfunctional telomeres might play a more important role in maintaining the stable 
growth arrest rather than being involved in the initiation of senescence. 
Although persistent telomere-associated foci are important players during senescence, we 
cannot exclude the possibility that non-telomeric damage also contributes to the establishment 
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and maintenance of melanocyte senescence. Our data demonstrate that DNA damage foci also 
remained significantly higher in melanocytes during stress-induced senescence (X-ray and 
UV), and to a lesser extent in replicative senescent melanocytes. In agreement with this, 
previous studies have shown that in senescent cells, half of the DNA damage foci were located 
at non-telomeric sites, and albeit short-lived, they are constantly renewed during senescence in 
a ROS-dependent manner (Passos et al., 2010; Hewitt et al., 2012). This would be consistent 
with our results showing that oxidative stress increases in senescent melanocytes, probably 
explaining a mechanism by which DNA damage remains elevated following genotoxic stress. 
Moreover, it has been shown that melanocytes are more prone to the accumulation of oxidative 
DNA damage upon UVA irradiation when compared to skin fibroblasts in culture, which was 
suggested to be due to the ROS-enhancing effects of melanin, as previously discussed (Wang 
et al., 2010). Interestingly, melanocytes also display reduced DNA repair capacity in response 
to such lesions (Wang et al., 2010). The authors showed that addition of melanin to fibroblast 
lysates was sufficient to diminish the repair capacity of oxidative DNA damage in these lysates.  
It was proposed that melanin could interact with proteins of the DNA repair machinery or with 
DNA itself, thus preventing DNA repair (Wang et al., 2010). Since melanin synthesis occurs 
within enclosed structures known as melanosomes, the extent of the interaction between 
melanin and DNA in a physiological setting is unclear. However, it is likely that the increased 
susceptibility of melanocytes to oxidative DNA damage could account for the large increase in 
DNA damage foci observed in UV-induced senescent melanocytes in our study. In order to 
investigate whether this damage can be repaired, immunofluorescence against DNA damage 
proteins should be done in melanocytes at later time points after UV exposure, which would 
allow us to gain a better understanding of the kinetics of damage repair following UV 
irradiation.    
We have also demonstrated that melanocytes develop a senescence-associated secretory 
phenotype during replicative and both models of stress-induced senescence. The molecular 
profile of the SASP was shown to differ depending on the senescence-inducing stimulus (Table 
4.1), which is consistent with previous observations showing that different stressors trigger the 
secretion of different pro-inflammatory signalling molecules in fibroblasts (Coppe et al., 2008; 
Rodier et al., 2009). Interestingly, IL-8 was up-regulated in all models of melanocyte 
senescence studied. This chemokine has been shown to participate in signalling that reinforces 
the growth arrest of senescent fibroblasts, such that knocking down the IL-8 receptor, CXCR2, 
prevented both replicative and oncogene-induced senescence, and diminished the DDR (Acosta 
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et al., 2008). It was hypothesised that CXCR2 signalling contributed to increased ROS 
generation, in turn inducing DNA damage, which is a main contributor to senescence (Acosta 
et al., 2008). Moreover, it was shown that the transcription factors NF-κB and C/EBPβ were 
up-regulated in cells undergoing OIS, and that these stimulated the expression of CXCR2 
ligands, thus activating a self-amplifying secretory network responsible for reinforcing the 
senescence phenotype (Acosta et al., 2008). Furthermore, secretion of the pro-inflammatory 
cytokine, IL-6, appears to be up-regulated in melanocytes undergoing replicative and X-ray-
induced senescence. Indeed, IL-6 is a prominent component of the SASP of many cells, 
including keratinocytes (Lu et al., 2006), fibroblasts and epithelial cells (Coppe et al., 2008), 
as well as OIS melanocytes (Kuilman et al., 2008). Similarly to IL-8, IL-6 has also been 
implicated in the induction and maintenance of oncogene-induced senescence (Kuilman et al., 
2008). A mechanism was proposed whereby the transcription factor C/EBPβ is activated upon 
oncogenic stress, stimulating the expression of SASP factors, such as IL-6, which engages in a 
positive feedback loop with C/EBPβ, also responsible for inducing the CDK inhibitor, p15. 
This feedback mechanism amplifies the inflammatory network and cooperates with cell cycle 
arrest (Kuilman et al., 2008). Although the mechanisms leading to SASP development during 
melanocyte senescence were not addressed in our study, it is possible that persistent DNA 
damage, both at telomeres and non-telomeric sites, could contribute to secretion of pro-
inflammatory factors. Indeed, secretion of SASP factors, such as IL-6 and IL-8, has been shown 
to be highly dependent on persistent DDR signalling associated with senescence, with depletion 
of DDR proteins, such as ATM and H2AX abolishing their secretion (Rodier et al., 2009; 
Rodier et al., 2011). However, the DDR alone cannot fully account for the development of the 
SASP, since this is a dynamic process which develops over time, whereas DDR activation is an 
almost immediate response following DNA damage (Coppe et al., 2010a). In fact, a DDR-
independent mechanism regulating the SASP has been identified, which involves the up-
regulation of p38MAPK (Freund et al., 2011). Indeed, senescence-inducing stimuli such as 
genotoxic stress, was shown to activate p38MAPK in human fibroblasts, whereas p38MAPK 
inhibition was sufficient to abolish the SASP in these cells (Freund et al., 2011). It was shown 
that p38MAPK induced the activity of the transcription factor NF-κB, which in turn regulates 
the expression of genes involved in the SASP (Freund et al., 2011). Consistently, preliminary 
data from our lab showed that inhibition of p38MAPK inhibits the SASP in stress-induced 
senescent melanocytes (data not shown), suggesting that this could be a potential mechanism 
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regulating the inflammatory phenotype of these cells. However, further experiments are needed 
to corroborate this hypothesis. 
Another possible scenario is that mTOR is involved in the development of a SASP in senescent 
melanocytes. Indeed, mTOR has been shown to promote NF-κB activity, which induces the 
expression of SASP genes (Dan et al., 2008; Chien et al., 2011a). Moreover, inhibition of 
mTORC1 by rapamycin treatment decreased the translation of IL-1α, thereby reducing the 
transcriptional activity of NF-κB, and diminishing the secretion of pro-inflammatory factors, 
such as IL-6, indicating that mTOR is also a regulator of the SASP (Laberge et al., 2015). 
Consistently, we have observed an increase in mTOR activity in replicative senescent 
melanocytes, and have shown that mTOR inhibition significantly decreases the SASP in stress-
induced senescent melanocytes, which will discussed in further detail in the next chapter. 
Therefore, it is likely that mTOR activation plays a role in the development of a pro-
inflammatory secretory phenotype during melanocyte senescence.  
Of note, the serine protease inhibitor, PAI-1, also known as Serpin E1, was highly up-regulated 
in UV-induced senescent melanocytes. This is consistent with other studies showing that PAI-
1 is increased in conditioned medium from lung and skin fibroblasts (West et al., 1996), and is 
also up-regulated in senescent fibroblasts and endothelial cells (Mu and Higgins, 1995; Mu et 
al., 1998; Martens et al., 2003). Interestingly, it was demonstrated that PAI-1 is a transcriptional 
target of p53 in both senescent MEFs and human fibroblasts, and it reinforces the senescence 
growth arrest by down-regulating PI3K-PKB signalling, in turn promoting nuclear exclusion of 
cyclin D1 (Kortlever et al., 2006). Consequently, the latter can no longer phosphorylate and 
inhibit pRb, and thus pRb remains associated with E2F transcription factors, which are required 
for induction of genes involved in cell-cycle progression (Kortlever et al., 2006). Indeed, 
silencing PAI-1 alleviates senescence in normal fibroblasts, whilst ectopically expressing PAI-
1 in p53-deficient fibroblasts induced senescence in these cells, suggesting that PAI-1 plays a 
major role in the induction of senescence (Kortlever et al., 2006). Although our results 
demonstrate that known SASP components are up-regulated in senescent melanocytes, further 
studies would need to be performed in order to conclude that specific pro-inflammatory 
cytokines are involved in the induction and maintenance of melanocyte senescence in an 
autocrine fashion.      
Additionally, components of the SASP, such as TGF-β family ligands have been shown to 
induce paracrine senescence in normal neighbouring cells (Acosta et al., 2013). Others, such as 
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IL-6 and IL-8, were reported to promote malignant transformation in cultured pre-malignant 
epithelial cells (Coppe et al., 2008). It is believed that senescent cells contribute to age-related 
tissue dysfunction partly through secretion of SASP factors (van Deursen, 2014), and the non-
cell autonomous effects of senescent melanocyte SASP will be discussed in greater detail in the 
following chapter.   
In summary, our results show that senescence can be induced in melanocytes in culture by 
replicative exhaustion, and by exposure to genotoxic stresses such as X-ray and UV irradiation. 
Senescence in these cells is associated with elevated p16, p21, and oxidative stress. Although 
there are some differences in the senescent phenotype of these cells, we demonstrate that length-
independent telomere dysfunction occurs in all models of melanocyte senescence, suggesting 
that telomere damage is not only a result of extensive shortening. We also provide evidence 
that telomeric DSBs are irreparable in melanocytes in vitro.     
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Chapter 5: Senescent melanocytes induce paracrine DNA damage and 
senescence in neighbouring cells 
Amounting evidence suggests that senescent cells contribute to age-related tissue dysfunction 
partly through paracrine mechanisms that affect surrounding healthy cells (Baker et al., 2011; 
Nelson et al., 2012; Acosta et al., 2013; Baker et al., 2016; Ritschka et al., 2017). Indeed, it has 
been shown that senescent cells can drive senescence in neighbouring cells in vitro both by 
direct cell-cell contact (Nelson et al., 2012) and through secretion of soluble factors (Acosta et 
al., 2013). Moreover, clusters of senescent cells have been observed in mouse liver with age 
(Nelson et al., 2012), and in the vicinity of human pre-malignant lesions undergoing oncogene-
induced senescence (Acosta et al., 2013), suggesting that senescence can also be transmitted to 
adjacent cells in vivo. 
Our previous results suggest that senescent melanocytes can induce paracrine telomere damage 
in neighbouring keratinocytes in human skin in vivo. Therefore, I aimed to further explore a 
bystander effect of senescent melanocytes in vitro and investigate possible mechanisms 
involved in this process. Moreover, although accumulation of senescent keratinocytes has been 
associated with skin ageing characteristics (Adamus et al., 2014; Velarde et al., 2015), the 
contribution of senescent melanocytes to age-related skin changes has not been extensively 
studied. Hence, by using a three-dimensional (3D) human epidermal equivalent comprising 
keratinocytes and melanocytes, I aimed to establish whether the presence of senescent 
melanocytes contributed to age-associated epidermal changes.  
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 Bystander telomere DNA damage induction is mediated by SASP factors 
5.1.1. Rapamycin treatment inhibits the SASP of senescent melanocytes 
Inhibition of mTORC1 activity by rapamycin has been previously shown to diminish the 
secretion of many pro-inflammatory cytokines by senescent cells in vitro (Herranz et al., 2015; 
Laberge et al., 2015; Correia-Melo et al., 2016). Therefore, in order to investigate whether 
SASP factors released by senescent melanocytes were involved in bystander DNA damage 
induction, melanocytes were irradiated using 10 Gy X-ray irradiation, and were then treated 
with rapamycin immediately after irradiation for 10 days until they reached senescence (Figure 
5.1 A). Control cells were treated with the same concentration of vehicle DMSO. Rapamycin 
treatment was shown to significantly inhibit mTORC1 activity, as indicated by a complete 
reduction in phosphorylated p70S6 kinase and pS6 protein levels in both proliferating (no IR) 
and senescent melanocytes treated with the drug (Figure 5.1 B). Although mTORC1 activity 
appears to decrease in senescent melanocytes at 10 days after irradiation compared to 
proliferating controls (Figure 5.1 B), a cytokine array indicated that rapamycin treatment 
significantly suppressed the secretion of major SASP factors (Coppe et al., 2008), such as IL-
8, IL-6, RANTES and IP-10 (Figure 5.1 C-F), suggesting that mTOR is involved in regulating 
the SASP of senescent melanocytes.      
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Figure 5.1 – Inhibition of mTORC1 suppresses the SASP of senescent melanocytes. (A) 
Scheme representing the experimental procedure. Melanocyte senescence was induced by 10 
Gy X-ray irradiation, and cells were treated with rapamycin for 10 days, when melanocytes 
reach the senescence state. (B) Representative Western blot showing analysis of p70S6K(T389) 
and phospho-pS6 expression in proliferating (No IR) and senescent (Sen) melanocytes with or 
without rapamycin treatment 10 days after irradiation. α-tubulin was used as the loading control. 
(C) Heatmap showing cytokines detected in conditioned media from proliferating and senescent 
melanocytes with or without rapamycin treatment. Blue represents low expression, and red 
denotes high expression. Heatmap was generated using Ingenuity Pathway Analysis. Each 
column represents one independent experiment for the corresponding condition (N=3). Graphs 
showing the concentration of (D) RANTES, (E) IP-10, (F) IL-6, and (G) IL-8 in CM from 
proliferating and senescent melanocytes with or without rapamycin. Data are mean ± S.E.M. of 
N=3 independent experiments. Statistical significance was assessed by a one-way ANOVA. 
**P<0.01, ***P<0.001. (Cytokine array done in collaboration with Duncan Talbot from 
Unilever). 
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5.1.2. Senescent melanocytes induce bystander telomeric DNA damage in dermal 
fibroblasts in direct co-culture 
Next, in order to corroborate the observations from human skin in vivo suggesting a bystander 
effect of senescent melanocytes, I wanted to assess whether these cells could induce paracrine 
DNA damage in neighbouring cells in vitro. Moreover, I also wanted to investigate the role of 
SASP factors in this process. For that, human dermal fibroblasts were co-cultured with either 
proliferating or senescent melanocytes that were treated with rapamycin prior to co-culture 
(Figure 5.2 A). Control melanocytes were treated with the same concentration of vehicle 
DMSO. Cells were co-cultured at a 1:3 fibroblast to melanocyte ratio for 48 hours.   
In order to analyse DNA damage in fibroblasts, I then performed immuno-FISH against γH2AX 
together with a telomere-specific probe, and also used a melanocyte-specific marker, known as 
melan-A, to ensure that only fibroblasts were considered in the analysis. I found that fibroblasts 
co-cultured with senescent melanocytes had, on average, higher amounts of DNA damage foci, 
as indicated by a 1.6 fold increase in total γH2AX foci in these cells when compared to 
fibroblasts co-cultured with proliferating melanocytes; however, this increase was not 
statistically significant (Figure 5.2 B) (P<0.05). Moreover, the amount of DNA damage in 
fibroblasts was not diminished by co-culture with rapamycin-treated senescent melanocytes 
(Figure 5.2 B) (P<0.05).  
Given that telomere-associated foci have been shown to be persistent (Fumagalli et al., 2012; 
Hewitt et al., 2012), and continuous DDR activation is an important initiator of senescence 
(d'Adda di Fagagna, 2008), I next analysed the co-localisation between γH2AX foci and 
telomeres. The frequency of telomere-associated foci was significantly higher in fibroblasts 
cultured with senescent melanocytes (P<0.001), which was on average 2.4-fold higher when 
compared to fibroblasts co-cultured with proliferating melanocytes (Figure 5.2 C, D).  
Although the number of dysfunctional telomeres was slightly decreased in fibroblasts cultured 
with rapamycin-treated senescent melanocytes, this decrease was very small and not 
statistically significant (P<0.05) (Figure 5.2 C, D). Therefore, these results indicate that 
senescent melanocytes can act in a paracrine manner and trigger a DDR at telomeres in 
neighbouring fibroblasts. Although in these experiments inhibition of melanocyte SASP did not 
appear to prevent paracrine damage induction, this could be a result of the experimental design. 
Since rapamycin was removed from melanocytes during the bystander experiments, it is 
possible that the SASP could have returned, thus affecting the results. Therefore, in order to 
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overcome this issue, these experiments could be performed with melanocytes with an mTOR 
knockdown.  
 
 
Figure 5.2 – Senescent melanocytes induce paracrine TAF in co-cultured fibroblasts. (A) 
Scheme representing the experimental procedure. Melanocytes were irradiated using 10 Gy X-
ray irradiation, and treated with rapamycin or vehicle DMSO for 10 days. Rapamycin was 
removed from melanocytes 24 hours prior to co-culture to ensure that rapamycin was not 
present during the culture with fibroblasts. Fibroblasts were co-cultured with either 
proliferating or senescent melanocytes (DMSO- or rapamycin-treated) for 48 hours. Graphs 
showing (B) mean number of γH2AX foci and (C) mean number of TAF in fibroblasts co-
cultured with melanocytes in the conditions indicated. Data are mean ± S.E.M. of N=4 
independent experiments. Statistical significance was determined by a one-way ANOVA. 
***P<0.001. (D) Representative immuno-FISH images of fibroblasts co-cultured with: 
proliferating melanocytes (left), senescent melanocytes (middle), and rapamycin-treated 
senescent melanocytes (right). Telomeres are shown in red, γH2AX is shown in green, and blue 
represents DAPI. Arrows indicate co-localisation between γH2AX and telomeres. Images were 
taken using a 63x objective. NHEM = normal human epidermal melanocytes.  
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5.1.3. Soluble factors secreted by senescent melanocytes mediate paracrine DNA 
damage induction 
It is possible that senescent melanocytes pre-treated with rapamycin reacquire the SASP once 
in co-culture with fibroblasts, thus impacting on the interpretation of the results. Therefore, in 
order to investigate if bystander telomere damage could be induced solely by the SASP, I 
collected conditioned medium (CM) from proliferating and stress-induced senescent 
melanocytes treated with either vehicle DMSO or rapamycin for 10 days, and cultured human 
dermal fibroblasts with melanocyte CM for 48 hours (Figure 5.3 A).  
By performing immuno-FISH, I found that although there was a small increase in DDR 
signalling in fibroblasts cultured with senescent melanocyte CM, this was not statistically 
significant when compared to fibroblasts cultured in CM from proliferating melanocytes 
(Figure 5.3 B) (P>0.05). Moreover, a small reduction in total γH2AX foci was observed by 
culturing fibroblasts with CM from rapamycin-treated senescent melanocytes; however, this 
also did not reach statistical significance (Figure 5.3 B) (P>0.05). On the other hand, 
conditioned medium from senescent melanocytes was sufficient to significantly increase the 
frequency of telomere-associated foci in fibroblasts, as indicated by a 2.5 fold increase in the 
number of TAF in these cells (Figure 5.3 C, D) (P<0.001), similarly to the results obtained 
from the previous co-culture experiments. Interestingly, rapamycin treatment was sufficient to 
significantly prevent bystander TAF induced by senescent melanocyte CM, as shown by a 2-
fold decrease in dysfunctional telomeres in fibroblasts cultured with control senescent 
melanocyte medium (Figure 5.3 C, D) (P<0.01). Therefore, these results suggest that paracrine 
damage induction is mediated by pro-inflammatory factors secreted by senescent melanocytes, 
which can be effectively prevented by inhibiting the SASP.  
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Figure 5.3 – Paracrine telomeric DDR signalling is triggered by SASP factors secreted by 
senescent melanocytes. (A) Scheme illustrating the experimental procedure. Proliferating and 
senescent (10 Gy) melanocytes were treated with DMSO or rapamycin for 10 days. Rapamycin 
was removed from melanocytes 24 hours prior to media collection to ensure that the drug was 
not present during fibroblast culture. Dermal fibroblasts were then cultured for 48 hours with 
conditioned medium collected from these cells. Graphs showing (B) mean number of γH2AX 
foci and (C) mean number of TAF in fibroblasts cultured with CM from proliferating or 
senescent melanocytes with or without rapamycin treatment. Data are mean ± S.E.M. of N=3 
independent experiments. Statistical significance was determined by a one-way ANOVA. 
**P<0.01, ***P<0.001. (D) Representative immuno-FISH images of fibroblasts cultured with 
CM from: proliferating melanocytes (left), senescent melanocytes (middle), and rapamycin-
treated senescent melanocytes (right). Telomeres are shown in red, γH2AX is shown in green, 
and blue represents DAPI. Arrows indicate co-localisation between γH2AX and telomeres. 
Images were taken using a 63x objective. NHEM = normal human epidermal melanocytes; CM 
= conditioned medium.  
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 Paracrine DDR signalling remains elevated in dermal fibroblasts following long-
term exposure to the SASP    
Given that previous data has demonstrated that DDR signalling at telomeres is persistent 
following a variety of senescence-inducing stimuli (Fumagalli et al., 2012; Hewitt et al., 2012), 
I next wanted to investigate whether bystander telomere dysfunction induced by senescent 
melanocytes persisted over longer culture periods in dermal fibroblasts. For that, I cultured 
fibroblasts for 30 days with conditioned medium obtained from proliferating and stress-induced 
senescent melanocytes, and performed immuno-FISH to analyse DNA damage specifically at 
telomeres. 
Firstly, I found that senescent melanocyte CM induced significantly higher levels of DNA 
damage in fibroblasts when compared to cells cultured in CM from proliferating melanocytes 
(Figure 5.4 A, D) (P=0.03). I also observed a 2-fold increase in telomere-associated foci in 
fibroblasts cultured with senescent melanocyte CM for 30 days (Figure 5.4 B, D) (P=0.0002), 
which is consistent with previous observations obtained from the short-term culture 
experiments. Moreover, 58% of fibroblasts cultured in senescent melanocyte CM displayed at 
least one damaged telomere compared to 35% of cells cultured in CM from proliferating 
melanocytes (Figure 5.4 C). These results suggest that long-term exposure to factors secreted 
by senescent melanocytes triggers DDR signalling at both non-telomeric and telomeric sites. 
Furthermore, these data also demonstrate that TAF levels remain constantly higher in 
fibroblasts cultured with senescent melanocyte CM. 
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Figure 5.4 – Long-term exposure to senescent melanocyte SASP leads to accumulation of 
DNA damage foci at both telomeric and non-telomeric regions. Dermal fibroblasts were 
cultured in either proliferating or senescent melanocyte conditioned medium for 30 days, and 
DNA damage at telomeres was assessed by immuno-FISH. Graphs showing (A) mean number 
of γH2AX foci in fibroblasts, (B) mean number of TAF in fibroblasts, and (C) percentage of 
fibroblasts containing TAF when cultured in conditioned medium from proliferating (Prol) or 
senescent (Sen) melanocytes for 30 days. Data are mean ± S.E.M. of N=3 independent 
experiments. Statistical significance was determined by a two-tailed unpaired t test. *P<0.05, 
**P<0.01, ***P<0.001. (D) Representative immuno-FISH images of fibroblasts cultured with 
CM from proliferating melanocytes (left), and CM from senescent melanocytes (right). 
Telomeres are shown in red, γH2AX is shown in green, and blue represents DAPI. Arrows 
indicate co-localisation between γH2AX and telomeres. Images were taken using a 63x 
objective. NHEM = normal human epidermal melanocytes; CM = conditioned medium. 
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 Long-term exposure to senescent melanocyte SASP causes proliferation arrest in 
fibroblasts 
Previous studies have shown that prolonged exposure to soluble factors secreted by senescent 
cells can induce a stable growth arrest in human and murine fibroblasts in a paracrine manner 
in vitro (Acosta et al., 2013). Therefore, in order to investigate the long-term implications of 
exposing fibroblasts to pro-inflammatory factors from senescent melanocytes, dermal 
fibroblasts were cultured for 20 days with conditioned media from either proliferating or 
senescent melanocytes, and proliferation status was assessed by EdU incorporation.  
Fibroblasts cultured in senescent melanocyte CM exhibited a small but significant decrease in 
proliferation. Whilst 79% of cells in proliferating melanocyte CM were EdU-positive, this was 
reduced to 56% when fibroblasts were cultured with senescent melanocyte CM (Figure 5.5 A, 
B) (P=0.01). This suggests that a fraction of cells become growth-arrested as a result of 
sustained exposure to the SASP from senescent melanocytes, although the majority of 
fibroblasts were still proliferation efficient at this time point.  
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Figure 5.5 – Soluble factors from senescent melanocytes inhibits fibroblast cell division. 
Dermal fibroblasts were cultured in either proliferating or senescent melanocyte conditioned 
medium for 20 days, and proliferation was assessed by EdU incorporation. (A) Graph showing 
percentage of EdU-positive fibroblasts at the indicated culture conditions. Data are mean ± 
S.E.M. of N=3 independent experiments. Statistical significance was assessed by a two-tailed 
unpaired t test. *P<0.01. (B) Representative EdU immunofluorescence images of fibroblasts 
cultured in proliferating (Prol) or senescent (Sen) melanocyte conditioned medium. EdU is 
shown in red, and DAPI is depicted in blue. Images were taken using a 20x objective. NHEM 
= normal human epidermal melanocytes; CM = conditioned medium. 
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 Paracrine DNA damage signalling is mediated by increased intracellular ROS 
generation 
Next, I wanted to further investigate the mechanisms leading to accumulation of dysfunctional 
telomeres in bystander cells. It is known that increased oxidative stress is an important 
contributor to activation of a DDR, with telomeres being particularly sensitive to imbalances in 
ROS homeostasis (Petersen et al., 1998; Oikawa and Kawanishi, 1999). In fact, mitochondria 
are a major source of ROS generation, and have been implicated as key components for the 
generation and replenishment of DNA damage foci, an important effector of senescence (Passos 
et al., 2007; Passos et al., 2010; Correia-Melo et al., 2016). Therefore, to assess whether 
paracrine DDR signalling triggered by senescent melanocytes was mediated by increased 
mitochondrial ROS production in bystander cells, dermal fibroblasts were cultured with either 
proliferating or senescent melanocyte conditioned medium in the presence of the mitochondrial 
targeted antioxidant, MitoQ, for 48 hours (Figure 5.6 A).  
By performing immuno-FISH, I found that senescent melanocyte CM is sufficient to induce a 
2-fold increase in DNA damage foci in dermal fibroblasts (P<0.01), which is significantly 
reduced by MitoQ treatment (P<0.05) (Figure 5.6 B, D). Consistently, fibroblasts cultured in 
CM from senescent melanocytes have a significantly higher amount of dysfunctional telomeres 
when compared to cells in proliferating melanocyte CM (P<0.05) (Figure 5.6 C), whereas 
bystander TAF induction is effectively prevented by lowering mitochondrial ROS production 
in fibroblasts (P<0.05) (Figure 5.6 C, D). Therefore, it is possible that soluble factors from 
senescent melanocytes activate paracrine signalling pathways that trigger an increase in ROS 
generation, which in turn induces non-telomeric and telomeric DNA damage in bystander cells.   
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Figure 5.6 – Bystander DNA damage signalling induction is mediated by an increase in 
intracellular ROS. (A) Scheme showing the experimental procedure. Dermal fibroblasts were 
cultured with either proliferating or senescent melanocyte conditioned medium, and were 
treated with MitoQ for 48 hours. Graphs showing (B) mean number of γH2AX foci and (C) 
mean number of TAF in fibroblasts in the conditions indicated. Data are mean ± S.E.M of N=3 
independent experiments. Statistical significance was determined by a one-way ANOVA. 
*P<0.05, **P<0.01. (D) Representative immuno-FISH images of fibroblasts cultured with CM 
from: proliferating melanocytes (left), senescent melanocytes (middle), and senescent 
melanocytes with the addition of MitoQ (right). Telomeres are shown in red, γH2AX is shown 
in green, and blue represents DAPI. Arrows indicate co-localisation between γH2AX and 
telomeres. Images were taken using a 63x objective. NHEM = normal human epidermal 
melanocytes; CM = conditioned medium. 
 
 
 
Chapter 5   Senescent melanocytes induce paracrine DNA damage and senescence in neighbouring 
cells 
181 
 
 CXCR3 activation is involved in the initiation of melanocyte senescence, and 
mediates induction of paracrine telomere-associated foci 
Following the observations that soluble factors secreted by senescent melanocytes can induce 
paracrine DNA damage signalling, I wanted to investigate whether specific components of the 
SASP were responsible for mediating bystander DDR induction. 
5.5.1. CXCR3 signalling inhibition ameliorates the senescent phenotype of 
melanocytes 
By performing a cytokine array analysis, we showed that IP-10 is one of the cytokines which 
is highly secreted by senescent melanocytes, as demonstrated in section 5.1. Previous studies 
from our lab revealed that CXCR3, a cell-surface receptor for the cytokine IP-10, is 
significantly up-regulated in senescent melanocytes in vitro (P=0.002) (Figure 5.7 A, B). 
Moreover, we also found that CXCR3 expression is significantly higher in melanocytes in the 
skin of older human donors in vivo (P=0.0002) (Figure 5.7 C, D). Therefore, we hypothesised 
that IP-10 secreted by senescent melanocytes could be involved in autocrine signalling, 
maintaining the senescent phenotype of melanocytes through continuous activation of CXCR3.  
In order to determine whether CXCR3 signalling was involved in melanocyte senescence, we 
irradiated melanocytes using 10Gy X-ray irradiation and treated these cells with a CXCR3 
antagonist, AMG487, for 10 days. We found that CXCR3 inhibition significantly reduced Sen-
β-Gal activity (P<0.01), albeit it still remained higher compared to control proliferating cells 
(P<0.01) (Figure 5.8 A, B). Similarly, p16 expression was also significantly decreased by 
inhibiting CXCR3 in senescent melanocytes (P<0.001), although it did not fully prevent p16 
up-regulation in response to stress-induced senescence (P<0.05) (Figure 5.8 C). Interestingly, 
the growth arrest induced by X-ray irradiation was not rescued by inhibition of CXCR3 (Figure 
5.8 D), suggesting that CXCR3 diminishes senescence-associated markers independently of 
proliferation in melanocytes. Since persistent DDR signalling is an important effector of 
senescence, we performed immunofluorescence for γH2AX, and found that although CXCR3 
inhibition reduced the number of DNA damage foci by 1.5-fold compared to untreated 
senescent cells, this was not statistically significant (Figure 5.8 E). Moreover, p21 expression, 
which is primarily up-regulated following irradiation, was not reduced by inhibiting CXCR3 in 
melanocytes (Figure 5.8 G). Furthermore, we measured mitochondrial ROS production by 
using the fluorescent probe, MitoSOX, which revealed that CXCR3 inhibition significantly 
reduced generation of ROS in irradiated melanocytes (Figure 5.8 F). Taken together, these 
results suggest that CXCR3 signalling is partly involved in the induction of the senescent 
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phenotype of melanocytes, although it does not significantly impact on the DNA damage 
response and growth arrest.  
Previous studies have shown that CXCR3 signalling activates MEK/ERK and PI3K/Akt 
pathways in human airway epithelial cells, and these are responsible for mediating chemotaxis 
(Shahabuddin et al., 2006). Moreover, these pathways have also been implicated in senescence 
signalling (Wang et al., 2002; Correia-Melo et al., 2016). In order to investigate whether these 
pathways were induced in the context of melanocyte senescence, and to assess whether CXCR3 
inhibition had an effect on their activation, we analysed the expression of ERK and Akt in 
irradiated melanocytes with and without AMG487 treatment (Figure 5.8 G). Since Akt has 
been previously shown to be activated in the first few days of senescence induction following 
X-ray irradiation (Correia-Melo et al., 2016), we chose to analyse these pathways at 8, 24, and 
48 hours after 10 Gy irradiation of melanocytes. The levels of phosphorylated ERK (p-ERK) 
increased 8 hours following irradiation, with CXCR3 inhibition reducing its expression. 
However, ERK phosphorylation is reduced after 24 hours, and decreases below control levels 
48 hours after irradiation, with CXCR3 inhibition having little effect at these time points 
(Figure 5.8 G). Unexpectedly, total ERK (t-ERK) expression also gradually decreases 
following X-ray irradiation, and declines below proliferating control levels from 24 hours. On 
the other hand, expression of phosphorylated Akt (p-Akt) is significantly up-regulated at 8 
hours post-irradiation, and gradually increases until 48 hours (Figure 5.8 G), suggesting that 
Akt is activated in melanocytes in response to stress-inducing stimuli, such as irradiation. 
Moreover, Akt phosphorylation was significantly reduced by CXCR3 inhibition, suggesting 
that CXCR3 signalling plays a role in Akt activation in response to senescence-inducing X-ray 
irradiation.  
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Figure 5.7 – CXCR3 is up-regulated in senescent melanocytes. (A) Graph showing CXCR3 
fluorescence signal intensity in proliferating and stress-induced senescent (10 Gy) melanocytes. 
Data are mean ± S.E.M. of N=3 independent experiments. (B) Representative CXCR3 
immunofluorescence images of proliferating (No IR) and senescent melanocytes. CXCR3 is 
shown in green, and DAPI is shown in blue. Images were taken using a 20x objective. (Analysis 
done in collaboration with Jessica Halim). (C) Dot plot showing CXCR3 fluorescence intensity 
in melanocytes in young and older human skin in vivo for each individual donor. The horizontal 
line represents the mean intensity for each group. Statistical significance was assessed by a two-
tailed unpaired t-test. **P<0.01, ***P<0.001. (D) Representative CXCR3 immunofluorescence 
images in skin biopsies from young and older human donors. The melanocyte marker, Melan-
A is shown in green, CXCR3 is shown in red, and DAPI is shown in blue. Images were taken 
using a 20x objective. Arrows indicate melanocytes, and cells enclosed within the square are 
amplified on the right. (CXCR3 in human skin was done in collaboration with Anthony 
Lagnado). 
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Figure 5.8 – CXCR3 inhibition is sufficient to ameliorate markers of melanocyte 
senescence. Senescence was induced in melanocytes by 10Gy X-ray irradiation, and cells were 
treated with either AMG487 or vehicle DMSO (control) for 10 days. (A) Graph showing the 
percentage of Sen-β-Gal-positive melanocytes at the conditions indicated. (B) Representative 
Sen-β-Gal images of proliferating and senescent melanocytes with or without AMG487 
treatment. Images were taken using a 20x objective. Graphs showing the percentage of (C) p16-
positive and (D) EdU-positive melanocytes at the conditions indicated. (E) Mean number of 
γH2AX foci in proliferating and senescent melanocytes with or without AMG487 treatment. 
(F) MitoSOX fluorescence intensity of melanocytes at the conditions indicated. Values are a 
percentage fold change normalised to proliferating controls (untreated). ROS measurements 
were performed at 3 days following irradiation. Data are mean ± S.E.M. of N=3 independent 
experiments. Statistical significance was determined by a one-way ANOVA. *P<0.05, 
**P<0.01, ***P<0.001. (G) Representative Western blot showing expression of p-ERK, t-
ERK, p-Akt, t-Akt, p21, and α-tubulin as a loading control, in proliferating (Prol) and irradiated 
melanocytes at the time points indicated. Irradiated cells were either treated with AMG487 or 
vehicle DMSO (untreated controls). (Experiments done in collaboration with Jessica Halim).  
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5.5.2. CXCR3 signalling is involved in paracrine telomeric DNA damage induction 
Our results so far suggest that CXCR3 activation is involved in autocrine signalling that, in 
part, regulates phenotypes of melanocyte senescence. Moreover, our cytokine array analysis 
showed that IP-10 secretion is significantly abolished by rapamycin treatment of senescent 
melanocytes (section 5.1). Therefore, I aimed to assess whether CXCR3 activation was also 
involved in paracrine signalling, mediating bystander DNA damage caused by senescent 
melanocytes.   
Dermal fibroblasts were cultured with either proliferating or senescent melanocyte conditioned 
medium, and were treated with the CXCR3 inhibitor, AMG487, for 48 hours (Figure 5.9 A). 
As previously demonstrated, CM from senescent melanocytes induced a 2-fold increase in the 
amount of γH2AX foci in dermal fibroblasts (P<0.05) (Figure 5.9 B, D), as determined by 
conducting immuno-FISH in these cells. However, DNA damage induction was not prevented 
by CXCR3 inhibition (Figure 5.9 B, D). On the other hand, a 3-fold increase in telomere-
associated foci was observed in fibroblasts cultured with senescent melanocyte CM (P<0.001), 
which was significantly suppressed by inhibiting CXCR3 activation (P<0.001) (Figure 5.9 C, 
D). These results suggest that soluble factors secreted by senescent melanocytes activate 
paracrine CXCR3 signalling, which in turn mediates the induction of bystander telomere 
dysfunction.  
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Figure 5.9 – CXCR3 signalling mediates the induction of paracrine telomere-associated 
foci. (A) Scheme demonstrating the experimental procedure. Dermal fibroblasts were cultured 
with conditioned medium from proliferating or senescent melanocytes, and were treated with 
AMG487, a CXCR3 inhibitor. Control cells were treated with vehicle DMSO. Graphs showing 
(B) mean γH2AX foci and (C) mean TAF in fibroblasts in the conditions indicated. Data are 
mean ± S.E.M. of N=3 independent experiments. Statistical significance was determined by a 
one-way ANOVA. *P<0.05, ***P<0.001. (D) Representative immuno-FISH images of 
fibroblasts cultured with CM from: proliferating melanocytes (left), senescent melanocytes 
(middle), and senescent melanocytes with the addition of AMG487 (right). Telomeres are 
shown in red, γH2AX is shown in green, and blue represents DAPI. Arrow indicates co-
localisation between γH2AX and telomeres, which is also amplified at the bottom left-hand 
corner. Images were taken using a 63x objective. NHEM = normal human epidermal 
melanocytes; CM = conditioned medium. 
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 Senescent melanocytes induce paracrine senescence in keratinocytes and 
contribute to skin ageing phenotypes in a living epidermal equivalent 
My data so far indicates that senescent melanocytes can induce paracrine telomere-associated 
foci and growth arrest in dermal fibroblasts in culture. However, given that melanocytes are in 
direct contact with keratinocytes in the skin, and that many age-associated epidermal changes 
can be attributed to loss of replicative capacity of keratinocytes (Farage et al., 2007), I wanted 
to determine whether senescent melanocytes could exert adverse paracrine effects in these cells. 
Moreover, I also aimed to assess whether accumulation of senescent melanocytes could 
contribute to phenotypes associated with skin ageing in living epidermal equivalents, also 
known as melanoderms. In order to achieve a more physiologically relevant model, we 
developed melanoderms containing either proliferating or UV-induced senescent melanocytes, 
as shown in section 4.3. Firstly, melanocytes were seeded with keratinocytes at a 1:10 
melanocyte: keratinocyte ratio, and during a period of 10 days they develop into a multi-layered, 
highly differentiated human epidermis equivalent (Figure 5.10). In the interest of this study, 
the tissues were then collected at days 0, 10 and 21 following epidermal development.   
 
 
Figure 5.10 – Development of human epidermal equivalents. Scheme representing the 
experimental procedure. Proliferating or senescent (0.4 J/cm2 UVA and UVB) melanocytes 
were co-cultured with keratinocytes at a 1:10 ratio, which fully develops into an epidermal 
equivalent following 10 days in culture. Melanoderms were collected at 0, 10 and 21 days post-
epidermal development. 
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5.6.1. Senescent melanocytes induce growth arrest in neighbouring keratinocytes 
In order to assess the proliferation status of keratinocytes in melanoderms, I performed 
immunofluorescence for Ki-67, and also used a melanocyte marker, melan-A, to ensure that 
only keratinocytes were included in the analysis. I found that melanoderms containing 
senescent melanocytes have a lower proportion of proliferating keratinocytes at all time points 
observed, with a statistically significant decrease in proliferation at day 21 following epidermal 
development (P<0.05) (Figure 5.11 A, B). In fact, 28% and 17% of keratinocytes show Ki-67 
positivity in melanoderms containing proliferating and senescent melanocytes, respectively 
(Figure 5.11 A), suggesting that senescent melanocytes induce paracrine growth arrest in 
neighbouring keratinocytes. Of note, the majority of Ki-67-positive keratinocytes are located 
in the basal layer of the epidermal equivalents (Figure 5.11 B), possibly due to keratinocytes 
reaching terminal differentiation as they approach the outermost layers of the epidermis.  
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Figure 5.11 – Keratinocytes in melanoderms with senescent melanocytes have reduced 
proliferative capacity. (A) Graph showing the percentage of Ki-67 positive keratinocytes in 
melanoderms containing either proliferating or senescent melanocytes at the time points 
indicated. Data are mean ± S.E.M. of N=3 melanoderms for each condition. Statistical 
significance was determined by a two-way ANOVA. *P<0.05. (B) Representative Ki-67 
immunofluorescence images in melanoderms containing proliferating (top) and senescent 
(bottom) melanocytes. Ki-67 is shown in red, melan-A is shown in green, and DAPI is depicted 
in blue. The white dotted line represents the basal layer of the melanoderms. Images were taken 
with a 20x objective.  
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5.6.2. Increased p16 expression in keratinocytes from melanoderms with senescent 
melanocytes  
In order to further investigate whether senescent melanocytes could induce paracrine 
senescence in surrounding keratinocytes, I performed immunofluorescence for p16. I found that 
p16 expression was significantly increased in keratinocytes from melanoderms containing 
senescent melanocytes at all time points investigated (P<0.05 and P<0.01) (Figure 5.12 A, B). 
In fact, there is at least a 2-fold increase in the percentage of p16-positive keratinocytes in 
senescent melanocyte-containing melanoderms (Figure 5.12 A), suggesting that senescent 
melanocytes exert a bystander effect that likely contributes to paracrine keratinocyte 
senescence.  
Although p16 expression in keratinocytes increases slightly at 10 days, both in proliferating and 
senescent melanocyte-containing melanoderms, this increase was not statistically significant. 
Interestingly, the number of p16-positive keratinocytes decreases between 10 and 21 days in 
both groups of melanoderms (Figure 5.12 A), albeit not significantly, possibly suggesting that 
a fraction of p16-positive keratinocytes are lost during this period.  
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Figure 5.12 – Keratinocytes in senescent melanocyte-containing melanoderms exhibit 
increased p16 expression. (A) Graph showing the percentage of p16-positive keratinocytes in 
melanoderms containing proliferating or senescent melanocytes at the time points indicated. 
Data are mean ± N=4 (proliferating) or N=3 (senescent) melanoderms for each time point. 
Statistical significance between groups was assessed using a two-way ANOVA, whilst a one-
way ANOVA was used to determine differences within groups. *P<0.05, **P<0.01. (B) 
Representative p16 immunofluorescence images of melanoderms containing either 
proliferating (left) or senescent (right) melanocytes. Red shows p16, green represents melan-A, 
and DAPI is shown in blue. The white dotted line represents the basal layer of the melanoderms. 
Images were taken using a 20x objective.  
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5.6.3. Senescent melanocytes induce paracrine telomere-associated foci in 
neighbouring keratinocytes in epidermal equivalents 
So far, my results provide evidence that senescent melanocytes induce paracrine TAF in 
surrounding cells both in human skin in vivo and also in vitro. Therefore, to corroborate these 
observations, and assess whether paracrine DDR activation, a main effector of senescence, also 
occurred in a living human epidermal equivalent, I performed immuno-FISH together with 
immunofluorescence for the melanocyte marker, melan-A, and analysed co-localisation of 
γH2AX at telomeres in keratinocytes surrounding melanocytes, as shown in Figure 5.13 D.  
Firstly, I found that there is a significant increase in total DNA damage signalling at 10 and 21 
days in keratinocytes from melanoderms containing both proliferating and senescent 
melanocytes (Figure 5.13 A), green and orange asterisks, respectively). Despite this time-
dependent increase in γH2AX foci, keratinocytes in melanoderms containing senescent 
melanocytes have a higher amount of DNA damage foci at all time points analysed, although 
this only reached statistical significance at day 0 (P<0.05) (Figure 5.13 A). Furthermore, the 
frequency of dysfunctional telomeres in keratinocytes also increases at both 10 and 21 days 
post-development when compared to day 0; however, this increase is only statistically 
significant in cells within melanoderms containing senescent melanocytes. In fact, these 
keratinocytes display, on average, a 3.2- and 2.2-fold increase in telomere-associated foci at 10 
and 21 days, respectively, in relation to cells at day 0 (P<0.01 and P<0.05) (Figure 5.13 B). 
Interestingly, keratinocytes in melanoderms with senescent melanocytes exhibit a significantly 
higher amount of damaged telomeres in comparison to those cultured with proliferating 
melanocytes, both at 10 and 21 days post-development (P<0.001 and P<0.01, respectively) 
(Figure 5.13 B, D). These observations are consistent with my previous results showing that 
senescent melanocytes can induce paracrine telomere dysfunction both in human skin in vivo 
and in monolayer cultures in vitro. Accordingly, melanoderms containing senescent 
melanocytes have a higher percentage of keratinocytes that contain more than one TAF, 
although this is only statistically significant at days 10 and 21 (P<0.001) (Figure 5.13 C). 
Whilst 31% and 27% of keratinocytes surrounding senescent melanocytes display more than 
one TAF at days 10 and 21, respectively, only 7% and 4% of cells in the vicinity of proliferating 
melanocytes contain more than one dysfunctional telomere at the same time points (Figure 5.13 
C). Moreover, although there is a significant increase in the percentage of keratinocytes 
containing more than one TAF at 10 days when compared to day 0 in melanoderms containing 
proliferating melanocytes (P<0.05), a more striking time-dependent increase is observed in 
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melanoderms with senescent melanocytes, which remains significantly elevated at day 21 
(P<0.05) (Figure 5.13 C), suggesting that chronic exposure to senescent melanocytes promotes 
accumulation of cells containing dysfunctional telomeres.  
Overall, these results indicate that senescent melanocytes trigger paracrine DDR signalling in 
surrounding keratinocytes, both at telomeres and non-telomeric sites, and implicate senescent 
melanocytes as important sources of paracrine signalling that contributes to bystander damage 
induction in living epidermal equivalents. 
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Figure 5.13 – Senescent melanocytes induce paracrine telomeric and non-telomeric DDR 
signalling in neighbouring keratinocytes. Graphs showing (A) mean number of γH2AX foci 
in keratinocytes, (B) mean number of TAF in keratinocytes, and (C) percentage of keratinocytes 
containing more than 1 TAF in melanoderms containing proliferating or senescent melanocytes 
at the time points indicated. Data are mean ± S.E.M. of N=3 melanoderms for each condition. 
Statistical significance between groups was determined by a two-way ANOVA, and differences 
within groups was assessed by a one-way ANOVA (green and orange asterisks). *P<0.05, 
**P<0.01, ***P<0.001. (D) Representative immuno-FISH image of a melanoderm containing 
senescent melanocytes. Telomeres are shown in red, γH2AX is shown in green, melan-A is 
shown in pink, and blue represents DAPI. Arrows indicate co-localisation between γH2AX and 
telomeres, which is amplified on the right. Images were taken using a 63x objective. 
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5.6.4. Keratinocytes in melanoderms with senescent melanocytes have increased 
markers of oxidative DNA damage 
Since my previous in vitro data suggested that paracrine DNA damage was mediated by 
increased intracellular ROS in bystander cells, I wanted to investigate whether oxidative stress 
was also a mechanism of bystander DNA lesion formation in keratinocytes in human epidermal 
equivalents. For that, I performed immunofluorescence for 8-oxo-G, which is indicative of 
oxidative DNA damage, together with the melanocyte marker melan-A, in order to distinguish 
melanocytes from keratinocytes.  
Melanoderms with senescent melanocytes contain significantly more keratinocytes positive for 
8-oxo-G (P=0.009, red asterisks) (Figure 5.14 A, B). Moreover, post-hoc analysis within each 
time point revealed a significant difference at day 0 (P=0.04), when 79% of keratinocytes are 
positive for 8-oxoG in senescent melanocyte-containing melanoderms compared to 49% of 8-
oxo-G-positive cells in the proliferating counterpart. These results suggest that oxidative stress 
contributes to bystander DNA damage induction in keratinocytes, although further experiments 
are needed to confirm this in a model of human epidermal equivalent.  
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Figure 5.14 – Increased marker of oxidative DNA lesions in keratinocytes from 
melanoderms with senescent melanocytes. (A) Graph showing the percentage of 8-oxo-G-
positive keratinocytes in melanoderms containing proliferating or senescent melanocytes at the 
time points indicated. Data are mean ± S.E.M. of N=4 (proliferating) and N=3 (senescent) 
melanoderms. Statistical significance was determined by a two-way ANOVA with a Holm-
Sidak post-hoc test. Red asterisk indicates difference between melanoderms with proliferating 
and senescent melanocytes. *P<0.05, **P<0.01. (B) Representative 8-oxo-G 
immunofluorescence images of melanoderms containing either proliferating (top) or senescent 
(bottom) melanocytes. Red shows 8-oxo-G, green represents melan-A, and DAPI is shown in 
blue. The white dotted line represents the basal layer of the melanoderms. Images were taken 
using a 20x objective. 
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5.6.5. Accumulation of senescent melanocytes contributes to decreased epidermal 
thinning in melanoderms 
Having shown that senescent melanocytes trigger paracrine DDR signalling and senescence in 
keratinocytes, I then wanted to assess whether the presence of senescent melanocytes, and their 
resulting bystander effects, could contribute to characteristics associated with skin ageing. By 
measuring the epidermal thickness of melanoderms, I found that thickness significantly 
increased with time in epidermal equivalents containing proliferating melanocytes (green 
asterisks); however, this time-dependent increase was not observed in melanoderms containing 
senescent melanocytes (Figure 5.15 A). This suggests that senescent melanocytes impair the 
differentiation and proliferation of keratinocytes, which in this case, is necessary for epidermal 
differentiation and renewal. Moreover, melanoderms containing senescent melanocytes have a 
significantly thinner epidermis at day 21 compared to their proliferating counterpart (P<0.001) 
(Figure 5.15 A, B), suggesting that accumulation of senescent melanocytes contributes to age-
associated epidermal thinning. This likely occurs through their ability to exert paracrine effects 
that induce senescence in neighbouring keratinocytes.  
In summary, these results suggest that senescent melanocytes induce paracrine DNA damage 
and senescence in surrounding keratinocytes. Our data support the hypothesis that paracrine 
senescence compromises the proliferative potential of keratinocytes in the skin, consequently 
resulting in age-associated characteristics such as epidermal thinning.  
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Figure 5.15 – Senescent melanocytes contribute to epidermal thinning. (A) Graph showing 
epidermal thickness of melanoderms containing either proliferating or senescent melanocytes 
at the time points indicated. Data are mean ± S.E.M. of N=4 (proliferating) and N=3 (senescent) 
melanoderms. Statistical analysis between groups was determined by a two-way ANOVA, 
whereas differences within groups was assessed by a one-way ANOVA (green asterisks show 
statistical significance within melanoderms containing proliferating melanocytes). *P<0.05, 
**P<0.01, ***P<0.001. (B) Representative H&E images showing epidermal thickness of 
melanoderms containing proliferating or senescent melanocytes. Images were taken using a 20x 
objective.  
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 Discussion 
In this study, we provide evidence that senescent melanocytes induce paracrine DNA damage 
foci at both telomeric and non-telomeric regions in dermal fibroblasts in vitro, which is 
mediated by secretion of SASP factors. Indeed, previous studies have shown that fibroblasts 
undergoing both oncogene-induced and replicative senescence can trigger DNA damage in 
neighbouring, otherwise healthy, fibroblasts (Nelson et al., 2012; Acosta et al., 2013). Although 
one study only observed bystander DNA damage when cells were in direct co-culture, 
suggesting that transmission of soluble factors occurs through gap junctions (Nelson et al., 
2012), others have demonstrated that exposure to conditioned medium of senescent cells is 
sufficient to elicit paracrine effects (Acosta et al., 2013), corroborating our observations. Such 
disparities may be due to the composition or amount of secreted SASP factors, and may also 
depend on the senescence-inducing stimuli. Unpublished observations from our lab have shown 
that MRC5 fibroblasts secreted considerably less amounts of SASP factors, such as IL-6 and 
IL-8, than IMR90 fibroblasts. Moreover, recent work has demonstrated that different senescent 
cell types display large transcriptional heterogeneity (Hernandez-Segura et al., 2017), which 
may explain the differences in bystander effects observed in different studies. 
Importantly, exposure to senescent cells was shown to stimulate the generation of large DNA 
damage foci in bystander fibroblasts (Nelson et al., 2012). Large foci tend to remain unresolved 
for longer compared to smaller ones (Nelson et al., 2012), and in fact, the majority of long-
lived foci have been shown to co-localise with telomeres (Hewitt et al., 2012). Although the 
authors did not distinguish between paracrine telomeric and non-telomeric damage, this 
observation would be consistent with our results showing that telomere dysfunction is induced 
in bystander cells upon exposure to senescent melanocytes. Our results show that despite the 
increase in non-telomeric DNA damage foci in fibroblasts co-cultured with senescent 
melanocytes, this was not statistically significant. One possibility is that some of the paracrine 
damage induced by senescent melanocytes is repaired by fibroblasts; however, further 
experiments involving live-cell imaging or a more extensive time-course analysis would need 
to be conducted to achieve this conclusion. Alternatively, this observation could be attributed 
to the different microscopy system used in this experiment, which was shown to be more 
sensitive and detect a higher number of γH2AX foci than previously used systems. Since a large 
amount of DNA damage foci was detected in fibroblasts in all co-culture conditions, this 
possibly makes it difficult to identify any subtle significant differences. Nevertheless, 
conditioned medium from senescent melanocytes was sufficient to trigger non-telomeric DDR 
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activation in fibroblasts, which was observed both at 2 days and 30 days of exposure, suggesting 
that non-telomeric DNA damage is also induced by soluble factors from senescent melanocytes.  
Of note, senescent melanocyte conditioned medium did not significantly induce γH2AX foci in 
fibroblasts during the experiments involving rapamycin-treated melanocyte CM, which 
contradicts the other experiments using CM in this study. One likely explanation is that the 
fibroblasts used in the former experiments had a higher basal level of DNA damage foci, and 
in turn, any subtle changes in damage induction could not be detected. Another possibility is 
that melanocytes were only cultured for 24 hours in the conditioned medium used to treat 
fibroblasts in the experiments involving rapamycin, since leaving melanocytes without 
rapamycin for any longer could have resulted in reactivation of the SASP. In contrast, in other 
experiments involving the use of CM, melanocytes were left for four days before CM was 
collected. Therefore, it is possible that a higher concentration of pro-inflammatory factors was 
present in the latter, explaining the significant induction of γH2AX foci in bystander fibroblasts 
in these experiments. Nevertheless, soluble factors released by senescent melanocytes were 
sufficient to trigger TAF in all experiments involving the use of conditioned medium. It is likely 
that telomeres are more sensitive to subtle disturbances in intracellular homeostasis that may 
occur as a result of paracrine signalling activation. In fact, our results indicate that bystander 
telomeric and non-telomeric DNA damage can be prevented by scavenging mitochondrial ROS 
generation, suggesting that paracrine damage is mediated by signals that enhance ROS 
production. Indeed, telomeres have been shown to be more susceptible to oxidative damage 
when compared to the rest of the genome, with mild oxidative stress causing single-stranded 
breaks to preferentially accumulate at telomeres (Petersen et al., 1998; Oikawa and Kawanishi, 
1999). Therefore, despite only representing 0.02% of the genome (Fumagalli et al., 2012), 
telomeres might act as more sensitive sensors to subtle alterations in intracellular oxidative 
status.   
In our model of co-culture, inhibiting the SASP of senescent melanocytes by rapamycin did not 
reduce paracrine TAF induction. On the other hand, culturing fibroblasts with conditioned 
medium obtained from rapamycin-treated senescent melanocytes did not trigger telomere 
dysfunction in bystander cells, suggesting that inhibition of the SASP is sufficient to prevent 
paracrine DDR signalling induction in this case. One possible explanation for this disparity 
could be the experimental approach; rapamycin was removed from melanocytes 24 hours prior 
to setting up co-culture with fibroblasts, which means that at 48 hours of co-culture, when DNA 
damage foci were analysed, melanocytes had not been treated with rapamycin for 3 days. 
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Therefore, it is possible that mTOR was no longer being inhibited during the co-culture, 
allowing secretion of SASP factors by senescent melanocytes to be restored. This would explain 
how rapamycin-treated senescent melanocytes are still efficient in inducing paracrine DNA 
damage foci in fibroblasts. In order to confirm this, mTOR activity should be evaluated in 
rapamycin-treated senescent melanocytes up to 3 days following removal of rapamycin, which 
would allow us to obtain a better understanding of the kinetics of mTOR reactivation in the 
absence of pharmacological inhibition. Moreover, a cytokine array could be performed in 
conditioned medium obtained from these cells to determine whether secretion of pro-
inflammatory cytokines is reinstated by senescent melanocytes after rapamycin removal.  
Nevertheless, our results indicate that paracrine DDR signalling induction, both at telomeres 
and non-telomeric sites, is mediated by soluble factors released by senescent melanocytes, and 
these persist with prolonged exposure of fibroblasts to conditioned medium from senescent 
cells. In fact, there is a slight increase in the mean number of telomere-associated foci in 
bystander fibroblasts following 30 days of culture in senescent melanocyte CM when compared 
to 2 days. Although this could suggest that paracrine TAF are persistent, another possibility is 
that they are constantly generated and repaired by fibroblasts, thus explaining the constant 
levels of TAF in bystander fibroblasts with time. In order to further investigate this, live-cell 
imaging would need to be performed to follow individual foci, providing a better insight into 
their repair kinetics. Moreover, we also show that paracrine non-telomeric DDR also remains 
higher in fibroblasts exposed to soluble factors from senescent melanocytes, although the 
difference is not as striking as the increase in TAF. It is possible that a fraction of non-telomeric 
DNA lesions become repaired, as it has been shown that non-telomeric foci are short lived 
(Hewitt et al., 2012). Since our data suggest an involvement of ROS in paracrine damage 
formation, it is likely that these short-lived foci become constantly replenished by increased 
oxidative stress, as it has been shown to occur in replicative and stress-induced senescence 
(Passos et al., 2010). Indeed, persistent DDR signalling is an important effector of senescence, 
activating downstream CDK inhibitors, such as p16 as p21, that mediate the stable growth arrest 
(Campisi and d'Adda di Fagagna, 2007b). According to previous studies, as well as inducing 
DNA damage, senescent cells can trigger paracrine senescence (Nelson et al., 2012; Acosta et 
al., 2013), with one group reporting that paracrine proliferation arrest is dependent on p16 and 
p21, and thus fully resembles the senescence response (Acosta et al., 2013). Despite senescent 
melanocytes triggering DDR signalling in fibroblasts in our study, we only observed a small, 
albeit significant, decrease in proliferation in bystander cells, and other markers of senescence 
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were not upregulated (data not shown). This disparity could be due to the different experimental 
approaches used in these studies. For example, one group reported paracrine senescence only 
in a co-culture setting (Nelson et al., 2012), whereas others used either co-cultures or 
Transwells, which ensures that young and senescent cells are physically separated whilst still 
sharing the same culture medium (Acosta et al., 2013). In either case, proliferating cells are 
constantly exposed to factors freshly secreted from senescent cells, whereas in our study we 
used conditioned medium which had to be stored to be used for the duration of the experiments. 
Although multiple thaw and freeze cycles were avoided by storing CM in aliquots, we cannot 
exclude the possibility that soluble factors undergo some degree of degradation, and thus the 
paracrine effects we observe in our study are not as striking as in previous reports. Nevertheless, 
Acosta et al. demonstrated that conditioned medium from senescent cells induced growth arrest 
in normal fibroblasts 4 days after culture (Acosta et al., 2013). However, in this study, they 
used cells undergoing oncogene-induced senescence. It is possible that the SASP from OIS 
cells triggers stronger mitogenic responses in bystander cells, resulting in faster development 
of paracrine senescence, although further experiments are needed to confirm this.   
Our data suggest that paracrine DNA damage induction by senescent melanocytes is mediated 
by increased intracellular ROS in bystander fibroblasts, consistent with previous studies 
showing that bystander DDR signalling activation could be rescued by antioxidants (Nelson et 
al., 2012). It is possible that increased ROS leads to telomeric DNA damage by contributing to 
telomere shortening in bystander fibroblasts. Indeed, mild oxidative stress has been shown to 
accelerate the rate of loss of telomeric repeats (von Zglinicki et al., 1995; Xu et al., 2000; von 
Zglinicki, 2002; Saretzki et al., 2003), which can be rescued by genetic or pharmacological 
manipulations that reduce ROS levels (von Zglinicki, 2000; Saretzki et al., 2003; Serra et al., 
2003). It is believed that when telomeres reach a critical length, shelterin proteins can no longer 
bind, leading to uncapping of the protective structure. This is turn exposes the ends of telomeres, 
which are then recognised as DSBs by the DNA repair machinery, leading to DDR activation 
at chromosome ends (O'Sullivan and Karlseder, 2010). Although extensive shortening is not 
likely to occur within 48 hours, it is possible that prolonged exposure to SASP factors from 
senescent melanocytes could contribute to paracrine telomere damage in this way. 
Alternatively, oxidative DNA lesions have been shown to disrupt binding of TRF1 and TRF2 
at telomeres (Opresko et al., 2005), providing a mechanism for loss of shelterin components 
independently of shortening. In order to investigate the mechanisms involved in paracrine DDR 
activation at telomeres, future experiments should be performed whereby fibroblasts 
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overexpressing either telomerase or TRF2 are cultured with senescent melanocyte CM. This 
will allow us to determine if telomere damage in bystander cells occurs due to shortening or 
loss of shelterin, respectively. 
Although we did not investigate the mechanisms leading to enhanced ROS generation in 
bystander cells, we demonstrate that CXCR3 activation plays a role in transducing signals that 
contribute to paracrine DNA damage foci induction in fibroblasts (Figure 5.16). Interestingly, 
stimulation of the CXCR3 receptor has been shown to increase oxidative stress in human kidney 
cells  through Ca2+-dependent up-regulation of the transcription factor early growth response 
gene (EGR)-1 (Bek et al., 2003). In turn, the antioxidant enzymes copper-zinc superoxide 
dismutase and manganese superoxide dismutase are down-regulated, and activity of 
NADH/NADPH-oxidase is increased, contributing to ROS generation (Bek et al., 2003). 
Moreover, CXCR3 activation in human airway epithelial cells, which regulates epithelial cell 
movement, was shown to activate p38 MAPK (Shahabuddin et al., 2006). In the context of 
senescence, p38 has been involved in signalling pathways that lead to mitochondrial 
dysfunction, and consequently, enhanced ROS production, which is important for maintaining 
DDR signalling and growth arrest (Passos et al., 2010). Indeed, increased p38 activity has been 
reported in bystander fibroblasts co-cultured with senescent cells, suggesting a role for p38 
MAPK in paracrine senescence (Nelson et al., 2012). Although we demonstrate that bystander 
telomere damage can be prevented by inhibiting CXCR3 or by scavenging mitochondrial ROS, 
further experiments are needed to establish whether oxidative stress increases as a direct result 
of CXCR3 signalling in bystander fibroblasts. For example, ROS levels could be measured by 
FACS following stimulation of fibroblasts with the CXCR3 agonist, IP-10. Additionally, 
fibroblasts cultured with senescent melanocyte CM could be treated with both AMG487 and 
MitoQ, to investigate whether CXCR3 signalling and ROS act synergistically to trigger 
paracrine DNA damage. To further corroborate the role of CXCR3 activation in paracrine DDR 
signalling induction, fibroblasts following knock-down (shRNA) or knock-out (through 
CRISPR-CAS9) of CXCR3 should be treated with senescent melanocyte conditioned medium, 
and DNA damage should then be analysed. This would allow us to determine whether the 
effects seen with AMG487 can be replicated, as pharmacological manipulation might not result 
in full inhibition of the pathway. Moreover, immuno-FISH could be performed in IP-10-treated 
fibroblasts to further assess the consequence of direct CXCR3 activation on the DNA damage 
response. Future experiments could also be conducted in order to examine the role of p38 
MAPK activation in paracrine DNA damage induction. For example, p38 protein levels could 
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be assessed following culture of fibroblasts with senescent melanocyte CM. Moreover, 
paracrine DNA damage induction should be investigated following p38 inhibition in bystander 
fibroblasts.  
Intriguingly, inhibiting CXCR3 in fibroblasts did not rescue paracrine total γH2AX foci, 
whereas it was sufficient to prevent TAF induction. It is possible that differences were not 
identified due to the larger variability in the number of γH2AX foci in AMG487-treated 
fibroblasts cultured with senescent melanocyte CM. 
We have also demonstrated that CXCR3 is up-regulated in senescent melanocytes in vitro and 
in vivo in human skin with age. Moreover, we showed that signalling through CXCR3 is partly 
involved in the development of phenotypes associated with melanocyte senescence. Our results 
show that IP-10, a ligand of CXCR3, is highly secreted by stress-induced senescent 
melanocytes. This is consistent with studies showing that autophagy-deficient murine 
melanocytes, previously described to enter premature senescence, (Zhang et al., 2015), secrete 
significantly larger amounts of IP-10 compared to control cells (Ni et al., 2016). Inhibition of 
CXCR3 in senescent melanocytes was sufficient to significantly reduce markers of senescence 
such as Sen-β-Gal activity and p16 expression, although these phenotypes were not completely 
prevented. Moreover, despite a small reduction in DNA damage foci, DDR signalling was not 
significantly rescued by CXCR3 inhibition, suggesting that additional mechanisms are 
responsible for maintaining the DDR during melanocyte senescence. Additionally, the 
senescence-associated growth arrest was also not prevented by inhibiting CXCR3. It is possible 
that the persistent DDR observed in AMG487-treated cells provides the signalling necessary to 
continuously activate p21, and maintain the growth arrest (Passos et al., 2010). Consistently, 
our data demonstrate that p21 levels are not reduced by CXCR3 inhibition, likely explaining 
how proliferation is not rescued in these cells. Interestingly, mitochondrial ROS production was 
effectively reduced by preventing CXCR3 activity. As previously mentioned, CXCR3 
activation has been shown to induce oxidative stress in kidney cells (Bek et al., 2003), although 
the mechanisms leading to signal transduction from CXCR3 to mitochondrial ROS generation 
remain unknown. One possibility is that CXCR3 acts through p38, inducing mitochondrial 
dysfunction and oxidative stress, as discussed above. Moreover, activation of PI3K/Akt also 
occurs downstream of CXCR3 signalling (Bonacchi et al., 2001; Shahabuddin et al., 2006), 
consistent with our data showing that CXCR3 inhibition reduces Akt phosphorylation in X-ray 
irradiated melanocytes. In fact, Akt has been involved in signalling cascades that converge 
signals from the DDR into PGC-1β-dependent mitochondrial biogenesis, contributing to 
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increased ROS generation (Correia-Melo et al., 2016). Therefore, it is possible that CXCR3 
contributes to mitochondrial oxidative stress via Akt, although further experiments are needed 
in order to confirm this. Furthermore, ERK phosphorylation has also been reported to occur as 
a result of CXCR3 activation (Shahabuddin et al., 2006; Jenkins et al., 2015); however, its 
involvement in the induction of melanocyte senescence remains elusive from our results. 
Although ERK appears to be initially activated in response to irradiation, with CXCR3 
inhibition reducing p-ERK levels at 8 hours, total ERK expression seems to gradually decrease 
in irradiated cells. Therefore, further analysis is needed in order to corroborate the involvement 
of ERK activation during stress-induced melanocyte senescence. Moreover, we cannot fully 
conclude that these signalling pathways are activated as a result of CXCR3 activation in our 
model. Further experiments should be conducted using the agonist IP-10 to determine whether 
direct CXCR3 activation leads to up-regulation of the aforementioned pathways, and to assess 
whether it also induces melanocyte senescence. Interestingly, CXCR3 signalling has been 
shown to mediate IL-8 expression in BRAFWT melanoma cells, which was shown to be 
dependent on the MEK/ERK pathway (Jenkins et al., 2015). Therefore, future work should also 
be performed to investigate the SASP of senescent melanocytes following CXCR3 inhibition. 
Overall, these results suggest that although CXCR3 signalling contributes, in part, to the 
establishment of melanocyte senescence, other mechanisms are also involved in this process, 
since CXCR3 inhibition only partly rescues senescence-associated phenotypes.  
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Figure 5.16 - Possible mechanisms contributing to ROS production and DNA damage in 
bystander cells. Senescent melanocytes (yellow cells) secrete soluble factors, such as IP-10, 
(indicated in red) which triggers an increase in ROS and telomere damage in surrounding cells 
(grey cells). Activation of CXCR3 has been shown to induce pathways that contribute to 
increased ROS production. For example, CXCR3 stimulation can activate the MEK/ERK 
pathway (Jenkins et al., 2015), and this favours ROS generation through up-regulation of the 
EGR-1 transcription factor, which down-regulates the antioxidant enzymes Cu-Zn dismutase 
and mitochondrial SOD2 (Bek et al., 2003). It is also possible that MEK/ERK contributes to 
ROS production via NF-κB activation (Monturiol-Gross et al., 2014). In addition, activation of 
the PI3K/Akt pathway has also been shown to occur downstream of CXCR3 signalling 
(Bonacchi et al., 2001; Shahabuddin et al., 2006). Akt can promote PGC-1β-dependent 
mitochondrial biogenesis, which in turn leads to increased oxidative stress (Correia-Melo et al., 
2016). Moreover, Akt can also activate p38 (Shahabuddin et al., 2006), and the latter has been 
involved in signalling pathways that lead to mitochondrial dysfunction, thus enhancing ROS 
production (Passos et al., 2010). Although, from our data, we cannot conclude that these 
pathways are activated in bystander cells, it is possible that they contribute to oxidative stress. 
Ultimately, increased ROS generation contributes to telomeric and non-telomeric DNA damage 
in bystander cells.  
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Although exposure to senescent melanocyte CM was not able to induce senescence in dermal 
fibroblasts over a period of 20 days, we did observe a small reduction in proliferation. This 
effect is relatively mild compared to paracrine senescence induced by OIS cells, where loss of 
proliferation and induction of senescence markers is observed after a few days (Acosta et al., 
2013). Nonetheless, we provide evidence that senescent melanocytes can trigger paracrine 
senescence in keratinocytes in a three-dimensional human epidermal equivalent, or 
melanoderms. Indeed, our data show that keratinocytes in melanoderms with senescent 
melanocytes have decreased proliferative potential, and increased p16 expression, suggesting 
that senescent melanocytes induce paracrine senescence in keratinocytes. Interestingly, the 
majority of Ki-67-positive keratinocytes were located in the basal layer of melanoderms, which 
likely reflects the fact that keratinocytes become fully differentiated and lose their proliferative 
capacity as they migrate up the epidermis (Elias et al., 1977).  Although there was a trend for 
increased γH2AX foci in keratinocytes cultured with senescent melanocytes, this was not 
statistically significant. On the other hand, these cells accumulate significantly higher numbers 
of dysfunctional telomeres compared to keratinocytes from melanoderms with proliferating 
melanocytes, suggesting that senescent melanocytes also trigger paracrine TAF in neighbouring 
keratinocytes. As previously mentioned, dysfunctional telomeres provide a source of persistent 
DDR that is important for the initiation and maintenance of senescence (Fumagalli et al., 2012; 
Hewitt et al., 2012). Indeed, triggering telomere dysfunction in keratinocytes by overexpressing 
a dominant-negative version of TRF2, which causes uncapping, induces senescence in these 
cells, suggesting that telomere damage is a trigger of keratinocyte senescence (Minty et al., 
2008).  
Intriguingly, we observe a small decrease in both the number of TAF and the percentage of 
keratinocytes containing more than one TAF at day 21 compared to day 10 in melanoderms 
containing senescent melanocytes. It is possible that some damaged telomeres become repaired, 
as recent studies have provided evidence that homologous recombination and alt-NHEJ occur 
at telomeres in response to DSBs (Doksani and de Lange, 2016; Mao et al., 2016). Another 
scenario is that keratinocytes with high numbers of dysfunctional telomeres, or senescent, 
undergo cell death. Consistent with this, studies have shown that senescent keratinocytes 
undergo autophagic programmed cell death in culture (Gosselin et al., 2009). The authors 
suggest that accumulation of DNA damage and dysfunctional mitochondria triggers autophagic 
degradation of nuclei and mitochondria, respectively, resulting in senescent keratinocyte death 
in vitro (Gosselin et al., 2009). Moreover, keratinocyte senescence has been associated with 
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increased levels of the mitochondrial antioxidant enzyme, manganese superoxide dismutase 
(MnSOD), which is responsible for converting oxygen radicals into H2O2 (Bernard et al., 2004). 
This is turn increases oxidative stress since catalase and glutathione peroxidase, which convert 
H2O2 into H2O, were not up-regulated, thus contributing to keratinocyte senescence (Bernard et 
al., 2004). It was later demonstrated that overexpression of MnSOD or H2O2 treatment could 
induce keratinocyte senescence with phenotypes resembling replicative senescence (Deruy et 
al., 2010). These cells displayed increased oxidative DNA damage as well as accumulation of 
damaged mitochondria, and underwent autophagic cell death as a result of oxidative stress 
(Deruy et al., 2010). Furthermore, we also observe a small decline in p16-positive keratinocytes 
in melanoderms containing senescent melanocytes between days 10 and 21, which would agree 
with the hypothesis that paracrine keratinocyte senescence partly contributes to cell death. 
However, further experiments are needed to confirm this hypothesis.   
Although there was a small increase in the frequency of TAF in melanoderms with proliferating 
melanocytes at day 10, this was not significant, and it could be a result of cell culture stress. 
Alternatively, it is possible that a fraction of these cells are undergoing senescence due to 
replicative exhaustion or other stresses, since a small increase in p16-positive keratinocytes is 
also observed at the same time point in these melanoderms.  
Our results also demonstrated accumulation of oxidative DNA damage in keratinocytes from 
melanoderms with senescent melanocytes. It is possible that increased oxidative stress mediates 
paracrine telomere dysfunction and senescence in keratinocytes, similarly to our data in dermal 
fibroblasts in culture. However, since the levels of 8-oxo-G are high in melanoderms containing 
both proliferating and senescent melanocytes, it is difficult to determine the extent of the 
contribution of ROS generation to paracrine DNA damage in these models. Nevertheless, 
studies have demonstrated that deletion of Sod2 (also known as MnSOD) specifically in 
keratinocytes induces mitochondrial oxidative stress and senescence, and results in delayed 
wound closure and epidermal thinning in mice (Velarde et al., 2015). As previously discussed 
in chapter 3, such phenotypes were attributed to premature senescence of transit-amplifying 
cells of the epidermis, which are needed for epidermal expansion. Since TA cells arise from 
stem cells, this exerts a strain on the stem cell population, ultimately leading to their depletion 
(Velarde et al., 2015). Although we cannot conclude that paracrine keratinocyte senescence is 
mediated by oxidative stress, published data suggest that enhanced ROS generation is a major 
trigger of keratinocyte senescence and an important contributor skin ageing phenotypes. 
Therefore, future experiments should include human epidermal equivalents generated with 
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keratinocytes overexpressing antioxidant enzymes. This would allow us to further explore the 
role of oxidative stress in bystander DNA damage induction and paracrine senescence triggered 
by senescent melanocytes. 
We also demonstrate for the first time that senescent melanocytes contribute to epidermal 
thinning of human epidermal equivalents, likely through inducing paracrine senescence in 
keratinocytes. Interestingly, living skin equivalent models using neonatal fibroblasts and 
senescent keratinocytes show decreased epidermal thickness, which can be rescued by silencing 
p16 expression in keratinocytes (Adamus et al., 2014). This suggests that accumulation of 
senescent keratinocytes contributes to skin ageing characteristics, such as epidermal thinning. 
However, in human skin in vivo, the majority of p16-positive cells in the epidermis have been 
shown to be melanocytes (Waaijer et al., 2012b; Waaijer et al., 2016b). It is possible that 
senescent keratinocytes are not retained in the epidermis in vivo, and become shed off as a result 
of the natural cycle of epidermal differentiation, which in fact occurs at a slower rate in older 
individuals (Fore, 2006). Alternatively, senescent keratinocytes could undergo cell death, as 
previously discussed, and thus age-associated epidermal changes could be partly a consequence 
of keratinocyte loss with age. Given that proliferation of stem and progenitor cells is also crucial 
for epidermal regeneration and homeostasis, it would also be important to assess the bystander 
effects of senescent melanocytes on epidermal stem cells. However, since our models do not 
comprise stem cells, it can be postulated that paracrine keratinocyte senescence triggered by 
senescent melanocytes is sufficient to affect the regenerative capacity of the epidermis. The 
finding that the presence of senescent melanocytes is sufficient to contribute to epidermal 
thinning in melanoderms contradicts our results in human skin in vivo, where we did not find a 
correlation between TAF in melanocytes and age-related epidermal thinning. However, it is 
important to note that in melanoderms, all melanocytes present are senescent, whereas in human 
skin only about 8% of melanocytes are p16-positive in older donors. Therefore, one possibility 
is that the effects exerted by senescent melanocytes in melanoderms are much more acute when 
compared to an in vivo setting. Another possibility is that the older human donor cohort used in 
our study are offspring of long-lived individuals, which could confer an advantage to these 
subjects in terms of milder skin ageing phenotypes compared to the general population. 
However, previous studies conducted on the same cohort did not find a slower rate of skin 
ageing (measured as epidermal thinning and flattening) in offspring of long-lived individuals 
when compared to their partners, which represent the general population (Waaijer et al., 2012a). 
Therefore, it is unlikely that our observations were confounded by familial longevity. 
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Moreover, the living epidermal equivalents also have other limitations, such that it lacks other 
skin layers and cell types, including immune cells, which may also play a role during the skin 
ageing process. Nonetheless, given that confounding factors from other components are not 
present in these models, they serve as useful tools to help dissect the role of senescent 
melanocytes in skin ageing. Although we hypothesise that the paracrine effects observed in 
melanoderms are due to the SASP of senescent melanocytes, we have not directly demonstrated 
that this is the case. It will be important to determine if melanoderms containing senescent 
melanocytes have increased levels of inflammatory factors by immunofluorescence, for 
example. Moreover, we cannot exclude the possibility that other mechanisms are involved in 
paracrine DDR signalling and keratinocyte senescence in melanoderms. Melanocytes are in 
direct contact with neighbouring keratinocytes through dendritic processes, which mediate 
melanin transport, and such interaction is also known as the epidermal melanin unit (Haass and 
Herlyn, 2005). Interestingly, senescent melanocytes have increased melanin content (Horikoshi 
et al., 1991; Bandyopadhyay and Medrano, 2000), and studies have shown that an increased 
pheomelanin: eumelanin ratio increases oxidative stress in melanocytes and sensitises these 
cells to UV-induced DNA damage (Wenczl et al., 1998; Smit et al., 2001). Although it has not 
been previously established whether senescent melanocytes contain a higher pheomelanin to 
eumelanin ratio, an interesting scenario is that senescent melanocytes might transport increased 
levels of pheomelanin to surrounding keratinocytes. In turn, this could contribute to oxidative 
stress, and lead to paracrine DNA damage and senescence of neighbouring keratinocytes. In 
order to further explore this possibility, future experiments could involve the measurement of 
melanin pigments in melanoderms with proliferating or senescent melanocytes, providing 
valuable insight into whether senescent melanocytes cause preferential accumulation of 
pheomelanin in surrounding keratinocytes.  
Moreover, our in vitro studies with dermal fibroblasts indicate that CXCR3 signalling plays a 
role in paracrine DDR signalling triggered by senescent melanocytes. Further experiments 
should investigate whether CXCR3 activation also mediates paracrine senescence in human 
epidermal equivalents, allowing us to determine its contribution to skin ageing phenotypes. As 
previously mentioned, studies have demonstrated that Akt is one of the downstream targets of 
CXCR3 in both human airway epithelial cells and vascular pericytes (Bonacchi et al., 2001; 
Shahabuddin et al., 2006). Interestingly, Akt phosphorylation has been recently shown to 
increase in epidermal cells of mouse skin with age, with a concomitant increase in NF-κB 
activation (Chen et al., 2017), a transcription factor responsible for regulating expression of 
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many SASP factors (Chien et al., 2011b). Pharmacological inhibition of Akt by perifosine 
treatment resulted in reduced NF-κB activity in the mouse epidermis, whereas Akt activation 
induced NF-κB signalling (Chen et al., 2017). Although the phenotypical consequences of these 
interventions were not investigated by the authors, these results suggest that increased Akt 
activity acts through NF-κB to promote a pro-inflammatory environment that could contribute 
to skin ageing. Future studies should assess whether senescent melanocytes can promote 
activation of CXCR3 in keratinocytes in a paracrine manner, and to investigate the downstream 
signalling pathways that are activated as a result. Another interesting observation is that CXCR3 
and its ligands (MIG, IP-10 and I-TAC) have been shown to be up-regulated in keratinocytes 
following UVB irradiation of a 3D epidermal equivalent (Kurata et al., 2010). UVB-induced 
pigmentation, which is partly mediated by pro-inflammatory paracrine signalling between 
keratinocytes and melanocytes, could be mimicked by treating keratinocyte-melanocyte co-
cultures with CXCR3 ligands, whereas melanin levels were reduced by downregulating 
CXCR3 expression in these co-cultures (Kurata et al., 2010). These results suggest that CXCR3 
signalling is involved in the UVB-induced inflammatory response that mediates melanin 
synthesis and pigmentation (Kurata et al., 2010). Given that UV exposure is also associated 
with senescence of both keratinocytes (Lewis et al., 2008) and melanocytes (shown by our 
studies), and that melanogenesis has been linked to melanocyte senescence (Bandyopadhyay 
and Medrano, 2000), it would be interesting to further investigate the role of CXCR3 signalling 
in paracrine keratinocyte senescence.  
Previous data have shown that mTOR activity is increased during the initiation of senescence, 
resulting in increased mitochondrial biogenesis which may drive the SASP (Correia-Melo et 
al., 2016). These results are consistent with other studies showing that mTOR activity, 
measured as phosphorylated S6, is increased during early time points after X-ray irradiation but 
it remains unchanged at later time points (Laberge et al., 2015). Our results show decreased 
mTOR activity in senescent melanocytes despite our observation that mTORC1 inhibition by 
rapamycin diminishes the SASP. It is possible that low mTOR activity in senescent melanocytes 
is still sufficient to regulate the pathways shown to be responsible for the SASP, namely protein 
translation (Herranz et al., 2015; Laberge et al., 2015) and mitochondrial biogenesis (Correia-
Melo et al., 2016). It should be noted that our results need to be independently confirmed as 
mTORC1 activity was only assessed in one independent experiment. Secondly, a more 
extensive kinetics of mTORC1 activity should be performed in melanocytes in order to assess 
whether up-regulation occurs during earlier time points following senescence-inducing stimuli. 
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In addition, it is possible that other mechanisms, such as p38MAPK, also play a role in 
regulating the SASP in senescent melanocytes. In fact, inhibition of p38 activity has been shown 
to reduce the secretion of a number of SASP factors in human fibroblasts, and the kinetics of 
p38 activation was very similar to the kinetics of early and mature SASP development, 
suggesting that it plays an important role in SASP regulation (Freund et al., 2011). However, 
further experiments would need to be conducted to determine the role of p38 in the development 
of the SASP in senescent melanocytes.  
In summary, our results indicate that soluble factors secreted by senescent melanocytes can 
induce paracrine DNA damage foci in both skin fibroblasts and keratinocytes, which is 
mediated by increased oxidative stress in bystander cells. More specifically, we have shown 
that CXCR3 signalling plays a role in paracrine TAF induction in fibroblasts, although the role 
of CXCR3 in paracrine keratinocyte senescence remains to be elucidated. Furthermore, we have 
shown for the first time that accumulation of senescent melanocytes can contribute to skin aging 
phenotypes, such as epidermal thinning. This likely occurs through their ability to induce 
paracrine senescence in surrounding keratinocytes, thus compromising epidermal regeneration. 
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Chapter 6: Conclusions 
Senescent cells have been shown to accumulate in a variety of mammalian tissues with age, and 
more recently, have been implicated causally in the development of age-related pathologies 
(Baker et al., 2011; Baker et al., 2016). Indeed, accumulation of senescent cells has been 
reported in human skin with age (Dimri et al., 1995; Ressler et al., 2006), with studies 
suggesting that senescent cells contribute to age-associated skin characteristics by 
compromising regeneration and structure (Adamus et al., 2014; Velarde et al., 2015). However, 
the majority of studies on senescence in the skin concentrate on dermal fibroblasts and 
keratinocytes, whereas the role of senescent melanocytes during skin ageing remains poorly 
understood. Moreover, telomere shortening has been documented in replicative melanocyte 
senescence in vitro (Bandyopadhyay et al., 2001), and dysfunctional telomeres were shown to 
accumulate in OIS melanocytic nevi in vivo (Suram et al., 2012); however, the contribution of 
telomere dysfunction to melanocyte senescence in response to other senescence-inducing 
stimuli remains understudied. Given that: (i) differentiated melanocytes rarely divide in vivo 
(Cichorek et al., 2013), making it less likely for them to undergo extensive proliferation-driven 
telomere shortening and senescence during ageing; and (ii) a fraction of melanoma cases arise 
from nevi (Goldstein and Tucker, 2013); perhaps these reasons provide a rationale for many 
studies giving more emphasis to oncogene-induced melanocyte senescence (Haferkamp et al., 
2009; Suram et al., 2012; Vredeveld et al., 2012). Therefore, in this study, I aimed to 
characterise melanocyte senescence both in human skin ageing in vivo and in different in vitro 
models, and determine the involvement of telomere dysfunction in this process. Given that 
senescent cells have also been shown to induce paracrine DNA damage and senescence in 
neighbouring cells (Nelson et al., 2012; Acosta et al., 2013), I also aimed to investigate whether 
soluble factors secreted by senescent melanocytes could act in a non-cell autonomous manner, 
and as a result, contribute to skin ageing phenotypes. 
We have shown that senescent melanocytes accumulate in human skin with age, and that the 
frequency of damaged telomeres is higher in melanocytes in the skin of older donors. 
Furthermore, we demonstrated that telomere dysfunction occurs during replicative and stress-
induced (X-ray and UV irradiation) melanocyte senescence in vitro, suggesting a role for 
telomere-associated foci during this process both in vivo and in culture. Interestingly, although 
telomere shortening was observed in replicative senescent melanocytes in vitro, we observed 
that telomere dysfunction also occurred irrespectively of length in replicative, X-ray- and UV-
induced senescence in vitro. Moreover, we found that longer telomeres preferentially 
Chapter 6   Conclusions 
214 
 
accumulate γH2AX foci in melanocytes in human skin in vivo. Damage at telomeres that are 
not critically short has been previously reported in hippocampal neurons and liver hepatocytes 
of aged baboons (Fumagalli et al., 2012), in mouse hepatocytes (Hewitt et al., 2012), and in 
human melanocytic nevi (Suram et al., 2012), suggesting that telomere attrition is not the sole 
cause of telomere dysfunction. In fact, it has been suggested that long telomeres may offer a 
more abundant target for DNA damage to occur (Fumagalli et al., 2012). In addition, we did 
not observe significant differences in telomere length between melanocytes in young and aged 
skin, supporting the hypothesis that damage does not occur primarily as a result of shortening 
in melanocytes in vivo. The lack of significant telomere erosion with age could be a 
consequence of the low replication rate of fully differentiated melanocytes in the skin, and other 
factors might play a more dominant role in causing telomere damage. However, we cannot 
exclude the possibility that loss of telomeric repeats contribute to DDR activation at telomeres 
in senescent melanocytes in vivo. It is possible that critically short telomeres do not contain 
sufficient tandem repeats for the PNA probe to bind, or they might generate very weak signals 
that cannot be detected by the microscopy methods used in our study. Alternatively, high signal 
intensity values could represent aggregates of multiple dysfunctional telomeres, as previously 
shown to occur in fibroblasts (Kaul et al., 2011), and these cannot be distinguished due to the 
limited resolution of imaging. Although the main stimulus responsible for triggering senescence 
in melanocytes in vivo is still unclear, our results show that telomere dysfunction may play a 
role in this process.  
Moreover, the mechanisms contributing to telomere dysfunction in melanocytes in vivo remain 
to be elucidated. Although we have demonstrated that replicative and stress-induced 
melanocyte senescence are accompanied by increased oxidative stress in culture, reducing 
mitochondrial ROS by MitoQ only caused a mild decrease Sen-β-Gal activity. However, other 
markers of senescence will need to be evaluated in order to determine the role of ROS in the 
induction of melanocyte senescence. Nevertheless, mild oxidative stress has been shown to 
induce SSB accumulation preferentially at telomeres, which accelerates telomere shortening 
and triggers premature senescence (Petersen et al., 1998; von Zglinicki, 2000; von Zglinicki, 
2002). In fact, telomeres are thought to be more sensitive to oxidative damage compared to the 
bulk of the genome due to their high content of guanine triplets, which are highly susceptible 
to oxidative modifications (Oikawa and Kawanishi, 1999). Furthermore, oxidative telomeric 
damage has been shown to displace shelterin proteins such as TRF1 and TRF2, leading to 
uncapping, and consequently triggering activation of a DDR at telomeres (Opresko et al., 2005). 
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However, DDR signalling at telomeres that still retain shelterin proteins has been demonstrated 
in melanocytic nevi in vivo (Suram et al., 2012) and in replicative senescent fibroblasts in vitro 
(Kaul et al., 2011), suggesting that telomere uncapping does not always precede DDR 
activation. In order to further elucidate the mechanisms leading to telomere dysfunction in 
senescent melanocytes in our study, future experiments need to be performed to investigate 
whether shelterin components are lost from dysfunctional telomeres in melanocytes.  Although 
from our data we cannot conclude that telomere damage is a direct consequence of enhanced 
ROS generation, it is likely that ROS contributes to the accumulation of dysfunctional telomeres 
during melanocyte senescence. In agreement with a role of oxidative stress in TAF generation, 
treatment of fibroblasts with MitoQ prevented paracrine TAF induced by senescent melanocyte 
CM, suggesting that increased mitochondrial ROS contributes to telomere dysfunction. 
Furthermore, inducing mitochondrial dysfunction and oxidative stress by Sod2 deletion, causes 
accumulation of DNA damage foci in the skin of mice (Velarde et al., 2012), suggesting that 
ROS are also major contributors to DNA breaks in the skin in vivo.    
The precise number of damaged telomeres necessary to induce senescence is not fully known; 
however, given the fact that a few TAF are also observed in young and proliferating 
melanocytes, it is likely that cells can tolerate a certain level of telomere damage, suggesting 
that DDR signalling at telomeres must surpass a threshold level in order to initiate senescence. 
It has been reported that accumulation of five dysfunctional telomeres precedes the initiation 
of replicative senescence in human fibroblasts and epithelial cells in culture (Kaul et al., 2011). 
Others have shown that fibroblasts undergoing senescence due to genotoxic stresses have an 
average of 2 TAF (Hewitt et al., 2012), and senescence of liver hepatocytes and intestinal 
enterocytes is associated with 1-2 TAF in a mouse model of chronic inflammation (nfkb1-/-) 
(Jurk et al., 2014). Our results suggest that an average of 1 dysfunctional telomere is associated 
with replicative, X-ray- and UV-induced melanocyte senescence in vitro and with melanocyte 
ageing in vivo, with 83%, 61%, 57% of and 87% of melanocytes, respectively, displaying at 
least one TAF. However, given the limitations of the methods used to analyse telomere damage, 
such that dysfunctional telomeres might aggregate or not be detected at all, it might be difficult 
to establish an absolute number of damaged telomeres required to induce senescence. 
Nevertheless, the presence of shelterin proteins hinders the repair of DNA damage at telomeres 
(Kruk et al., 1995; Bombarde et al., 2010), consistent with our results showing that telomere 
damage is not repaired in senescent melanocytes. This results in persistent DDR signalling at 
telomeres (Fumagalli et al., 2012; Hewitt et al., 2012), which is important for the initiation and 
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maintenance of the senescent state (d'Adda di Fagagna et al., 2003; Takai et al., 2003; Jacobs 
and de Lange, 2004). Therefore, TAF may also play a role in the initiation of melanocyte 
senescence. 
Interestingly, the majority of p16-positive cells in the epidermis of human skin have been shown 
to be melanocytes (Waaijer et al., 2012b; Waaijer et al., 2016b), which were associated with 
increased facial wrinkling, higher perceived age, and age-associated elastin morphology 
(Waaijer et al., 2016b). Despite these associations, the consequences of senescent melanocyte 
accumulation during skin ageing have not been previously explored. Here, we demonstrated 
that senescent melanocytes can induce paracrine DNA damage, both at telomeres and non-
telomeric sites, and senescence in neighbouring cells. Bystander DNA damage induction was 
shown to be mediated by pro-inflammatory soluble factors secreted by senescent melanocytes, 
consistent with previous data showing paracrine damage induction by fibroblasts (Nelson et al., 
2012; Acosta et al., 2013). Our results indicate that paracrine signalling enhances ROS 
generation in bystander cells, in turn causing DNA damage accumulation in these cells. 
Although the SASP of senescent melanocytes was only able to induce a small decrease in 
proliferation in dermal fibroblasts, our experiments using three-dimensional human epidermal 
equivalents revealed that senescent melanocytes trigger paracrine senescence in surrounding 
keratinocytes, and contribute to epidermal thinning, a characteristic associated with skin ageing. 
Despite our data in human skin in vivo showing that TAF in melanocytes only correlates with 
loss of epidermal curvature and not with epidermal thinning, it is possible that a larger cohort 
is required to establish stronger associations between melanocyte senescence and other features 
of skin ageing in human donors.  
We have also shown that CXCR3 is up-regulated in senescent melanocytes in vitro and in 
human skin with age, and that CXCR3 signalling is partly involved in the induction of 
melanocyte senescence. Moreover, our results demonstrated that CXCR3 activation in 
bystander cells plays a role in paracrine TAF induction by senescent melanocytes. We postulate 
that IP-10 released by senescent melanocytes activates CXCR3 signalling in bystander cells, 
which in turn contributes to oxidative stress and DNA damage accumulation. However, further 
experiments are required to corroborate this hypothesis. Moreover, in order to further assess the 
role of CXCR3 signalling in the paracrine effects of senescent melanocytes, it will be important 
to determine whether CXCR3 is up-regulated in melanoderms. 
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Overall, we show that senescent melanocytes accumulate in human skin with age, and that 
telomere dysfunction occurs independently of length in this process. Furthermore, we 
demonstrate for the first time that senescent melanocytes can induce paracrine DNA damage 
and senescence in neighbouring cells, and contribute to epidermal thinning. We hypothesise 
that accumulation of senescent melanocytes with age compromises keratinocyte proliferation 
in a paracrine manner, in turn affecting epidermal turnover, and contributing epidermal changes 
associated with human skin ageing.   
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